<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7911163</article-id><article-id pub-id-type="pmid">33573169</article-id><article-id pub-id-type="doi">10.3390/nu13020462</article-id><article-id pub-id-type="publisher-id">nutrients-13-00462</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Detopoulou</surname><given-names>Paraskevi</given-names></name><xref ref-type="aff" rid="af1-nutrients-13-00462">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2038-4411</contrib-id><name><surname>Demopoulos</surname><given-names>Constantinos A.</given-names></name><xref ref-type="aff" rid="af2-nutrients-13-00462">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7071-5920</contrib-id><name><surname>Antonopoulou</surname><given-names>Smaragdi</given-names></name><xref ref-type="aff" rid="af3-nutrients-13-00462">3</xref><xref rid="c1-nutrients-13-00462" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Barbagallo</surname><given-names>Mario</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-13-00462"><label>1</label>Department of Clinical Nutrition, General Hospital Korgialenio Benakio, 11526 Athens, Greece; <email>viviandeto@gmail.com</email></aff><aff id="af2-nutrients-13-00462"><label>2</label>Laboratory of Biochemistry, Faculty of Chemistry, National &#x00026; Kapodistrian University of Athens, 16121 Athens, Greece; <email>demopoulos@chem.uoa.gr</email></aff><aff id="af3-nutrients-13-00462"><label>3</label>Laboratory of Biology, Biochemistry and Microbiology, Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 70 El. Venizelou Street, 17671 Athens, Greece</aff><author-notes><corresp id="c1-nutrients-13-00462"><label>*</label>Correspondence: <email>antonop@hua.gr</email>; Tel.: +30-210-954-9230; Fax: +30-210-957-7050</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>462</elocation-id><history><date date-type="received"><day>29</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The new coronavirus disease 2019 (COVID-19) pandemic is an emerging situation with high rates of morbidity and mortality, in the pathophysiology of which inflammation and thrombosis are implicated. The disease is directly connected to the nutritional status of patients and a well-balanced diet is recommended by official sources. Recently, the role of platelet activating factor (PAF) was suggested in the pathogenesis of COVID-19. In the present review several micronutrients (vitamin A, vitamin C, vitamin E, vitamin D, selenium, omega-3 fatty acids, and minerals), phytochemicals and Mediterranean diet compounds with potential anti-COVID activity are presented. We further underline that the well-known anti-inflammatory and anti-thrombotic actions of the investigated nutrients and/or holistic dietary schemes, such as the Mediterranean diet, are also mediated through PAF. In conclusion, there is no single food to prevent coronavirus Although the relationship between PAF and COVID-19 is not robust, a healthy diet containing PAF inhibitors may target both inflammation and thrombosis and prevent the deleterious effects of COVID-19. The next step is the experimental confirmation or not of the PAF-COVID-19 hypothesis.</p></abstract><kwd-group><kwd>platelet activating factor</kwd><kwd>thrombosis</kwd><kwd>inflammation</kwd><kwd>Mediterranean diet</kwd><kwd>PAF-inhibitors</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-13-00462"><title>1. Introduction</title><p>The new coronavirus disease 2019 (COVID-19) pandemic is an emerging situation with high rates of infectivity, morbidity and mortality [<xref rid="B1-nutrients-13-00462" ref-type="bibr">1</xref>]. The pathophysiology of the disease involves a cytokine storm and the activation of thrombotic pathways [<xref rid="B2-nutrients-13-00462" ref-type="bibr">2</xref>]. It was recently documented in Wuhan, China, that the disease is directly connected to the nutritional status of severely and critically ill patients [<xref rid="B3-nutrients-13-00462" ref-type="bibr">3</xref>]. Although &#x0201c;there is no diet to prevent coronavirus&#x0201d; [<xref rid="B4-nutrients-13-00462" ref-type="bibr">4</xref>] and there are limited applied clinical nutrition protocols for COVID-19 patients [<xref rid="B5-nutrients-13-00462" ref-type="bibr">5</xref>,<xref rid="B6-nutrients-13-00462" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-13-00462" ref-type="bibr">7</xref>], the focus of the international community shifts to recommending a healthy dietary pattern [<xref rid="B8-nutrients-13-00462" ref-type="bibr">8</xref>], intended to control inflammation and thrombosis, which accompany the syndromes&#x02019; complications [<xref rid="B2-nutrients-13-00462" ref-type="bibr">2</xref>]. Indeed, a well-balanced diet ensures the proper functioning of the immune system [<xref rid="B4-nutrients-13-00462" ref-type="bibr">4</xref>] and several micro-constituents alone or as part of a healthy dietary pattern, such as the Mediterranean diet, play a role in viral infections [<xref rid="B9-nutrients-13-00462" ref-type="bibr">9</xref>], inflammation [<xref rid="B10-nutrients-13-00462" ref-type="bibr">10</xref>] and thrombosis [<xref rid="B11-nutrients-13-00462" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-13-00462" ref-type="bibr">12</xref>]. A key molecule implicated in COVID-19 pathology is platelet activating factor (PAF), as recently highlighted by our group [<xref rid="B2-nutrients-13-00462" ref-type="bibr">2</xref>,<xref rid="B13-nutrients-13-00462" ref-type="bibr">13</xref>]. More particularly, PAF is a glyceryl-ether phospholipid (1-O-alkyl-2-acetyl-<italic>sn</italic>-glycero-3-phosphocholine) [<xref rid="B14-nutrients-13-00462" ref-type="bibr">14</xref>], which is a potent mediator of inflammation and thrombosis [<xref rid="B15-nutrients-13-00462" ref-type="bibr">15</xref>,<xref rid="B16-nutrients-13-00462" ref-type="bibr">16</xref>]. It is produced by various cells such as platelets, endothelial cells, macrophages, monocytes, neutrophils and other cells continuously or upon inflammatory stimuli [<xref rid="B15-nutrients-13-00462" ref-type="bibr">15</xref>]. It is noted that the main biosynthetic enzymes of PAF are lyso-PAF-acetyltransferases and dithiothreitol-insensitive CDP-choline: 1-alkyl-2-acetyl-<italic>sn</italic>-glycerol cholinephosphotransferase (PAF-CPT). PAF is catabolized by PAF acetylhydrolase or lipoprotein associated phospholipase A<sub>2</sub> (Lp-PLA<sub>2</sub>) [<xref rid="B15-nutrients-13-00462" ref-type="bibr">15</xref>]. PAF levels, PAF induced platelet aggregation and the activity of its metabolic enzymes correlate with various clinical states such as asthma, stroke, atherosclerosis, heart failure, cancer, kidney disease and viral diseases [<xref rid="B9-nutrients-13-00462" ref-type="bibr">9</xref>,<xref rid="B15-nutrients-13-00462" ref-type="bibr">15</xref>,<xref rid="B17-nutrients-13-00462" ref-type="bibr">17</xref>].</p><p>With respect to COVID-19, PAF is a highly pyrogenic agent [<xref rid="B18-nutrients-13-00462" ref-type="bibr">18</xref>] and it affects the activity of angiotensin converting enzyme 2 (ACE2) [<xref rid="B19-nutrients-13-00462" ref-type="bibr">19</xref>], which is used as a receptor to facilitate the entrance of SARS-CoV-2 into the cells [<xref rid="B20-nutrients-13-00462" ref-type="bibr">20</xref>]. According to a lipidomic analysis human cells infected with the coronavirus HCoV-229E are enriched in PAF [<xref rid="B21-nutrients-13-00462" ref-type="bibr">21</xref>]. Moreover, oxidized phospholipids, which contain PAF and PAF-like lipids [<xref rid="B22-nutrients-13-00462" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-13-00462" ref-type="bibr">23</xref>] have been detected in the respiratory system of patients with SARS-CoV-1 and seem to increase cytokine production and lung injury via Toll-like receptor (TLR)4 [<xref rid="B24-nutrients-13-00462" ref-type="bibr">24</xref>]. Another similarity between the phenotypic manifestations of COVID-19 and PAF actions is that they are both connected to Kawasaki-like disease in children [<xref rid="B25-nutrients-13-00462" ref-type="bibr">25</xref>]. PAF has been also found to increase phagocytic capacity in equine alveolar macrophages [<xref rid="B26-nutrients-13-00462" ref-type="bibr">26</xref>] and its levels are increased in acute pulmonary disease [<xref rid="B27-nutrients-13-00462" ref-type="bibr">27</xref>], pulmonary hypertension [<xref rid="B28-nutrients-13-00462" ref-type="bibr">28</xref>] and sepsis [<xref rid="B29-nutrients-13-00462" ref-type="bibr">29</xref>]. Interestingly, the first-line drugs used in the COVID-19 epidemic, such as chloroquine have been also found to reduce PAF induced pulmonary edema [<xref rid="B30-nutrients-13-00462" ref-type="bibr">30</xref>]. Hopefully, specific inhibitors such as rupatadine can modulate the action of PAF [<xref rid="B31-nutrients-13-00462" ref-type="bibr">31</xref>] and they have been proposed as potential candidate therapeutic compounds against COVID-19 [<xref rid="B13-nutrients-13-00462" ref-type="bibr">13</xref>]. Inversely, widely prescribed medicines, such as statins or antiretroviral drugs with pleiotropic actions also influence PAF [<xref rid="B32-nutrients-13-00462" ref-type="bibr">32</xref>,<xref rid="B33-nutrients-13-00462" ref-type="bibr">33</xref>].</p><p>The inhibitors of PAF found in natural products and microconstituents of the diet are of increasing interest [<xref rid="B11-nutrients-13-00462" ref-type="bibr">11</xref>,<xref rid="B34-nutrients-13-00462" ref-type="bibr">34</xref>]. In fact, diet can directly affect PAF induced platelet aggregation, PAF levels and/or the activity and expression of PAF metabolic enzymes [<xref rid="B35-nutrients-13-00462" ref-type="bibr">35</xref>] or it can act indirectly by modifying its environment (i.e., oxidative stress) [<xref rid="B23-nutrients-13-00462" ref-type="bibr">23</xref>]. Furthermore, the modulation of PAF by dietary parameters has been shown to affect the manifestation of disease [<xref rid="B36-nutrients-13-00462" ref-type="bibr">36</xref>]. Given the newly suggested role of PAF and its dietary inhibitors in relation to the COVID-19 epidemic in limited works [<xref rid="B2-nutrients-13-00462" ref-type="bibr">2</xref>,<xref rid="B10-nutrients-13-00462" ref-type="bibr">10</xref>,<xref rid="B13-nutrients-13-00462" ref-type="bibr">13</xref>,<xref rid="B37-nutrients-13-00462" ref-type="bibr">37</xref>], the scope of the present mini-review is to thoroughly present the potential anti-PAF actions of nutrients providing &#x0201c;protection&#x0201d; against COVID-19. We further suggest that the well-known anti-inflammatory and anti-thrombotic actions of micronutrients, phytochemicals and/or holistic dietary schemes are also mediated through PAF.</p></sec><sec id="sec2-nutrients-13-00462"><title>2. Micronutrients, COVID-19 and PAF</title><p>Several micronutrients have been suggested to act as immunomodulatory agents against COVID-19 [<xref rid="B38-nutrients-13-00462" ref-type="bibr">38</xref>]. Their main actions along with their potential anti-thrombotic and anti-PAF effect, are briefly presented and are depicted in <xref ref-type="fig" rid="nutrients-13-00462-f001">Figure 1</xref>.</p><sec id="sec2dot1-nutrients-13-00462"><title>2.1. Vitamin A</title><p>Carotenoids have immunoregulatory actions including reducing free radicals [<xref rid="B39-nutrients-13-00462" ref-type="bibr">39</xref>] and pro-inflammatory molecules, such as IL-2 and TNF-&#x003b1;. Moreover, vitamin A downregulates IFN&#x003b3; production, an action which is more evident in a high oxidative stress environment [<xref rid="B40-nutrients-13-00462" ref-type="bibr">40</xref>]. Vitamin A is implicated in respiratory diseases since it plays a role in the formation of a healthy mucus layer [<xref rid="B41-nutrients-13-00462" ref-type="bibr">41</xref>] and its overt or subclinical deficiency increases morbidity and mortality from infections and respiratory diseases [<xref rid="B41-nutrients-13-00462" ref-type="bibr">41</xref>].</p><p>Retinoic acid can modulate the gene expression of PAF-receptor [<xref rid="B42-nutrients-13-00462" ref-type="bibr">42</xref>] and acts synergistically with PAF to activate the inducible prostaglandin synthase gene [<xref rid="B43-nutrients-13-00462" ref-type="bibr">43</xref>]. Prostaglandins synthesis contributes to gastric mucosal defense, although different effects are attributed to the many kinds of prostaglandins [<xref rid="B44-nutrients-13-00462" ref-type="bibr">44</xref>]. It is also noted that serum retinol has been inversely related to the activity of Lp-PLA<sub>2</sub> in epidemiological studies [<xref rid="B45-nutrients-13-00462" ref-type="bibr">45</xref>]. The interplay of vitamin A and PAF in immunity is also highlighted by the fact that the host-versus- graft reaction, in which PAF is implicated [<xref rid="B46-nutrients-13-00462" ref-type="bibr">46</xref>], is enhanced by high levels of vitamin A (34).</p></sec><sec id="sec2dot2-nutrients-13-00462"><title>2.2. Vitamin C</title><p>Vitamin C acts as an antioxidant and can boost the immune system [<xref rid="B47-nutrients-13-00462" ref-type="bibr">47</xref>]. It is involved in the function and integrity of mucosal cells, the normal functioning of T cells while it also exerts antimicrobial effects [<xref rid="B37-nutrients-13-00462" ref-type="bibr">37</xref>]. Vitamin C and concentration is high in leukocytes and it is utilized in the case of infection [<xref rid="B48-nutrients-13-00462" ref-type="bibr">48</xref>]. Vitamin C reduces the risk, the severity, and the duration of different infectious diseases, its status has been associated with pneumonia [<xref rid="B49-nutrients-13-00462" ref-type="bibr">49</xref>] and the supplementation with vitamin C may prevent and treat respiratory and systemic infections [<xref rid="B47-nutrients-13-00462" ref-type="bibr">47</xref>]. Therapeutic doses of vitamin C (24 gr/day intravenously, for seven days) are currently being tested in hospitalized COVID-19 patients [<xref rid="B7-nutrients-13-00462" ref-type="bibr">7</xref>]. However, official sources indicate that there is no evidence yet to support intravenous super doses of vitamin C in the management of COVID-19 [<xref rid="B50-nutrients-13-00462" ref-type="bibr">50</xref>].</p><p>In addition, vitamin C decreased markers of thrombosis, such as tissue plasminogen activator and von Willebrand factor in high risk patients with cardiovascular disease and diabetes [<xref rid="B51-nutrients-13-00462" ref-type="bibr">51</xref>], an action already suggested in the 1970s [<xref rid="B52-nutrients-13-00462" ref-type="bibr">52</xref>]. In the same context, it has been found to reduce PAF levels in vitro [<xref rid="B53-nutrients-13-00462" ref-type="bibr">53</xref>]. Indeed, vitamin C reduces oxidative stress [<xref rid="B47-nutrients-13-00462" ref-type="bibr">47</xref>], which is a strong trigger for synthesis of PAF [<xref rid="B54-nutrients-13-00462" ref-type="bibr">54</xref>] and its receptor [<xref rid="B55-nutrients-13-00462" ref-type="bibr">55</xref>]. It is also noted that in frailty, which worsens COVID-19 outcomes [<xref rid="B56-nutrients-13-00462" ref-type="bibr">56</xref>] the PAF catabolic enzyme Lp-PLA<sub>2</sub> is increased (suggesting its upregulation to counter-balance PAF levels) while anti-oxidant status is decreased (vitamin C, E, &#x003b1;-tocopherol, biological anti-oxidant potential, and total thiol levels) [<xref rid="B57-nutrients-13-00462" ref-type="bibr">57</xref>]. Vitamin C status could thus affect the inflammatory and micro-thrombotic environment including PAF and the morbidity of COVID-19.</p></sec><sec id="sec2dot3-nutrients-13-00462"><title>2.3. Vitamin D</title><p>Vitamin D exerts antimicrobial and anti-oxidant effects and supports the immune system against respiratory infection [<xref rid="B58-nutrients-13-00462" ref-type="bibr">58</xref>]. According to a meta-analysis vitamin D supplementation reduces the risk of acute respiratory infections [<xref rid="B59-nutrients-13-00462" ref-type="bibr">59</xref>], has been inversely related to hepatitis viral load [<xref rid="B60-nutrients-13-00462" ref-type="bibr">60</xref>] and improves antibacterial immunity in HIV-1 patients [<xref rid="B61-nutrients-13-00462" ref-type="bibr">61</xref>]. An inverse association between mean levels of vitamin D and the number of COVID-19 cases/1 M was recently reported in a cross-sectional European study [<xref rid="B62-nutrients-13-00462" ref-type="bibr">62</xref>] whereas a UK study did not find an association between the vitamin&#x02019;s status and COVID-19 risk [<xref rid="B63-nutrients-13-00462" ref-type="bibr">63</xref>]. Moreover, low levels of vitamin D were found in COVID-19 positive patients [<xref rid="B64-nutrients-13-00462" ref-type="bibr">64</xref>] or hospitalized patients with COVID-19 [<xref rid="B65-nutrients-13-00462" ref-type="bibr">65</xref>] and have been connected to the severity of the disease. The hypothesis that vitamin D may explain susceptibility to COVID-19 infection in dark colored skin individuals does not seem to be valid [<xref rid="B63-nutrients-13-00462" ref-type="bibr">63</xref>]. It is noteworthy that several clinical trials are on the way regarding the role of vitamin D in the prevention and treatment of COVID-19, reviewed elsewhere [<xref rid="B48-nutrients-13-00462" ref-type="bibr">48</xref>].</p><p>In vitro data suggest that 1,25-dihydroxyvitamin D3 reduces the secretion of the catabolic enzyme PAF-AH from placenta macrophages [<xref rid="B66-nutrients-13-00462" ref-type="bibr">66</xref>], which implies an interrelation between PAF and the vitamin. Moreover, paricalcitol has an anti-inflammatory and anti-PAF action in hemodialysis patients inhibiting PAF/thrombin-induced platelet aggregation, reducing the activity of PAF biosynthetic enzymes and increasing the activity of the catabolic enzyme of PAF, i.e., PAF-AH [<xref rid="B67-nutrients-13-00462" ref-type="bibr">67</xref>]. The connection between vitamin D and PAF is further substantiated by the known anti-thrombotic effects of vitamin D [<xref rid="B68-nutrients-13-00462" ref-type="bibr">68</xref>].</p></sec><sec id="sec2dot4-nutrients-13-00462"><title>2.4. Vitamin E</title><p>Vitamin E acts as an antioxidant and has a role in the proper functioning of the immune system [<xref rid="B58-nutrients-13-00462" ref-type="bibr">58</xref>]. Indeed, it protects cell membranes, including those of immune cells from lipid peroxidation [<xref rid="B69-nutrients-13-00462" ref-type="bibr">69</xref>]. In cases of influenza infection, the lung levels of vitamin E are reduced [<xref rid="B70-nutrients-13-00462" ref-type="bibr">70</xref>], and supplementation with the vitamin reduces the severity and duration of the disease [<xref rid="B71-nutrients-13-00462" ref-type="bibr">71</xref>,<xref rid="B72-nutrients-13-00462" ref-type="bibr">72</xref>]. In the same context, in a meta-analysis of randomized controlled trials vitamin E reduced C-reactive protein (CRP) levels [<xref rid="B73-nutrients-13-00462" ref-type="bibr">73</xref>]. A combination of vitamin E and C has been recently proposed for ameliorating cardiac injuries of critically ill COVID-19 patients, which furthers underline their role in the COVID-19 disease [<xref rid="B74-nutrients-13-00462" ref-type="bibr">74</xref>].</p><p>Vitamin E deficiency is connected to increased PAF synthesis in rat polynuclear cells [<xref rid="B75-nutrients-13-00462" ref-type="bibr">75</xref>]. Moreover, vitamin E inhibits PAF induced platelet aggregation [<xref rid="B76-nutrients-13-00462" ref-type="bibr">76</xref>,<xref rid="B77-nutrients-13-00462" ref-type="bibr">77</xref>,<xref rid="B78-nutrients-13-00462" ref-type="bibr">78</xref>] and PAF synthesis [<xref rid="B79-nutrients-13-00462" ref-type="bibr">79</xref>]. In addition, lycopene alone or in combination with a-tocopherol reduces PAF synthesis in stimulated endothelial cells [<xref rid="B80-nutrients-13-00462" ref-type="bibr">80</xref>], which can further blunt the inflammatory cataract. Vitamin E and increased Lp-PLA<sub>2</sub> have been associated with decreased asthma development [<xref rid="B81-nutrients-13-00462" ref-type="bibr">81</xref>], and the vitamin may indirectly affect Lp-PLA<sub>2</sub> since it improves LDL quality, in which the enzyme is attached [<xref rid="B82-nutrients-13-00462" ref-type="bibr">82</xref>]. However, high levels of vitamin E ingested as a supplement (1500 IU for two weeks) seem not to influence the concentration of lyso-PAF [<xref rid="B83-nutrients-13-00462" ref-type="bibr">83</xref>]. In total, vitamin E can affect PAF levels, metabolism and its actions on platelets, i.e., the pro-thrombotic state.</p></sec><sec id="sec2dot5-nutrients-13-00462"><title>2.5. Selenium</title><p>Selenium has been proposed to potentially play a role in COVID-19 prevention, since in the form of sodium selenite it can oxidize thiol groups in the virus protein disulfide isomerase and thus inhibit the entrance viruses into the cell [<xref rid="B84-nutrients-13-00462" ref-type="bibr">84</xref>]. It also has an antioxidant role since it is a structural component of glutathione peroxidases, a family of antioxidant enzymes [<xref rid="B85-nutrients-13-00462" ref-type="bibr">85</xref>]. In parallel, selenoprotein H is involved in redox transcription while selenoprotein K found in the endoplasmic reticulum, is involved in calcium flux in immune cells which is a critical step in immune response [<xref rid="B85-nutrients-13-00462" ref-type="bibr">85</xref>]. Selenium deficiency is associated with an increase in inflammatory molecules [<xref rid="B86-nutrients-13-00462" ref-type="bibr">86</xref>], and selenium supplementation has been found to improve the response against H1N1 virus [<xref rid="B87-nutrients-13-00462" ref-type="bibr">87</xref>]. In mouse models of asthma there seems to be a reverse-U relation with selenium concentration since too little or too much contributed to asthma attenuation [<xref rid="B88-nutrients-13-00462" ref-type="bibr">88</xref>]. The relationship selenium and the immune system is further corroborated in hospitalized patients with COVID-19, in which selenium levels were found to be sub-optimal [<xref rid="B65-nutrients-13-00462" ref-type="bibr">65</xref>]. Moreover, good selenium status, as assessed by the selenium hair content, has been connected to a higher recovery rate from COVID-19 [<xref rid="B89-nutrients-13-00462" ref-type="bibr">89</xref>].</p><p>The relationship between selenium and PAF can be considered under the prism of the effects of selenium on oxidative stress and phospholipid metabolism. Firstly, the modulation of oxidative stress by selenium could affect PAF metabolism, as for example it deactivates Lp-PLA<sub>2</sub> [<xref rid="B23-nutrients-13-00462" ref-type="bibr">23</xref>] and increases PAF synthesis [<xref rid="B54-nutrients-13-00462" ref-type="bibr">54</xref>]. Secondly, selenoprotein I is implicated in phospholipid biosynthesis [<xref rid="B85-nutrients-13-00462" ref-type="bibr">85</xref>]. Moreover, PAF production is increased in the case of selenium deficiency in endothelial cells [<xref rid="B90-nutrients-13-00462" ref-type="bibr">90</xref>,<xref rid="B91-nutrients-13-00462" ref-type="bibr">91</xref>] possibly through activation of its biosynthetic enzyme lyso-PAF-acetyltransferase [<xref rid="B90-nutrients-13-00462" ref-type="bibr">90</xref>]. It is noted that the content of diet in selenium did not alter Lp-PLA<sub>2</sub> in rats [<xref rid="B92-nutrients-13-00462" ref-type="bibr">92</xref>], while selenium deficiency is associated with arterial thrombosis and selenium seems to decrease platelet aggregation [<xref rid="B93-nutrients-13-00462" ref-type="bibr">93</xref>]. It can be thus hypothesized that worse outcomes of COVID-19 on the grounds of selenium deficiency may be at least in part attributed to increased PAF and an associated pro-thrombotic state.</p></sec><sec id="sec2dot6-nutrients-13-00462"><title>2.6. Omega-3 Fatty Acids</title><p>Omega-3 fatty acids have anti-inflammatory and anti-thrombotic effects [<xref rid="B10-nutrients-13-00462" ref-type="bibr">10</xref>], and they may interfere with virus entry and replication through modulation of lipid rafts [<xref rid="B94-nutrients-13-00462" ref-type="bibr">94</xref>]. The results from animal studies show that mice with Klebsiella pneumoniae or Streptococcus pneumoniae had an upregulated immune defense and less bacterial burden when fed omega-3 fatty acids [<xref rid="B95-nutrients-13-00462" ref-type="bibr">95</xref>,<xref rid="B96-nutrients-13-00462" ref-type="bibr">96</xref>]. However, it is noted that fish oil-fed mice display impaired resistance to influenza infection [<xref rid="B97-nutrients-13-00462" ref-type="bibr">97</xref>,<xref rid="B98-nutrients-13-00462" ref-type="bibr">98</xref>] denoting a more complex immunomodulating effect of omega-3 fatty acids.</p><p>Omega-3 fatty acids also exert antithrombotic effects by various mechanisms including a reduction in thromboxane synthesis [<xref rid="B99-nutrients-13-00462" ref-type="bibr">99</xref>] and PAF [<xref rid="B100-nutrients-13-00462" ref-type="bibr">100</xref>,<xref rid="B101-nutrients-13-00462" ref-type="bibr">101</xref>]. Omega-3 fatty acids are incorporated in the cell membrane and may regulate the activity of PLA<sub>2</sub> and thus lyso-PAF production, which is a prodrome molecule for PAF production [<xref rid="B102-nutrients-13-00462" ref-type="bibr">102</xref>]. DHA inhibits PAF increase in cell lines [<xref rid="B103-nutrients-13-00462" ref-type="bibr">103</xref>]. Moreover, omega-3 can reduce PAF production in Human Umbilical Vein Endothelial Cells (HUVEC) [<xref rid="B101-nutrients-13-00462" ref-type="bibr">101</xref>]. In cases of endotoxemia, which is also observed in seriously ill COVID-19 patients [<xref rid="B104-nutrients-13-00462" ref-type="bibr">104</xref>], linolenic acid has been found to reduce PAF production in Sprague-Dawley rats [<xref rid="B105-nutrients-13-00462" ref-type="bibr">105</xref>]. In addition, a diet rich in fish oils (10%) has been found to reduce PAF and LTB<sub>4</sub> [<xref rid="B106-nutrients-13-00462" ref-type="bibr">106</xref>]. As far as PAF enzymes are concerned, a negative association has been documented between the PAF catabolic enzyme Lp-PLA<sub>2</sub> and adipose tissue omega-3 fatty acids [<xref rid="B107-nutrients-13-00462" ref-type="bibr">107</xref>] while the effects of supplementation did not change the enzyme&#x02019;s activity in healthy adults [<xref rid="B108-nutrients-13-00462" ref-type="bibr">108</xref>] but decreased the enzyme in volunteers with stable angina [<xref rid="B109-nutrients-13-00462" ref-type="bibr">109</xref>] and hypertriglyceridemia [<xref rid="B110-nutrients-13-00462" ref-type="bibr">110</xref>]. It is noted that Lp-PLA<sub>2</sub>, increases as a result of increased PAF in order to catabolize it, thus, the trend for an inverse association of Lp-PLA<sub>2</sub> with omega-3 fatty acids, implies a negative association with PAF. Moreover, results from a cross-sectional study of our group have shown that omega-6 fatty acids were positively correlated with PAF-CPT while no significant correlations were observed with omega-3 fatty acids and PAF or its enzymes [<xref rid="B111-nutrients-13-00462" ref-type="bibr">111</xref>].</p></sec><sec id="sec2dot7-nutrients-13-00462"><title>2.7. Zinc, Copper, Magnesium and Iron</title><p>Zinc plays a role in maintaining the integrity of mucosal cells and antigen response [<xref rid="B37-nutrients-13-00462" ref-type="bibr">37</xref>]. It has antimicrobial, anti-inflammatory and antioxidant effects [<xref rid="B37-nutrients-13-00462" ref-type="bibr">37</xref>]. Moreover, it has been found to inhibit the activity and replication of coronavirus (SARS-CoV-1) [<xref rid="B112-nutrients-13-00462" ref-type="bibr">112</xref>], and it has a role in interferon-&#x003b3; production [<xref rid="B113-nutrients-13-00462" ref-type="bibr">113</xref>]. Zinc deficiency can increase susceptibility to various infections, including those of the respiratory system [<xref rid="B114-nutrients-13-00462" ref-type="bibr">114</xref>]. Zinc supplementation in mechanically ventilated trauma patients was related to decreased risk of ventilator-associated pneumonia [<xref rid="B115-nutrients-13-00462" ref-type="bibr">115</xref>]. Moreover, zinc may mediate the beneficial effects of the chloroquine, a drug which is widely used against COVID-19. Indeed, chloroquine is a zinc ionophore, which increases intracellular Zn<sup>2+</sup> levels [<xref rid="B116-nutrients-13-00462" ref-type="bibr">116</xref>].</p><p>Copper can prevent oxidative DNA damage and decrease inflammatory markers [<xref rid="B37-nutrients-13-00462" ref-type="bibr">37</xref>], as it is a part of antioxidant enzymes such as Zn-Cu-superoxide dismutase and ceruloplasmin [<xref rid="B117-nutrients-13-00462" ref-type="bibr">117</xref>]. Its deficiency is connected with an increased rate of infections [<xref rid="B118-nutrients-13-00462" ref-type="bibr">118</xref>], which may be related to its role in T-cell proliferation and Natural Killer (NK) activity [<xref rid="B113-nutrients-13-00462" ref-type="bibr">113</xref>]. On the other hand, macrophages can attack pathogens with high copper and as a result the concentration of copper may be found increased in lung infection [<xref rid="B119-nutrients-13-00462" ref-type="bibr">119</xref>]. However, no direct connection to COVID-19 has been identified to date.</p><p>Iron participates in the differentiation and growth of epithelial tissue and the production of reactive oxygen species, which combat pathogens [<xref rid="B58-nutrients-13-00462" ref-type="bibr">58</xref>]. Supplementary iron intake has been found to reduce respiratory infections [<xref rid="B120-nutrients-13-00462" ref-type="bibr">120</xref>] while pulmonary iron modulation represents a defensive mechanism against various respiratory pathogens [<xref rid="B121-nutrients-13-00462" ref-type="bibr">121</xref>]. Despite the important role of iron in the immune system, iron-containing enzymes are essential for the replication of coronavirus [<xref rid="B122-nutrients-13-00462" ref-type="bibr">122</xref>] and the chelation of iron compounds may prove beneficial [<xref rid="B37-nutrients-13-00462" ref-type="bibr">37</xref>]. Iron can also modulate interferon production [<xref rid="B113-nutrients-13-00462" ref-type="bibr">113</xref>].</p><p>The interrelation between PAF and zinc, copper and magnesium is not very clear. A low zinc diet reduces platelet aggregation suggesting a role of this nutrient in hemostasis [<xref rid="B123-nutrients-13-00462" ref-type="bibr">123</xref>], while zinc and copper chelate complexes have a PAF inhibitory activity mainly attributed to stereochemical interactions [<xref rid="B124-nutrients-13-00462" ref-type="bibr">124</xref>,<xref rid="B125-nutrients-13-00462" ref-type="bibr">125</xref>]. Chelating agents such as Mg<sup>2+</sup>, reduce the activity of PAF biosynthetic enzymes, such as Lyso-PAF-acetyltransferase [<xref rid="B126-nutrients-13-00462" ref-type="bibr">126</xref>]. The relationship between PAF and copper and iron with has been investigated under the prism of copper and iron induced oxidation of lipids and PAF-related enzymes [<xref rid="B23-nutrients-13-00462" ref-type="bibr">23</xref>]. It is noted that metal- induced oxidative stress in the presence of superoxide can inactivate PAF acetylhydrolase [<xref rid="B127-nutrients-13-00462" ref-type="bibr">127</xref>] and thus potentially increase PAF levels. In addition, macrophage responsiveness to PAF is altered by interferon [<xref rid="B128-nutrients-13-00462" ref-type="bibr">128</xref>] and provides protection against PAF induced injury [<xref rid="B129-nutrients-13-00462" ref-type="bibr">129</xref>], which may reflect an indirect connection of some minerals with PAF through interferon.</p></sec><sec id="sec2dot8-nutrients-13-00462"><title>2.8. Phytochemicals</title><p>Phytochemicals, such as polyphenols, act as antioxidants, modulate LDL oxidation [<xref rid="B130-nutrients-13-00462" ref-type="bibr">130</xref>], and also exert anti-inflammatory, antiplatelet [<xref rid="B131-nutrients-13-00462" ref-type="bibr">131</xref>] and antiviral activity [<xref rid="B132-nutrients-13-00462" ref-type="bibr">132</xref>]. Resveratrol, is an inhibitor of SARS-CoV-1 [<xref rid="B133-nutrients-13-00462" ref-type="bibr">133</xref>] and curcumin was recently reported to bind to the target receptors of SARS-CoV-2 [<xref rid="B134-nutrients-13-00462" ref-type="bibr">134</xref>]. In addition, curcumin combined with vitamin C glycyrrhizic acid promotes interferons production and has immunomodulatory properties [<xref rid="B135-nutrients-13-00462" ref-type="bibr">135</xref>]. Luteolin binds to the surface spike protein of SARS-Cov-2 inhibiting in this way its entry into cells and it is a potential inhibitor of SARS-CoV-2&#x02019;s main protease (SARS-CoV 3CL) [<xref rid="B136-nutrients-13-00462" ref-type="bibr">136</xref>]. Moreover, lignans exhibit antiviral activity [<xref rid="B137-nutrients-13-00462" ref-type="bibr">137</xref>].</p><p>With respect to PAF, resveratrol and tyrosol as well as their acetylated derivatives inhibit PAF induced platelet aggregation [<xref rid="B138-nutrients-13-00462" ref-type="bibr">138</xref>] while curcumin is a PAF inhibitor [<xref rid="B139-nutrients-13-00462" ref-type="bibr">139</xref>] and plays a role in thrombosis and coagulation [<xref rid="B140-nutrients-13-00462" ref-type="bibr">140</xref>,<xref rid="B141-nutrients-13-00462" ref-type="bibr">141</xref>]. Moreover, curcumin and phenolic compounds acting as antioxidants can modulate LDL oxidation [<xref rid="B130-nutrients-13-00462" ref-type="bibr">130</xref>] and the subsequent production of PAF and PAF-like lipids [<xref rid="B22-nutrients-13-00462" ref-type="bibr">22</xref>]. Their effect could be also directly exerted on PAF biosynthetic enzymes as demonstrated by in vitro studies. Indeed, resveratrol and quercetin can inhibit both PAF&#x02019;s main biosynthetic enzymes in vitro [<xref rid="B142-nutrients-13-00462" ref-type="bibr">142</xref>,<xref rid="B143-nutrients-13-00462" ref-type="bibr">143</xref>], phenolic compounds reduce the activity of PAF biosynthetic enzymes in cell cultures stimulated with IL-1&#x003b2; [<xref rid="B144-nutrients-13-00462" ref-type="bibr">144</xref>] and flavonoids, have been documented to reduce lyso-PAF acetyltransferase activity [<xref rid="B145-nutrients-13-00462" ref-type="bibr">145</xref>]. More particularly, pro-anthocyanidins [<xref rid="B146-nutrients-13-00462" ref-type="bibr">146</xref>], luteolin [<xref rid="B145-nutrients-13-00462" ref-type="bibr">145</xref>], quercetin [<xref rid="B80-nutrients-13-00462" ref-type="bibr">80</xref>,<xref rid="B147-nutrients-13-00462" ref-type="bibr">147</xref>], hesperidin [<xref rid="B147-nutrients-13-00462" ref-type="bibr">147</xref>] and naringin [<xref rid="B147-nutrients-13-00462" ref-type="bibr">147</xref>] reduce the activity of lyso-PAF acetyltransferase in cell lines. Licoricidin and other components were also documented to inhibit lyso-PAF acetyltransferase [<xref rid="B148-nutrients-13-00462" ref-type="bibr">148</xref>]. Moreover, the antioxidant capacity of the diet, which is at least in part affected by phytochemical intake, was inversely related with PAF levels and the activity of lyso-PAF-acetyltransferase in healthy volunteers as evidenced by our group [<xref rid="B34-nutrients-13-00462" ref-type="bibr">34</xref>]. In parallel, PAF has been inversely related to antioxidant-rich foods (herbal drinks and coffee) [<xref rid="B34-nutrients-13-00462" ref-type="bibr">34</xref>]. Lignans, which have been proposed as an anti-COVID compound [<xref rid="B137-nutrients-13-00462" ref-type="bibr">137</xref>] are also PAF inhibitors [<xref rid="B149-nutrients-13-00462" ref-type="bibr">149</xref>]. Thus, the effects of flavonoids and other phytochemicals on PAF levels, actions, and its metabolic enzymes generate the hypothesis that their anti-inflammatory and anti-thrombotic actions are at least in part mediated by the PAF circuit.</p><p>Interestingly, certain natural flavonoids also have anti-PAF activity, in addition to their anti-inflammatory actions and ability to block coronavirus from binding to target cells [<xref rid="B2-nutrients-13-00462" ref-type="bibr">2</xref>,<xref rid="B13-nutrients-13-00462" ref-type="bibr">13</xref>,<xref rid="B136-nutrients-13-00462" ref-type="bibr">136</xref>].</p></sec></sec><sec id="sec3-nutrients-13-00462"><title>3. Mediterranean Diet, Mediterranean Foods, COVID-19 and PAF</title><p>The Mediterranean diet including olive oil, fish, honey, fruits, vegetables and herbs is rich in polyphenols and other micro-constituents [<xref rid="B35-nutrients-13-00462" ref-type="bibr">35</xref>] and it has been inversely related to respiratory diseases [<xref rid="B150-nutrients-13-00462" ref-type="bibr">150</xref>], inflammation [<xref rid="B151-nutrients-13-00462" ref-type="bibr">151</xref>] and thrombosis [<xref rid="B11-nutrients-13-00462" ref-type="bibr">11</xref>,<xref rid="B35-nutrients-13-00462" ref-type="bibr">35</xref>]. It is possible that the combination of phytochemicals as those occurring in the Mediterranean diet have amplified actions in comparison to sole compounds [<xref rid="B152-nutrients-13-00462" ref-type="bibr">152</xref>]. In fact, complex natural product mixtures synergistically target multiple networks involved in inflammatory and thrombosis [<xref rid="B152-nutrients-13-00462" ref-type="bibr">152</xref>]. The adoption of Mediterranean diet as a whole reduces PAF induced platelet aggregation in patients with 2 diabetes [<xref rid="B153-nutrients-13-00462" ref-type="bibr">153</xref>,<xref rid="B154-nutrients-13-00462" ref-type="bibr">154</xref>]. Moreover, it has been suggested to be a potentially protective diet against COVID-19 [<xref rid="B10-nutrients-13-00462" ref-type="bibr">10</xref>,<xref rid="B155-nutrients-13-00462" ref-type="bibr">155</xref>]. It is noted that the adoption of the Mediterranean Diet decreases length of stay and mortality in hospitalized patients &#x0003e;65 y of age [<xref rid="B156-nutrients-13-00462" ref-type="bibr">156</xref>,<xref rid="B157-nutrients-13-00462" ref-type="bibr">157</xref>], which is of interest in the era of COVID-19 and the challenges of health systems.</p><p>Several natural products which are intrinsic characteristics of the Mediterranean diet such as garlic, salvia and olive oil have been proposed as additional measures for the prevention and treatment of COVID-19 [<xref rid="B158-nutrients-13-00462" ref-type="bibr">158</xref>]. These and additional Mediterranean foods will be briefly presented and a special reference will be provided on their relation with PAF and its enzymes. It is noted that PAF has been inversely related to a healthy dietary pattern including legumes, vegetables, poultry and fish [<xref rid="B34-nutrients-13-00462" ref-type="bibr">34</xref>].</p><sec id="sec3dot1-nutrients-13-00462"><title>3.1. Olive Oil</title><p>Olive oil contains monounsaturated fatty acids and several microconstituents with antioxidant and anti-thrombotic action, such as polyphenols [<xref rid="B159-nutrients-13-00462" ref-type="bibr">159</xref>] and polar lipids [<xref rid="B36-nutrients-13-00462" ref-type="bibr">36</xref>]. Its anti-oxidant, anti-inflammatory and anti-thrombotic action render it a candidate food against COVID-19 [<xref rid="B158-nutrients-13-00462" ref-type="bibr">158</xref>]. It is noted that olive oil polar lipids act as PAF antagonists [<xref rid="B36-nutrients-13-00462" ref-type="bibr">36</xref>,<xref rid="B160-nutrients-13-00462" ref-type="bibr">160</xref>], and bioactive compounds have also been found in olive oil pomace and its byproducts [<xref rid="B161-nutrients-13-00462" ref-type="bibr">161</xref>]. From in vitro data it has been shown that olive oil polar lipids inhibit PAF-CPT which is a biosynthetic enzyme for PAF [<xref rid="B142-nutrients-13-00462" ref-type="bibr">142</xref>]. Moreover, lyso-PAF-AT has been negatively associated with a dietary pattern rich in olive oil and whole-wheat products as documented by our research team [<xref rid="B34-nutrients-13-00462" ref-type="bibr">34</xref>]. Lastly, the consumption of a yogurt enriched with PAF-inhibitors isolated from olive-oil by-products, led to attenuation of subclinical inflammation and platelet sensitivity to thrombotic stimuli in apparently healthy volunteers [<xref rid="B162-nutrients-13-00462" ref-type="bibr">162</xref>].</p></sec><sec id="sec3dot2-nutrients-13-00462"><title>3.2. Fish</title><p>Fish have anti-inflammatory and anti-thrombotic properties, and they exert beneficial effects in the respiratory tract (see also omega-3 fatty acids) [<xref rid="B159-nutrients-13-00462" ref-type="bibr">159</xref>]. Indeed, fish has anti-aggregatory effects mediated by PAF inhibition [<xref rid="B153-nutrients-13-00462" ref-type="bibr">153</xref>,<xref rid="B163-nutrients-13-00462" ref-type="bibr">163</xref>,<xref rid="B164-nutrients-13-00462" ref-type="bibr">164</xref>] attributed to polar lipids, neutral lipids [<xref rid="B165-nutrients-13-00462" ref-type="bibr">165</xref>] and other lipids, such as gangliosides [<xref rid="B166-nutrients-13-00462" ref-type="bibr">166</xref>]. Moreover, from in vitro data it has been shown that fish polar lipids inhibit PAF-CPT [<xref rid="B142-nutrients-13-00462" ref-type="bibr">142</xref>]. Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism [<xref rid="B167-nutrients-13-00462" ref-type="bibr">167</xref>]. Interestingly, the antibacterial properties of fish go hand in hand with their anti-PAF activity, suggesting that PAF antagonists and agonists in fish may also have antibacterial activity [<xref rid="B168-nutrients-13-00462" ref-type="bibr">168</xref>].</p></sec><sec id="sec3dot3-nutrients-13-00462"><title>3.3. Honey</title><p>Detailed nutritional records of Cretan participants of the Seven Countries Study, highlight the presence of honey in their every-day diet [<xref rid="B169-nutrients-13-00462" ref-type="bibr">169</xref>] and Plato considered honey an essential component of a healthy diet [<xref rid="B170-nutrients-13-00462" ref-type="bibr">170</xref>]. Indeed, stingless bee honey has been found to inhibit TNF-&#x003b1;, IL-6 and interferon secretion from stimulated macrophages [<xref rid="B171-nutrients-13-00462" ref-type="bibr">171</xref>] and to reduce inflammation in animal models [<xref rid="B172-nutrients-13-00462" ref-type="bibr">172</xref>]. Honey has anti-bacterial properties due to its content of phenolic compounds, the production of hydrogen peroxide and other mechanisms such as osmosis [<xref rid="B173-nutrients-13-00462" ref-type="bibr">173</xref>]. Moreover, it has been suggested to have a role against COVID-19 epidemic [<xref rid="B174-nutrients-13-00462" ref-type="bibr">174</xref>,<xref rid="B175-nutrients-13-00462" ref-type="bibr">175</xref>], it has six compounds related to the receptor active site of COVID-19&#x02019;s main protease according to a in silico approach [<xref rid="B176-nutrients-13-00462" ref-type="bibr">176</xref>] and is currently being tested in a clinical trial (clinical trial NCT04323345) [<xref rid="B176-nutrients-13-00462" ref-type="bibr">176</xref>]. It is noted that honey displays anti-thrombotic activity [<xref rid="B177-nutrients-13-00462" ref-type="bibr">177</xref>] and it especially acts as a PAF inhibitor [<xref rid="B178-nutrients-13-00462" ref-type="bibr">178</xref>]. In total, the anti-bacterial, the anti-thrombotic and anti-PAF effects of honey render it a potentially useful food against the COVID epidemic.</p></sec><sec id="sec3dot4-nutrients-13-00462"><title>3.4. Milk and Yogurt</title><p>Dairy products constitute a principal source of vitamin D, which has been proposed to play a role in the fight against the COVID-19 epidemic [<xref rid="B179-nutrients-13-00462" ref-type="bibr">179</xref>,<xref rid="B180-nutrients-13-00462" ref-type="bibr">180</xref>,<xref rid="B181-nutrients-13-00462" ref-type="bibr">181</xref>]. It is noted that milk, yogurt and fermented milk products also contain PAF inhibitors [<xref rid="B182-nutrients-13-00462" ref-type="bibr">182</xref>,<xref rid="B183-nutrients-13-00462" ref-type="bibr">183</xref>,<xref rid="B184-nutrients-13-00462" ref-type="bibr">184</xref>], with goat yogurt presenting a more protective effect [<xref rid="B185-nutrients-13-00462" ref-type="bibr">185</xref>].</p></sec><sec id="sec3dot5-nutrients-13-00462"><title>3.5. Plant Foods</title><p>Plant foods with antiviral properties have been recently reviewed as anti-COVID agents, as they prevent viral replication, enhance antibody production against influenza virus, and improve T-cell function [<xref rid="B159-nutrients-13-00462" ref-type="bibr">159</xref>]. A recent work reported the inhibition of COVID-19 with the use of molecular docking by plant terpenoids, such as Ginkgolide A [<xref rid="B186-nutrients-13-00462" ref-type="bibr">186</xref>], which is also one of the most potent PAF inhibitors [<xref rid="B187-nutrients-13-00462" ref-type="bibr">187</xref>]. Garlic and onion which are also used in many recipes of the Mediterranean diet [<xref rid="B188-nutrients-13-00462" ref-type="bibr">188</xref>] also contain PAF inhibitors [<xref rid="B189-nutrients-13-00462" ref-type="bibr">189</xref>,<xref rid="B190-nutrients-13-00462" ref-type="bibr">190</xref>]. Moreover, wild greens, which are rich in polyphenols have a postprandial anti-PAF effect [<xref rid="B191-nutrients-13-00462" ref-type="bibr">191</xref>]. Rice (Oryza sativa L.), traditionally used in several Mediterranean meals [<xref rid="B188-nutrients-13-00462" ref-type="bibr">188</xref>] may also be implicated in COVID-19, since rice bran policosanol extract has anti-aggregatory activity (although studies have researched only ADP-induced platelet aggregation and not PAF as an aggregatory agent) [<xref rid="B192-nutrients-13-00462" ref-type="bibr">192</xref>]. In addition, rice policosanol has been found to activate the nuclear factor erythroid 2-related factor 2 (Nrf-2) pathway[<xref rid="B193-nutrients-13-00462" ref-type="bibr">193</xref>], a molecular pathway playing a role in combating COVID-19 [<xref rid="B194-nutrients-13-00462" ref-type="bibr">194</xref>], which can also modulate PAF-acetylhydrolase transcription [<xref rid="B195-nutrients-13-00462" ref-type="bibr">195</xref>].</p></sec><sec id="sec3dot6-nutrients-13-00462"><title>3.6. Wine and Its Products</title><p>Although wine is not recommended by national bodies as a means to fight coronavirus [<xref rid="B8-nutrients-13-00462" ref-type="bibr">8</xref>], the Mediterranean way of living and eating incorporates moderate wine consumption in its philosophy. A Mediterranean diet with moderate wine quantities could affect the pro-thrombotic status [<xref rid="B196-nutrients-13-00462" ref-type="bibr">196</xref>] and possibly the body&#x02019;s response to a virus. As it has been documented by our group wine consumption reduces PAF-induced platelet aggregation [<xref rid="B197-nutrients-13-00462" ref-type="bibr">197</xref>] and specific wine varieties affect PAF biosynthetic enzymes [<xref rid="B198-nutrients-13-00462" ref-type="bibr">198</xref>] in the postprandial state. Moreover, several bioactive lipids have been isolated from wines that exhibit anti-PAF biological activity [<xref rid="B199-nutrients-13-00462" ref-type="bibr">199</xref>,<xref rid="B200-nutrients-13-00462" ref-type="bibr">200</xref>,<xref rid="B201-nutrients-13-00462" ref-type="bibr">201</xref>,<xref rid="B202-nutrients-13-00462" ref-type="bibr">202</xref>] and reduce the activity of its biosynthetic enzymes in monocytes [<xref rid="B143-nutrients-13-00462" ref-type="bibr">143</xref>]. Last but not least, bioactive compounds with anti-aggregatory have been also isolated from grape pomace extracts [<xref rid="B203-nutrients-13-00462" ref-type="bibr">203</xref>], which may render winery by-products useful for the production of functional foods.</p></sec></sec><sec id="sec4-nutrients-13-00462"><title>4. Data from Clinical Trials</title><p>Since the results of clinical trials can be different from those obtained from in vitro studies a special reference is made to clinical trials regarding nutrient/foods and PAF metabolism (<xref rid="nutrients-13-00462-t001" ref-type="table">Table 1</xref>). As it can be seen, the majority of studies have focused on platelet aggregation [<xref rid="B153-nutrients-13-00462" ref-type="bibr">153</xref>,<xref rid="B154-nutrients-13-00462" ref-type="bibr">154</xref>,<xref rid="B162-nutrients-13-00462" ref-type="bibr">162</xref>,<xref rid="B191-nutrients-13-00462" ref-type="bibr">191</xref>,<xref rid="B197-nutrients-13-00462" ref-type="bibr">197</xref>,<xref rid="B203-nutrients-13-00462" ref-type="bibr">203</xref>,<xref rid="B204-nutrients-13-00462" ref-type="bibr">204</xref>,<xref rid="B205-nutrients-13-00462" ref-type="bibr">205</xref>,<xref rid="B206-nutrients-13-00462" ref-type="bibr">206</xref>,<xref rid="B207-nutrients-13-00462" ref-type="bibr">207</xref>] and/or PAF catabolic enzymes [<xref rid="B108-nutrients-13-00462" ref-type="bibr">108</xref>,<xref rid="B206-nutrients-13-00462" ref-type="bibr">206</xref>,<xref rid="B208-nutrients-13-00462" ref-type="bibr">208</xref>,<xref rid="B209-nutrients-13-00462" ref-type="bibr">209</xref>,<xref rid="B210-nutrients-13-00462" ref-type="bibr">210</xref>,<xref rid="B211-nutrients-13-00462" ref-type="bibr">211</xref>,<xref rid="B212-nutrients-13-00462" ref-type="bibr">212</xref>,<xref rid="B213-nutrients-13-00462" ref-type="bibr">213</xref>,<xref rid="B214-nutrients-13-00462" ref-type="bibr">214</xref>,<xref rid="B215-nutrients-13-00462" ref-type="bibr">215</xref>] and had promising results in both healthy subjects [<xref rid="B108-nutrients-13-00462" ref-type="bibr">108</xref>,<xref rid="B154-nutrients-13-00462" ref-type="bibr">154</xref>,<xref rid="B162-nutrients-13-00462" ref-type="bibr">162</xref>,<xref rid="B197-nutrients-13-00462" ref-type="bibr">197</xref>,<xref rid="B198-nutrients-13-00462" ref-type="bibr">198</xref>,<xref rid="B206-nutrients-13-00462" ref-type="bibr">206</xref>,<xref rid="B207-nutrients-13-00462" ref-type="bibr">207</xref>,<xref rid="B216-nutrients-13-00462" ref-type="bibr">216</xref>] and high-risk individuals [<xref rid="B153-nutrients-13-00462" ref-type="bibr">153</xref>,<xref rid="B191-nutrients-13-00462" ref-type="bibr">191</xref>,<xref rid="B204-nutrients-13-00462" ref-type="bibr">204</xref>,<xref rid="B208-nutrients-13-00462" ref-type="bibr">208</xref>,<xref rid="B209-nutrients-13-00462" ref-type="bibr">209</xref>,<xref rid="B210-nutrients-13-00462" ref-type="bibr">210</xref>,<xref rid="B211-nutrients-13-00462" ref-type="bibr">211</xref>,<xref rid="B212-nutrients-13-00462" ref-type="bibr">212</xref>,<xref rid="B213-nutrients-13-00462" ref-type="bibr">213</xref>,<xref rid="B214-nutrients-13-00462" ref-type="bibr">214</xref>,<xref rid="B215-nutrients-13-00462" ref-type="bibr">215</xref>,<xref rid="B217-nutrients-13-00462" ref-type="bibr">217</xref>,<xref rid="B218-nutrients-13-00462" ref-type="bibr">218</xref>,<xref rid="B219-nutrients-13-00462" ref-type="bibr">219</xref>,<xref rid="B220-nutrients-13-00462" ref-type="bibr">220</xref>,<xref rid="B221-nutrients-13-00462" ref-type="bibr">221</xref>,<xref rid="B222-nutrients-13-00462" ref-type="bibr">222</xref>]. Additionally, ongoing or recently finished clinical trials regarding CODIV-19 are displayed in <xref rid="nutrients-13-00462-t002" ref-type="table">Table 2</xref>. It is noted that only nutrients or foods which may modulate PAF and/or its enzymes are displayed. To our knowledge there is no ongoing trial with such nutrients and PAF measurement as an end point.</p></sec><sec id="sec5-nutrients-13-00462"><title>5. Hypothesis versus Epidemiological Data</title><p>The hypothesis of the protective effect of the Mediterranean Diet against COVID-19 should be regarded in parallel with epidemiological data. It can be argued that several Mediterranean countries, such as Italy and Spain had a high burden of the disease. It is difficult to make a safe assumption since the adherence of Southern European Mediterranean countries to the Mediterranean diet is generally considered rather moderate [<xref rid="B228-nutrients-13-00462" ref-type="bibr">228</xref>]. However, the adoption of the Mediterranean diet is lower in northern Italy than in the south of the country, which may in part explain the observed situation in Italy [<xref rid="B229-nutrients-13-00462" ref-type="bibr">229</xref>].</p><p>Moreover, dietary changes in the quarantine may account for some differences, since limited access to fresh foods may be observed, in favor of packaged foods, which have a longer shelf life. Indeed, in Italy, 37.3% of respondents changed their diet and physical activity levels but only 16.7% of them improved their habits [<xref rid="B230-nutrients-13-00462" ref-type="bibr">230</xref>]. Italian adolescents increased their intake of legumes, fruit, sweets, and fast food during quarantine and had no change in vegetables intake, while Spanish adolescents and the general population displayed more healthy changes in their diet [<xref rid="B231-nutrients-13-00462" ref-type="bibr">231</xref>,<xref rid="B232-nutrients-13-00462" ref-type="bibr">232</xref>].</p><p>In contrast, preliminary results from the COVIdiet in Greece, presented at the Webinar held by the Hellenic Dietetic Association have shown that participants improved their eating habits and reduced their consumption of fast food, especially those who were already more aware of the importance of a healthy diet. However, cooking increased, and the preparation and consumption of homemade sweets and pastries also increased increased [<xref rid="B233-nutrients-13-00462" ref-type="bibr">233</xref>].</p></sec><sec sec-type="conclusions" id="sec6-nutrients-13-00462"><title>6. Conclusions</title><p>In conclusion, there is no single food to prevent, heal, or treat coronavirus. Although the relationship between PAF and COVID-19 is not robust, a healthy diet containing PAF inhibitors may target both inflammation and thrombosis and prevent the deleterious effects of COVID-19. After completing our theoretical new approach on PAF and COVID-19, the next step is the experimental confirmation or not of the PAF&#x02013;COVID-19 hypothesis.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>P.D. performed the literature search and data analysis and drafted the manuscript, C.A.D. and S.A. conceived the idea for the article and critically revised the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors have no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">PAF</td><td align="left" valign="middle" rowspan="1" colspan="1">platelet-activating factor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PAF-CPT</td><td align="left" valign="middle" rowspan="1" colspan="1">dithiothreitol-insensitive cholinephosphotransferase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CDP-choline</td><td align="left" valign="middle" rowspan="1" colspan="1">cytidine diphosphate-choline</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lp-PLA<sub>2</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">lipoprotein associated phospholipase A<sub>2</sub></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ACE2</td><td align="left" valign="middle" rowspan="1" colspan="1">angiotensin converting enzyme 2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TLR</td><td align="left" valign="middle" rowspan="1" colspan="1">Toll-like receptor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EPA</td><td align="left" valign="middle" rowspan="1" colspan="1">Eicosapentaenoic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DHA</td><td align="left" valign="middle" rowspan="1" colspan="1">Docosahexaenoic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CRP</td><td align="left" valign="middle" rowspan="1" colspan="1">C-reactive protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALA</td><td align="left" valign="middle" rowspan="1" colspan="1">alpha-linolenic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AT</td><td align="left" valign="middle" rowspan="1" colspan="1">acetyltransferase</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-nutrients-13-00462"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>W.J.</given-names></name><name><surname>Ni</surname><given-names>Z.Y.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>W.H.</given-names></name><name><surname>Ou</surname><given-names>C.Q.</given-names></name><name><surname>He</surname><given-names>J.X.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Shan</surname><given-names>H.</given-names></name><name><surname>Lei</surname><given-names>C.L.</given-names></name><name><surname>Hui</surname><given-names>D.S.C.</given-names></name><etal/></person-group><article-title>Clinical Characteristics of coronavirus disease 2019 in China</article-title><source>N. Engl. J. Med.</source><year>2020</year><volume>382</volume><fpage>1708</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id><?supplied-pmid 32109013?><pub-id pub-id-type="pmid">32109013</pub-id></element-citation></ref><ref id="B2-nutrients-13-00462"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demopoulos</surname><given-names>C.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Theocharides</surname><given-names>T.</given-names></name></person-group><article-title>CoVid-19, microthromboses, inflammation and platelet activating factor (PAF)</article-title><source>Biofactors</source><year>2002</year><volume>46</volume><fpage>927</fpage><lpage>933</lpage></element-citation></ref><ref id="B3-nutrients-13-00462"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>K.</given-names></name><name><surname>Lin</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Evaluation of nutrition risk and its association with mortality risk in severely and critically Ill COVID-19 Patients</article-title><source>J. Parenter. Enter. Nutr.</source><year>2020</year><pub-id pub-id-type="doi">10.1002/jpen.1953</pub-id><?supplied-pmid 32613660?><pub-id pub-id-type="pmid">32613660</pub-id></element-citation></ref><ref id="B4-nutrients-13-00462"><label>4.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>British Dietetic Association</collab></person-group><article-title>COVID-19/Coronavirus&#x02014;Advice for the General Public</article-title><year>2020</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.bda.uk.com/resource/covid-19-corona-virus-advice-for-the-general-public.html">https://www.bda.uk.com/resource/covid-19-corona-virus-advice-for-the-general-public.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-04-14">(accessed on 14 April 2020)</date-in-citation></element-citation></ref><ref id="B5-nutrients-13-00462"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caccialanza</surname><given-names>R.</given-names></name><name><surname>Laviano</surname><given-names>A.</given-names></name><name><surname>Lobascio</surname><given-names>F.</given-names></name><name><surname>Montagna</surname><given-names>E.</given-names></name><name><surname>Bruno</surname><given-names>R.</given-names></name><name><surname>Ludovisi</surname><given-names>S.</given-names></name><name><surname>Corsico</surname><given-names>A.G.</given-names></name><name><surname>Di Sabatino</surname><given-names>A.</given-names></name><name><surname>Belliato</surname><given-names>M.</given-names></name><name><surname>Calvi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol</article-title><source>Nutrition</source><year>2020</year><volume>74</volume><fpage>110835</fpage><pub-id pub-id-type="doi">10.1016/j.nut.2020.110835</pub-id><?supplied-pmid 32280058?><pub-id pub-id-type="pmid">32280058</pub-id></element-citation></ref><ref id="B6-nutrients-13-00462"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cintoni</surname><given-names>M.</given-names></name><name><surname>Rinninella</surname><given-names>E.</given-names></name><name><surname>Annetta</surname><given-names>M.G.</given-names></name><name><surname>Mele</surname><given-names>M.C.</given-names></name></person-group><article-title>Nutritional management in hospital setting during SARS-CoV-2 pandemic: A real-life experience</article-title><source>Eur. J. Clin. Nutr.</source><year>2020</year><volume>74</volume><fpage>846</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1038/s41430-020-0625-4</pub-id><?supplied-pmid 32253375?><pub-id pub-id-type="pmid">32253375</pub-id></element-citation></ref><ref id="B7-nutrients-13-00462"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>A.C.</given-names></name></person-group><article-title>A new clinical trial to test high-dose vitamin C in patients with COVID-19</article-title><source>Crit. Care</source><year>2020</year><volume>24</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1186/s13054-020-02851-4</pub-id><pub-id pub-id-type="pmid">31898531</pub-id></element-citation></ref><ref id="B8-nutrients-13-00462"><label>8.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>Food and Agriculture Organization of the United Nations</collab></person-group><article-title>Maintaining a Healthy Diet during the COVID-19 Pandemic</article-title><year>2020</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.fao.org/3/ca8380en/CA8380EN.pdf">http://www.fao.org/3/ca8380en/CA8380EN.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-01-27">(accessed on 27 January 2021)</date-in-citation></element-citation></ref><ref id="B9-nutrients-13-00462"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelesidis</surname><given-names>T.</given-names></name><name><surname>Papakonstantinou</surname><given-names>V.</given-names></name><name><surname>Detopoulou</surname><given-names>P.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Chini</surname><given-names>M.</given-names></name><name><surname>Lazanas</surname><given-names>M.C.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>The role of platelet-activating factor in chronic inflammation, immune activation, and comorbidities associated with hiv infection</article-title><source>Aids Rev.</source><year>2015</year><volume>17</volume><fpage>191</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">26616844</pub-id></element-citation></ref><ref id="B10-nutrients-13-00462"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabetakis</surname><given-names>I.</given-names></name><name><surname>Lordan</surname><given-names>R.</given-names></name><name><surname>Norton</surname><given-names>C.</given-names></name><name><surname>Tsoupras</surname><given-names>A.</given-names></name></person-group><article-title>COVID-19: The Inflammation link and the role of nutrition in potential mitigation</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1466</elocation-id><pub-id pub-id-type="doi">10.3390/nu12051466</pub-id></element-citation></ref><ref id="B11-nutrients-13-00462"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Panagiotakos</surname><given-names>D.B.</given-names></name></person-group><article-title>Mediterranean diet and platelet-activating factor; a systematic review</article-title><source>Clin. Biochem.</source><year>2018</year><volume>60</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2018.08.004</pub-id><pub-id pub-id-type="pmid">30142319</pub-id></element-citation></ref><ref id="B12-nutrients-13-00462"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoupras</surname><given-names>A.</given-names></name><name><surname>Lordan</surname><given-names>R.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Thrombosis and COVID-19: The Potential role of nutrition</article-title><source>Front. Nutr.</source><year>2020</year><volume>7</volume><pub-id pub-id-type="doi">10.3389/fnut.2020.583080</pub-id></element-citation></ref><ref id="B13-nutrients-13-00462"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theoharides</surname><given-names>T.C.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Coronavirus 2019, Microthromboses, and platelet activating factor</article-title><source>Clin. Ther.</source><year>2020</year><volume>42</volume><fpage>1850</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2020.08.006</pub-id><?supplied-pmid 32883529?><pub-id pub-id-type="pmid">32883529</pub-id></element-citation></ref><ref id="B14-nutrients-13-00462"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Pinckard</surname><given-names>R.N.</given-names></name><name><surname>Hanahan</surname><given-names>D.J.</given-names></name></person-group><article-title>Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)</article-title><source>J. Biol. Chem.</source><year>1979</year><volume>254</volume><fpage>9355</fpage><lpage>9358</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)83523-8</pub-id><pub-id pub-id-type="pmid">489536</pub-id></element-citation></ref><ref id="B15-nutrients-13-00462"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>M.A.</given-names></name><name><surname>Nookala</surname><given-names>V.</given-names></name></person-group><article-title>Biochemistry, Platelet activating factor</article-title><source>StatPearls</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2020</year></element-citation></ref><ref id="B16-nutrients-13-00462"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lordan</surname><given-names>R.</given-names></name><name><surname>Tsoupras</surname><given-names>A.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Forty years since the structural elucidation of platelet-activating factor (PAF): Historical, Current, and future research perspectives</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>4414</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24234414</pub-id><?supplied-pmid 31816871?><pub-id pub-id-type="pmid">31816871</pub-id></element-citation></ref><ref id="B17-nutrients-13-00462"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Detopoulou</surname><given-names>P.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Chrysohoou</surname><given-names>C.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>Platelet activating factor in heart failure: Potential role in disease progression and novel target for therapy</article-title><source>Curr. Heart Fail. Rep.</source><year>2013</year><volume>10</volume><fpage>122</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1007/s11897-013-0131-2</pub-id><pub-id pub-id-type="pmid">23389700</pub-id></element-citation></ref><ref id="B18-nutrients-13-00462"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>A.I.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Kulchitsky</surname><given-names>V.A.</given-names></name><name><surname>Romanovsky</surname><given-names>A.A.</given-names></name></person-group><article-title>Platelet-Activating factor: A Previously unrecognized mediator of fever</article-title><source>J. Physiol.</source><year>2003</year><volume>553</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.055616</pub-id><pub-id pub-id-type="pmid">14565987</pub-id></element-citation></ref><ref id="B19-nutrients-13-00462"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>H.</given-names></name><name><surname>Sawa</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>H.</given-names></name></person-group><article-title>Mechanism of increased angiotensin-converting enzyme activity stimulated by platelet-activating factor</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><year>1990</year><volume>1052</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1016/0167-4889(90)90162-7</pub-id></element-citation></ref><ref id="B20-nutrients-13-00462"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>P.K.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Fischer</surname><given-names>T.</given-names></name><name><surname>Rappaport</surname><given-names>J.</given-names></name><name><surname>Qin</surname><given-names>X.</given-names></name></person-group><article-title>SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy</article-title><source>Theranostics</source><year>2020</year><volume>10</volume><fpage>7448</fpage><lpage>7464</lpage><pub-id pub-id-type="doi">10.7150/thno.48076</pub-id><pub-id pub-id-type="pmid">32642005</pub-id></element-citation></ref><ref id="B21-nutrients-13-00462"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Sze</surname><given-names>K.-H.</given-names></name><name><surname>Lai</surname><given-names>P.-M.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name><name><surname>Shuai</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Kao</surname><given-names>R.Y.T.</given-names></name><name><surname>Chan</surname><given-names>J.F.-W.</given-names></name><etal/></person-group><article-title>Characterization of the Lipidomic profile of human coronavirus-infected cells: Implications for Lipid metabolism remodeling upon coronavirus replication</article-title><source>Viruses</source><year>2019</year><volume>11</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.3390/v11010073</pub-id></element-citation></ref><ref id="B22-nutrients-13-00462"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marathe</surname><given-names>G.</given-names></name></person-group><article-title>Oxidized LDL Contains inflammatory PAF-Like phospholipids</article-title><source>Trends Cardiovasc. Med.</source><year>2001</year><volume>11</volume><fpage>139</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/S1050-1738(01)00100-1</pub-id><pub-id pub-id-type="pmid">11686003</pub-id></element-citation></ref><ref id="B23-nutrients-13-00462"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liapikos</surname><given-names>T.A.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Karabina</surname><given-names>S.-A.P.</given-names></name><name><surname>Tsoukatos</surname><given-names>D.C.A.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Tselepis</surname><given-names>A.D.</given-names></name></person-group><article-title>Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated</article-title><source>Biochim. Biophys. Acta Lipids Lipid Metab.</source><year>1994</year><volume>1212</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(94)90210-0</pub-id></element-citation></ref><ref id="B24-nutrients-13-00462"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>Y.</given-names></name><name><surname>Kuba</surname><given-names>K.</given-names></name><name><surname>Neely</surname><given-names>G.G.</given-names></name><name><surname>Yaghubian-Malhami</surname><given-names>R.</given-names></name><name><surname>Perkmann</surname><given-names>T.</given-names></name><name><surname>van Loo</surname><given-names>G.</given-names></name><name><surname>Ermolaeva</surname><given-names>M.</given-names></name><name><surname>Veldhuizen</surname><given-names>R.</given-names></name><name><surname>Leung</surname><given-names>Y.H.C.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Identification of Oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury</article-title><source>Cell</source><year>2008</year><volume>133</volume><fpage>235</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.02.043</pub-id><?supplied-pmid 18423196?><pub-id pub-id-type="pmid">18423196</pub-id></element-citation></ref><ref id="B25-nutrients-13-00462"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name></person-group><article-title>Elevated Levels of platelet activating factor and its acetylhydrolase indicate high risk of kawasaki disease</article-title><source>J. Interferon Cytokine Res.</source><year>2020</year><volume>40</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1089/jir.2019.0141</pub-id><?supplied-pmid 31841639?><pub-id pub-id-type="pmid">31841639</pub-id></element-citation></ref><ref id="B26-nutrients-13-00462"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muehlmann</surname><given-names>L.A.</given-names></name><name><surname>Michelotto</surname><given-names>P.V.</given-names></name><name><surname>Nunes</surname><given-names>E.A.</given-names></name><name><surname>Grando</surname><given-names>F.C.C.</given-names></name><name><surname>da Silva</surname><given-names>F.T.</given-names></name><name><surname>Nishiyama</surname><given-names>A.</given-names></name></person-group><article-title>PAF increases phagocytic capacity and superoxide anion production in equine alveolar macrophages and blood neutrophils</article-title><source>Res. Vet. Sci.</source><year>2012</year><volume>93</volume><fpage>393</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.rvsc.2011.07.008</pub-id><?supplied-pmid 21820686?><pub-id pub-id-type="pmid">21820686</pub-id></element-citation></ref><ref id="B27-nutrients-13-00462"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagiorga</surname><given-names>G.</given-names></name><name><surname>Nakos</surname><given-names>G.</given-names></name><name><surname>Galiatsou</surname><given-names>E.</given-names></name><name><surname>Lekka</surname><given-names>M.E.</given-names></name></person-group><article-title>Biochemical parameters of bronchoalveolar lavage fluid in fat embolism</article-title><source>Intensive Care Med.</source><year>2005</year><volume>32</volume><fpage>116</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1007/s00134-005-2868-x</pub-id><?supplied-pmid 16322975?><pub-id pub-id-type="pmid">16322975</pub-id></element-citation></ref><ref id="B28-nutrients-13-00462"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caplan</surname><given-names>M.S.</given-names></name><name><surname>Hsueh</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Gidding</surname><given-names>S.S.</given-names></name><name><surname>Hageman</surname><given-names>J.R.</given-names></name></person-group><article-title>Circulating plasma platelet activating factor in persistent pulmonary hypertension of the newborn</article-title><source>Am. Rev. Respir. Dis.</source><year>1990</year><volume>142</volume><fpage>1258</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1164/ajrccm/142.6_Pt_1.1258</pub-id><pub-id pub-id-type="pmid">2252241</pub-id></element-citation></ref><ref id="B29-nutrients-13-00462"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trimoreau</surname><given-names>F.</given-names></name><name><surname>Fran&#x000e7;ois</surname><given-names>B.</given-names></name><name><surname>Desachy</surname><given-names>A.</given-names></name><name><surname>Besse</surname><given-names>A.</given-names></name><name><surname>Vignon</surname><given-names>P.</given-names></name><name><surname>Denizot</surname><given-names>Y.</given-names></name></person-group><article-title>Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome</article-title><source>Mediat. Inflamm.</source><year>2000</year><volume>9</volume><fpage>197</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1080/09629350020002921</pub-id></element-citation></ref><ref id="B30-nutrients-13-00462"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>S.</given-names></name><name><surname>G&#x000f6;ggel</surname><given-names>R.</given-names></name><name><surname>Heydasch</surname><given-names>U.</given-names></name><name><surname>Brasch</surname><given-names>F.</given-names></name><name><surname>Muller</surname><given-names>K.-M.</given-names></name><name><surname>Wendel</surname><given-names>A.</given-names></name><name><surname>Uhlig</surname><given-names>S.</given-names></name></person-group><article-title>Quinolines Attenuate paf-induced pulmonary pressor responses and edema formation</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>1999</year><volume>160</volume><fpage>1734</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.160.5.9902033</pub-id><pub-id pub-id-type="pmid">10556149</pub-id></element-citation></ref><ref id="B31-nutrients-13-00462"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz-Cano</surname><given-names>R.M.</given-names></name><name><surname>Casas-Saucedo</surname><given-names>R.</given-names></name><name><surname>Santiago</surname><given-names>A.V.</given-names></name><name><surname>Bobolea</surname><given-names>I.</given-names></name><name><surname>Rib&#x000f3;</surname><given-names>P.</given-names></name><name><surname>Mullol</surname><given-names>J.</given-names></name></person-group><article-title>Platelet-Activating factor (PAF) in Allergic rhinitis: Clinical and therapeutic implications</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><elocation-id>1338</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8091338</pub-id></element-citation></ref><ref id="B32-nutrients-13-00462"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsantila</surname><given-names>N.</given-names></name><name><surname>Tsoupras</surname><given-names>A.B.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Iatrou</surname><given-names>C.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>In Vitro and in vivo effects of statins on platelet-activating factor and its metabolism</article-title><source>Angiology</source><year>2010</year><volume>62</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1177/0003319710375089</pub-id><pub-id pub-id-type="pmid">20805097</pub-id></element-citation></ref><ref id="B33-nutrients-13-00462"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoupras</surname><given-names>A.B.</given-names></name><name><surname>Chini</surname><given-names>M.</given-names></name><name><surname>Tsogas</surname><given-names>N.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Lioni</surname><given-names>A.</given-names></name><name><surname>Mangafas</surname><given-names>N.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Lazanas</surname><given-names>M.C.</given-names></name></person-group><article-title>Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): A New insight in the drug therapy of HIV infection?</article-title><source>AIDS Res. Hum. Retrovir.</source><year>2008</year><volume>24</volume><fpage>1079</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1089/aid.2007.0263</pub-id><pub-id pub-id-type="pmid">18620493</pub-id></element-citation></ref><ref id="B34-nutrients-13-00462"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Detopoulou</surname><given-names>P.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Yannakoulia</surname><given-names>M.</given-names></name><name><surname>Stamatakis</surname><given-names>G.</given-names></name><name><surname>Panagiotakos</surname><given-names>D.B.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>The relation of diet with PAF and its metabolic enzymes in healthy volunteers</article-title><source>Eur. J. Nutr.</source><year>2014</year><volume>54</volume><fpage>25</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1007/s00394-014-0682-3</pub-id><?supplied-pmid 24639073?><pub-id pub-id-type="pmid">24639073</pub-id></element-citation></ref><ref id="B35-nutrients-13-00462"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Detopoulou</surname><given-names>P.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>Mediterranean diet and its protective mechanisms against cardiovascular disease: An insight into Platelet Activating Factor (PAF) and diet interplay</article-title><source>Ann. Nutr. Disord. Ther.</source><year>2015</year><volume>2</volume><fpage>1016</fpage></element-citation></ref><ref id="B36-nutrients-13-00462"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsantila</surname><given-names>N.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Perrea</surname><given-names>D.N.</given-names></name><name><surname>Theocharis</surname><given-names>S.E.</given-names></name><name><surname>Iliopoulos</surname><given-names>D.G.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Antithrombotic and Antiatherosclerotic Properties of olive oil and olive pomace polar extracts in rabbits</article-title><source>Mediat. Inflamm.</source><year>2007</year><volume>2007</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1155/2007/36204</pub-id><?supplied-pmid 18253466?><pub-id pub-id-type="pmid">18253466</pub-id></element-citation></ref><ref id="B37-nutrients-13-00462"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Quintela</surname><given-names>A.</given-names></name><name><surname>Milton-Lask&#x000ed;bar</surname><given-names>I.</given-names></name><name><surname>Trepiana</surname><given-names>J.</given-names></name><name><surname>G&#x000f3;mez-Zorita</surname><given-names>S.</given-names></name><name><surname>Kajarabille</surname><given-names>N.</given-names></name><name><surname>L&#x000e9;niz</surname><given-names>A.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>M.</given-names></name><name><surname>Portillo</surname><given-names>M.P.</given-names></name></person-group><article-title>Key Aspects in nutritional management of COVID-19 Patients</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>2589</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9082589</pub-id><?supplied-pmid 32785121?><pub-id pub-id-type="pmid">32785121</pub-id></element-citation></ref><ref id="B38-nutrients-13-00462"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasmi</surname><given-names>A.</given-names></name><name><surname>Tippairote</surname><given-names>T.</given-names></name><name><surname>Mujawdiya</surname><given-names>P.K.</given-names></name><name><surname>Peana</surname><given-names>M.</given-names></name><name><surname>Menzel</surname><given-names>A.</given-names></name><name><surname>Dadar</surname><given-names>M.</given-names></name><name><surname>Benahmed</surname><given-names>A.G.</given-names></name><name><surname>Bj&#x000f8;rklund</surname><given-names>G.</given-names></name></person-group><article-title>Micronutrients as immunomodulatory tools for COVID-19 management</article-title><source>Clin. Immunol.</source><year>2020</year><volume>220</volume><fpage>108545</fpage><pub-id pub-id-type="doi">10.1016/j.clim.2020.108545</pub-id><pub-id pub-id-type="pmid">32710937</pub-id></element-citation></ref><ref id="B39-nutrients-13-00462"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>B.P.</given-names></name><name><surname>Park</surname><given-names>J.S.</given-names></name></person-group><article-title>Carotenoid action on the immune response</article-title><source>J. Nutr.</source><year>2004</year><volume>134</volume><fpage>257S</fpage><lpage>261S</lpage><pub-id pub-id-type="doi">10.1093/jn/134.1.257S</pub-id><pub-id pub-id-type="pmid">14704330</pub-id></element-citation></ref><ref id="B40-nutrients-13-00462"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sezavar</surname><given-names>H.</given-names></name><name><surname>Saboor-Yaraghi</surname><given-names>A.-A.</given-names></name><name><surname>Salehi</surname><given-names>E.</given-names></name><name><surname>Mottaghi</surname><given-names>A.</given-names></name></person-group><article-title>Whether vitamin A supplementation is effective in T-bet and IFN-&#x00263; gene expression reduction?</article-title><source>Immunol. Investig.</source><year>2014</year><volume>44</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.3109/08820139.2014.953635</pub-id><pub-id pub-id-type="pmid">25496023</pub-id></element-citation></ref><ref id="B41-nutrients-13-00462"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timoneda</surname><given-names>J.</given-names></name><name><surname>Rodr&#x000ed;guez-Fern&#x000e1;ndez</surname><given-names>L.</given-names></name><name><surname>Zaragoz&#x000e1;</surname><given-names>R.</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>M.</given-names></name><name><surname>Cabezuelo</surname><given-names>M.</given-names></name><name><surname>Torres</surname><given-names>L.</given-names></name><name><surname>Vi&#x000f1;a</surname><given-names>J.</given-names></name><name><surname>Barber</surname><given-names>T.</given-names></name></person-group><article-title>Vitamin A deficiency and the lung</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1132</elocation-id><pub-id pub-id-type="doi">10.3390/nu10091132</pub-id></element-citation></ref><ref id="B42-nutrients-13-00462"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutoh</surname><given-names>H.</given-names></name><name><surname>Fukuda</surname><given-names>T.</given-names></name><name><surname>Kitamaoto</surname><given-names>T.</given-names></name><name><surname>Masushige</surname><given-names>S.</given-names></name><name><surname>Sasaki</surname><given-names>H.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>S.</given-names></name></person-group><article-title>Tissue-specific response of the human platelet-activating factor receptor gene to retinoic acid and thyroid hormone by alternative promoter usage</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>774</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.2.774</pub-id><pub-id pub-id-type="pmid">8570633</pub-id></element-citation></ref><ref id="B43-nutrients-13-00462"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazan</surname><given-names>N.G.</given-names></name><name><surname>Fletcher</surname><given-names>B.S.</given-names></name><name><surname>Herschman</surname><given-names>H.R.</given-names></name><name><surname>Mukherjee</surname><given-names>P.K.</given-names></name></person-group><article-title>Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>5252</fpage><lpage>5256</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.12.5252</pub-id><pub-id pub-id-type="pmid">8202477</pub-id></element-citation></ref><ref id="B44-nutrients-13-00462"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claar</surname><given-names>D.</given-names></name><name><surname>Hartert</surname><given-names>T.V.</given-names></name><name><surname>Peebles</surname><given-names>R.S.</given-names></name></person-group><article-title>The role of prostaglandins in allergic lung inflammation and asthma</article-title><source>Expert Rev. Respir. Med.</source><year>2014</year><volume>9</volume><fpage>55</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1586/17476348.2015.992783</pub-id><?supplied-pmid 25541289?><pub-id pub-id-type="pmid">25541289</pub-id></element-citation></ref><ref id="B45-nutrients-13-00462"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsimikas</surname><given-names>S.</given-names></name><name><surname>Willeit</surname><given-names>J.</given-names></name><name><surname>Knoflach</surname><given-names>M.</given-names></name><name><surname>Mayr</surname><given-names>M.</given-names></name><name><surname>Egger</surname><given-names>G.</given-names></name><name><surname>Notdurfter</surname><given-names>M.</given-names></name><name><surname>Witztum</surname><given-names>J.L.</given-names></name><name><surname>Wiedermann</surname><given-names>C.J.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Kiechl</surname><given-names>S.</given-names></name></person-group><article-title>Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: Results from the Bruneck study</article-title><source>Eur. Heart J.</source><year>2008</year><volume>30</volume><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehn502</pub-id><?supplied-pmid 19019993?><pub-id pub-id-type="pmid">19019993</pub-id></element-citation></ref><ref id="B46-nutrients-13-00462"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Camussi</surname><given-names>G.</given-names></name><name><surname>Tetta</surname><given-names>C.</given-names></name><name><surname>Milgrom</surname><given-names>F.</given-names></name><name><surname>Andres</surname><given-names>G.</given-names></name></person-group><article-title>Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets</article-title><source>Lab. Investig.</source><year>1984</year><volume>51</volume><fpage>148</fpage><lpage>161</lpage><?supplied-pmid 6379289?><pub-id pub-id-type="pmid">6379289</pub-id></element-citation></ref><ref id="B47-nutrients-13-00462"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>A.C.</given-names></name><name><surname>Maggini</surname><given-names>S.</given-names></name></person-group><article-title>Vitamin C and Immune function</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>1211</elocation-id><pub-id pub-id-type="doi">10.3390/nu9111211</pub-id><?supplied-pmid 29099763?><pub-id pub-id-type="pmid">29099763</pub-id></element-citation></ref><ref id="B48-nutrients-13-00462"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakoor</surname><given-names>H.</given-names></name><name><surname>Feehan</surname><given-names>J.</given-names></name><name><surname>Al Dhaheri</surname><given-names>A.S.</given-names></name><name><surname>Ali</surname><given-names>H.I.</given-names></name><name><surname>Platat</surname><given-names>C.</given-names></name><name><surname>Ismail</surname><given-names>L.C.</given-names></name><name><surname>Apostolopoulos</surname><given-names>V.</given-names></name><name><surname>Stojanovska</surname><given-names>L.</given-names></name></person-group><article-title>Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?</article-title><source>Maturitas</source><year>2021</year><volume>143</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2020.08.003</pub-id><pub-id pub-id-type="pmid">33308613</pub-id></element-citation></ref><ref id="B49-nutrients-13-00462"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemil&#x000e4;</surname><given-names>H.</given-names></name><name><surname>Louhiala</surname><given-names>P.</given-names></name></person-group><article-title>Vitamin C for preventing and treating pneumonia</article-title><source>Cochrane Database Syst. Rev.</source><year>2013</year><volume>8</volume><fpage>CD005532</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD005532.pub3</pub-id></element-citation></ref><ref id="B50-nutrients-13-00462"><label>50.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Australian Governement, Department of Health</collab></person-group><source>No Evidence to Support Intravenous High-Dose Vitamin C in the Management of COVID-19</source><publisher-name>Therapeutic Group Administration</publisher-name><publisher-loc>Canberra, Australia</publisher-loc><year>2020</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.tga.gov.au/node/904121">https://www.tga.gov.au/node/904121</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-01-27">(accessed on 27 January 2021)</date-in-citation></element-citation></ref><ref id="B51-nutrients-13-00462"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tousoulis</surname><given-names>D.</given-names></name><name><surname>Antoniades</surname><given-names>C.</given-names></name><name><surname>Tountas</surname><given-names>C.</given-names></name><name><surname>Bosinakou</surname><given-names>E.</given-names></name><name><surname>Kotsopoulou</surname><given-names>M.</given-names></name><name><surname>Toutouzas</surname><given-names>P.</given-names></name><name><surname>Stefanadis</surname><given-names>C.</given-names></name></person-group><article-title>Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><fpage>2749</fpage><lpage>2753</lpage><pub-id pub-id-type="doi">10.2337/diacare.26.10.2749</pub-id><pub-id pub-id-type="pmid">14514574</pub-id></element-citation></ref><ref id="B52-nutrients-13-00462"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spittle</surname><given-names>C.R.</given-names></name></person-group><article-title>Vitamin C and deep vein thrombosis</article-title><source>Lancet</source><year>1973</year><volume>302</volume><fpage>199</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(73)93027-4</pub-id></element-citation></ref><ref id="B53-nutrients-13-00462"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloberas</surname><given-names>N.</given-names></name><name><surname>Torras</surname><given-names>J.</given-names></name><name><surname>Herrero-Fresneda</surname><given-names>I.</given-names></name><name><surname>Cruzado</surname><given-names>J.M.</given-names></name><name><surname>Riera</surname><given-names>M.</given-names></name><name><surname>Hurtado</surname><given-names>I.</given-names></name><name><surname>Griny&#x000f3;</surname><given-names>J.M.</given-names></name></person-group><article-title>Postischemic renal oxidative stress induces an inflammatory response through PAF and oxidized phospholipids: Prevention by antioxidant treatment</article-title><source>FASEB J.</source><year>2002</year><volume>16</volume><fpage>908</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1096/fj.01-0880fje</pub-id><pub-id pub-id-type="pmid">12039876</pub-id></element-citation></ref><ref id="B54-nutrients-13-00462"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>M.S.</given-names></name><name><surname>Whatley</surname><given-names>R.E.</given-names></name><name><surname>Cain</surname><given-names>P.</given-names></name><name><surname>McIntyre</surname><given-names>T.M.</given-names></name><name><surname>Prescott</surname><given-names>S.M.</given-names></name><name><surname>Zimmerman</surname><given-names>G.A.</given-names></name></person-group><article-title>Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion</article-title><source>J. Clin. Investig.</source><year>1988</year><volume>82</volume><fpage>2045</fpage><lpage>2055</lpage><pub-id pub-id-type="doi">10.1172/JCI113825</pub-id><pub-id pub-id-type="pmid">3198764</pub-id></element-citation></ref><ref id="B55-nutrients-13-00462"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verouti</surname><given-names>S.N.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Dimitriou</surname><given-names>A.A.</given-names></name><name><surname>Tselepis</surname><given-names>A.D.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with OxLDL and IL-1&#x003b2; effects</article-title><source>Atherosclerosis</source><year>2011</year><volume>219</volume><fpage>519</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2011.07.123</pub-id><?supplied-pmid 21920519?><pub-id pub-id-type="pmid">21920519</pub-id></element-citation></ref><ref id="B56-nutrients-13-00462"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>J.</given-names></name><name><surname>Carter</surname><given-names>B.</given-names></name><name><surname>Vilches-Moraga</surname><given-names>A.</given-names></name><name><surname>Quinn</surname><given-names>T.J.</given-names></name><name><surname>Braude</surname><given-names>P.</given-names></name><name><surname>Verduri</surname><given-names>A.</given-names></name><name><surname>Pearce</surname><given-names>L.</given-names></name><name><surname>Stechman</surname><given-names>M.</given-names></name><name><surname>Short</surname><given-names>R.</given-names></name><name><surname>Price</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The effect of frailty on survival in patients with COVID-19 (COPE): A multicentre, european, observational cohort study</article-title><source>Lancet Public Health</source><year>2020</year><volume>5</volume><fpage>e444</fpage><lpage>e451</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(20)30146-8</pub-id><pub-id pub-id-type="pmid">32619408</pub-id></element-citation></ref><ref id="B57-nutrients-13-00462"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soysal</surname><given-names>P.</given-names></name><name><surname>Isik</surname><given-names>A.T.</given-names></name><name><surname>Carvalho</surname><given-names>A.F.</given-names></name><name><surname>Fernandes</surname><given-names>B.S.</given-names></name><name><surname>Solmi</surname><given-names>M.</given-names></name><name><surname>Schofield</surname><given-names>P.</given-names></name><name><surname>Veronese</surname><given-names>N.</given-names></name><name><surname>Stubbs</surname><given-names>B.</given-names></name></person-group><article-title>Oxidative stress and frailty: A systematic review and synthesis of the best evidence</article-title><source>Maturitas</source><year>2017</year><volume>99</volume><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2017.01.006</pub-id><?supplied-pmid 28364871?><pub-id pub-id-type="pmid">28364871</pub-id></element-citation></ref><ref id="B58-nutrients-13-00462"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourbour</surname><given-names>F.</given-names></name><name><surname>Dahka</surname><given-names>S.M.</given-names></name><name><surname>Gholamalizadeh</surname><given-names>M.</given-names></name><name><surname>Akbari</surname><given-names>M.E.</given-names></name><name><surname>Shadnoush</surname><given-names>M.</given-names></name><name><surname>Haghighi</surname><given-names>M.</given-names></name><name><surname>Taghvaye-Masoumi</surname><given-names>H.</given-names></name><name><surname>Ashoori</surname><given-names>N.</given-names></name><name><surname>Doaei</surname><given-names>S.</given-names></name></person-group><article-title>Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus</article-title><source>Arch. Physiol. Biochem.</source><year>2020</year><volume>1&#x02013;10</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1080/13813455.2020.1791188</pub-id><?supplied-pmid 32644876?><pub-id pub-id-type="pmid">32644876</pub-id></element-citation></ref><ref id="B59-nutrients-13-00462"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>A.R.</given-names></name><name><surname>Jolliffe</surname><given-names>D.A.</given-names></name><name><surname>Hooper</surname><given-names>R.L.</given-names></name><name><surname>Greenberg</surname><given-names>L.</given-names></name><name><surname>Aloia</surname><given-names>J.F.</given-names></name><name><surname>Bergman</surname><given-names>P.</given-names></name><name><surname>Dubnov-Raz</surname><given-names>G.</given-names></name><name><surname>Esposito</surname><given-names>S.</given-names></name><name><surname>Ganmaa</surname><given-names>D.</given-names></name><name><surname>Ginde</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data</article-title><source>BMJ</source><year>2017</year><volume>356</volume><fpage>i6583</fpage><pub-id pub-id-type="doi">10.1136/bmj.i6583</pub-id><pub-id pub-id-type="pmid">28202713</pub-id></element-citation></ref><ref id="B60-nutrients-13-00462"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.-C.</given-names></name><name><surname>Wang</surname><given-names>W.-W.</given-names></name><name><surname>Jiang</surname><given-names>W.-Y.</given-names></name><name><surname>Li</surname><given-names>C.-Q.</given-names></name><name><surname>Guo</surname><given-names>J.-C.</given-names></name><name><surname>Xun</surname><given-names>Y.</given-names></name></person-group><article-title>Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: A systematic review and meta-analysis</article-title><source>BMC Gastroenterol.</source><year>2019</year><volume>19</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s12876-019-1004-2</pub-id><?supplied-pmid 31185932?><pub-id pub-id-type="pmid">30611218</pub-id></element-citation></ref><ref id="B61-nutrients-13-00462"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>R.F.</given-names></name><name><surname>Liu</surname><given-names>N.Q.</given-names></name><name><surname>Lee</surname><given-names>T.</given-names></name><name><surname>Schall</surname><given-names>J.I.</given-names></name><name><surname>Denburg</surname><given-names>M.R.</given-names></name><name><surname>Rutstein</surname><given-names>R.M.</given-names></name><name><surname>Adams</surname><given-names>J.S.</given-names></name><name><surname>Zemel</surname><given-names>B.S.</given-names></name><name><surname>Stallings</surname><given-names>V.A.</given-names></name><name><surname>Hewison</surname><given-names>M.</given-names></name></person-group><article-title>Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS</article-title><source>J. Steroid Biochem. Mol. Biol.</source><year>2015</year><volume>148</volume><fpage>290</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/j.jsbmb.2014.07.013</pub-id><pub-id pub-id-type="pmid">25092518</pub-id></element-citation></ref><ref id="B62-nutrients-13-00462"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilie</surname><given-names>P.C.</given-names></name><name><surname>Stefanescu</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>L.</given-names></name></person-group><article-title>The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality</article-title><source>Aging Clin. Exp. Res.</source><year>2020</year><volume>32</volume><fpage>1195</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1007/s40520-020-01570-8</pub-id><pub-id pub-id-type="pmid">32377965</pub-id></element-citation></ref><ref id="B63-nutrients-13-00462"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastie</surname><given-names>C.E.</given-names></name><name><surname>Mackay</surname><given-names>D.F.</given-names></name><name><surname>Ho</surname><given-names>F.K.</given-names></name><name><surname>Celis-Morales</surname><given-names>C.A.</given-names></name><name><surname>Katikireddi</surname><given-names>S.V.</given-names></name><name><surname>Niedzwiedz</surname><given-names>C.L.</given-names></name><name><surname>Jani</surname><given-names>B.D.</given-names></name><name><surname>Welsh</surname><given-names>P.</given-names></name><name><surname>Mair</surname><given-names>F.S.</given-names></name><name><surname>Gray</surname><given-names>S.R.</given-names></name><etal/></person-group><article-title>Vitamin D concentrations and COVID-19 infection in UK Biobank</article-title><source>Diabetes Metab. Syndr. Clin. Res. Rev.</source><year>2020</year><volume>14</volume><fpage>561</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.dsx.2020.04.050</pub-id></element-citation></ref><ref id="B64-nutrients-13-00462"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Avolio</surname><given-names>A.</given-names></name><name><surname>Avataneo</surname><given-names>V.</given-names></name><name><surname>Manca</surname><given-names>A.</given-names></name><name><surname>Cusato</surname><given-names>J.</given-names></name><name><surname>De Nicol&#x000f2;</surname><given-names>A.</given-names></name><name><surname>Lucchini</surname><given-names>R.</given-names></name><name><surname>Keller</surname><given-names>F.</given-names></name><name><surname>Cant&#x000f9;</surname><given-names>M.</given-names></name></person-group><article-title>25-Hydroxyvitamin D Concentrations are lower in patients with positive PCR for SARS-CoV-2</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1359</elocation-id><pub-id pub-id-type="doi">10.3390/nu12051359</pub-id></element-citation></ref><ref id="B65-nutrients-13-00462"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>J.H.</given-names></name><name><surname>Je</surname><given-names>Y.S.</given-names></name><name><surname>Baek</surname><given-names>J.</given-names></name><name><surname>Chung</surname><given-names>M.-H.</given-names></name><name><surname>Kwon</surname><given-names>H.Y.</given-names></name><name><surname>Lee</surname><given-names>J.-S.</given-names></name></person-group><article-title>Nutritional status of patients with COVID-19</article-title><source>Int. J. Infect. Dis.</source><year>2020</year><volume>100</volume><fpage>390</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.08.018</pub-id><?supplied-pmid 32795605?><pub-id pub-id-type="pmid">32795605</pub-id></element-citation></ref><ref id="B66-nutrients-13-00462"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narahara</surname><given-names>H.</given-names></name><name><surname>Miyakawa</surname><given-names>I.</given-names></name><name><surname>Johnston</surname><given-names>J.M.</given-names></name></person-group><article-title>The inhibitory effect of 1,25-dihydroxyvitamin D3 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages</article-title><source>J. Clin. Endocrinol. Metab.</source><year>1995</year><volume>80</volume><fpage>3121</fpage><lpage>3126</lpage><pub-id pub-id-type="doi">10.1210/jcem.80.11.7593412</pub-id><?supplied-pmid 7593412?><pub-id pub-id-type="pmid">7593412</pub-id></element-citation></ref><ref id="B67-nutrients-13-00462"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verouti</surname><given-names>S.N.</given-names></name><name><surname>Tsoupras</surname><given-names>A.B.</given-names></name><name><surname>Alevizopoulou</surname><given-names>F.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Iatrou</surname><given-names>C.</given-names></name></person-group><article-title>Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients</article-title><source>Int. J. Artif. Organs</source><year>2013</year><volume>36</volume><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.5301/ijao.5000187</pub-id><?supplied-pmid 23335378?><pub-id pub-id-type="pmid">23335378</pub-id></element-citation></ref><ref id="B68-nutrients-13-00462"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>S.</given-names></name><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Ashraf</surname><given-names>M.Z.</given-names></name></person-group><article-title>Emerging role of vitamin d and its associated molecules in pathways related to pathogenesis of thrombosis</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><elocation-id>649</elocation-id><pub-id pub-id-type="doi">10.3390/biom9110649</pub-id></element-citation></ref><ref id="B69-nutrients-13-00462"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coquette</surname><given-names>A.</given-names></name><name><surname>Vray</surname><given-names>B.</given-names></name><name><surname>Vanderpas</surname><given-names>J.</given-names></name></person-group><article-title>Role of vitamin E in the protection of the resident macrophage membrane against oxidative damage</article-title><source>Arch. Int. Physiol. Biochim.</source><year>1986</year><volume>94</volume><fpage>S29</fpage><lpage>S34</lpage><pub-id pub-id-type="pmid">2440399</pub-id></element-citation></ref><ref id="B70-nutrients-13-00462"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mileva</surname><given-names>M.</given-names></name><name><surname>Bakalova</surname><given-names>R.</given-names></name><name><surname>Tancheva</surname><given-names>L.</given-names></name><name><surname>Galabov</surname><given-names>A.</given-names></name><name><surname>Ribarov</surname><given-names>S.</given-names></name></person-group><article-title>Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice</article-title><source>Comp. Immunol. Microbiol. Infect. Dis.</source><year>2002</year><volume>25</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0147-9571(01)00010-8</pub-id><pub-id pub-id-type="pmid">11831742</pub-id></element-citation></ref><ref id="B71-nutrients-13-00462"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayek</surname><given-names>M.G.</given-names></name><name><surname>Taylor</surname><given-names>S.F.</given-names></name><name><surname>Bender</surname><given-names>B.S.</given-names></name><name><surname>Han</surname><given-names>S.N.</given-names></name><name><surname>Meydani</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>D.E.</given-names></name><name><surname>Eghtesada</surname><given-names>S.</given-names></name><name><surname>Meydani</surname><given-names>S.N.</given-names></name></person-group><article-title>Vitamin E Supplementation decreases lung virus titers in mice infected with influenza</article-title><source>J. Infect. Dis.</source><year>1997</year><volume>176</volume><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1086/517265</pub-id><pub-id pub-id-type="pmid">9207381</pub-id></element-citation></ref><ref id="B72-nutrients-13-00462"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galabov</surname><given-names>A.S.</given-names></name><name><surname>Mileva</surname><given-names>M.</given-names></name><name><surname>Simeonova</surname><given-names>L.</given-names></name><name><surname>Gegova</surname><given-names>G.</given-names></name></person-group><article-title>Combination activity of neuraminidase inhibitor oseltamivir and &#x003b1;-tocopherol in influenza virus A (H3N2) infection in mice</article-title><source>Antivir. Chem. Chemother.</source><year>2015</year><volume>24</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1177/2040206616656263</pub-id><pub-id pub-id-type="pmid">27341844</pub-id></element-citation></ref><ref id="B73-nutrients-13-00462"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saboori</surname><given-names>S.</given-names></name><name><surname>Shab-Bidar</surname><given-names>S.</given-names></name><name><surname>Speakman</surname><given-names>J.R.</given-names></name><name><surname>Rad</surname><given-names>E.Y.</given-names></name><name><surname>Djafarian</surname><given-names>K.</given-names></name></person-group><article-title>Effect of vitamin E supplementation on serum C-reactive protein level: A meta-analysis of randomized controlled trials</article-title><source>Eur. J. Clin. Nutr.</source><year>2015</year><volume>69</volume><fpage>867</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1038/ejcn.2014.296</pub-id><pub-id pub-id-type="pmid">25669317</pub-id></element-citation></ref><ref id="B74-nutrients-13-00462"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.-Z.</given-names></name><name><surname>Zhang</surname><given-names>R.-Y.</given-names></name><name><surname>Bai</surname><given-names>J.</given-names></name></person-group><article-title>An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients</article-title><source>Int. J. Cardiol.</source><year>2020</year><volume>312</volume><fpage>137</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2020.04.009</pub-id><pub-id pub-id-type="pmid">32321655</pub-id></element-citation></ref><ref id="B75-nutrients-13-00462"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuzawa</surname><given-names>K.</given-names></name><name><surname>Kurotori</surname><given-names>Y.</given-names></name><name><surname>Tokumura</surname><given-names>A.</given-names></name><name><surname>Tsukatani</surname><given-names>H.</given-names></name></person-group><article-title>Vitamin E. deficiency increases the synthesis of platelet-activating factor (PAF) in rat polymorphonuclear leucocytes</article-title><source>Lipids</source><year>1989</year><volume>24</volume><fpage>236</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1007/BF02535242</pub-id><?supplied-pmid 2761359?><pub-id pub-id-type="pmid">2761359</pub-id></element-citation></ref><ref id="B76-nutrients-13-00462"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akada</surname><given-names>S.</given-names></name><name><surname>Iioka</surname><given-names>H.</given-names></name><name><surname>Moriyama</surname><given-names>I.</given-names></name><name><surname>Hisanaga</surname><given-names>H.</given-names></name><name><surname>Morimoto</surname><given-names>K.</given-names></name><name><surname>Ichijo</surname><given-names>M.</given-names></name></person-group><article-title>The role of vitamin E during pregnancy&#x02014;anti-platelet aggregation activity of alpha-tocopherol</article-title><source>Nihon Sanka Fujinka Gakkai Zasshi</source><year>1991</year><volume>43</volume><fpage>523</fpage><lpage>528</lpage><?supplied-pmid 2056228?><pub-id pub-id-type="pmid">2056228</pub-id></element-citation></ref><ref id="B77-nutrients-13-00462"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Violi</surname><given-names>F.</given-names></name><name><surname>Pratico</surname><given-names>D.</given-names></name><name><surname>Ghiselli</surname><given-names>A.</given-names></name><name><surname>Alessandri</surname><given-names>C.</given-names></name><name><surname>Iuliano</surname><given-names>L.</given-names></name><name><surname>Cordova</surname><given-names>C.</given-names></name><name><surname>Balsano</surname><given-names>F.</given-names></name></person-group><article-title>Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration</article-title><source>Atherosclerosis</source><year>1990</year><volume>82</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/0021-9150(90)90046-L</pub-id><pub-id pub-id-type="pmid">2115784</pub-id></element-citation></ref><ref id="B78-nutrients-13-00462"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.</given-names></name></person-group><article-title>On the mediterranean diet</article-title><source>INFORM</source><year>1997</year><volume>8</volume><fpage>776</fpage><lpage>777</lpage></element-citation></ref><ref id="B79-nutrients-13-00462"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakishita</surname><given-names>E.</given-names></name><name><surname>Suehiro</surname><given-names>A.</given-names></name><name><surname>Oura</surname><given-names>Y.</given-names></name><name><surname>Nagai</surname><given-names>K.</given-names></name></person-group><article-title>Inhibitory effect of vitamin E (&#x003b1;-tocopherol) on spontaneous platelet aggregation in whole blood</article-title><source>Thromb. Res.</source><year>1990</year><volume>60</volume><fpage>489</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1016/0049-3848(90)90233-3</pub-id><pub-id pub-id-type="pmid">2082481</pub-id></element-citation></ref><ref id="B80-nutrients-13-00462"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balestrieri</surname><given-names>M.L.</given-names></name><name><surname>De Prisco</surname><given-names>R.</given-names></name><name><surname>Nicolaus</surname><given-names>B.</given-names></name><name><surname>Pari</surname><given-names>P.</given-names></name><name><surname>Moriello</surname><given-names>V.</given-names></name><name><surname>Strazzullo</surname><given-names>G.</given-names></name><name><surname>Iorio</surname><given-names>E.L.</given-names></name><name><surname>Servillo</surname><given-names>L.</given-names></name><name><surname>Balestrieri</surname><given-names>C.</given-names></name></person-group><article-title>Lycopene in association with &#x003b1;-tocopherol or tomato lipophilic extracts enhances acyl-platelet-activating factor biosynthesis in endothelial cells during oxidative stress</article-title><source>Free. Radic. Biol. Med.</source><year>2004</year><volume>36</volume><fpage>1058</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.01.014</pub-id><pub-id pub-id-type="pmid">15059646</pub-id></element-citation></ref><ref id="B81-nutrients-13-00462"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname><given-names>E.K.</given-names></name><name><surname>Gao</surname><given-names>Y.-T.</given-names></name><name><surname>Gebretsadik</surname><given-names>T.</given-names></name><name><surname>Hartman</surname><given-names>T.J.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Wen</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Bai</surname><given-names>C.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>Roberts</surname><given-names>L.J.</given-names></name><etal/></person-group><article-title>New risk factors for adult-onset incident asthma. A nested case&#x02013;control study of host antioxidant defense</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2015</year><volume>191</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1164/rccm.201405-0948OC</pub-id><pub-id pub-id-type="pmid">25408961</pub-id></element-citation></ref><ref id="B82-nutrients-13-00462"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rainwater</surname><given-names>D.L.</given-names></name><name><surname>Mahaney</surname><given-names>M.C.</given-names></name><name><surname>VandeBerg</surname><given-names>J.L.</given-names></name><name><surname>Wang</surname><given-names>X.L.</given-names></name></person-group><article-title>Vitamin E dietary supplementation significantly affects multiple risk factors for cardiovascular disease in baboons</article-title><source>Am. J. Clin. Nutr.</source><year>2007</year><volume>86</volume><fpage>597</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1093/ajcn/86.3.597</pub-id><pub-id pub-id-type="pmid">17823422</pub-id></element-citation></ref><ref id="B83-nutrients-13-00462"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silbert</surname><given-names>P.L.</given-names></name><name><surname>Leong</surname><given-names>L.L.L.</given-names></name><name><surname>Sturm</surname><given-names>M.J.</given-names></name><name><surname>Strophair</surname><given-names>J.</given-names></name><name><surname>Taylor</surname><given-names>R.R.</given-names></name></person-group><article-title>Short term vitamin e supplementation has no effect on platelet function, plasma phospholipase a2and lyso-paf in male volunteers</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><year>1990</year><volume>17</volume><fpage>645</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.1990.tb01365.x</pub-id><pub-id pub-id-type="pmid">2279352</pub-id></element-citation></ref><ref id="B84-nutrients-13-00462"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieliszek</surname><given-names>M.</given-names></name><name><surname>Lipinski</surname><given-names>B.</given-names></name></person-group><article-title>Selenium supplementation in the prevention of coronavirus infections (COVID-19)</article-title><source>Med. Hypotheses</source><year>2020</year><volume>143</volume><fpage>109878</fpage><pub-id pub-id-type="doi">10.1016/j.mehy.2020.109878</pub-id><pub-id pub-id-type="pmid">32464491</pub-id></element-citation></ref><ref id="B85-nutrients-13-00462"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avery</surname><given-names>J.C.</given-names></name><name><surname>Hoffmann</surname><given-names>P.R.</given-names></name></person-group><article-title>Selenium, Selenoproteins, and Immunity</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1203</elocation-id><pub-id pub-id-type="doi">10.3390/nu10091203</pub-id><?supplied-pmid 30200430?><pub-id pub-id-type="pmid">30200430</pub-id></element-citation></ref><ref id="B86-nutrients-13-00462"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Rose</surname><given-names>A.H.</given-names></name><name><surname>Hoffmann</surname><given-names>P.R.</given-names></name></person-group><article-title>The role of selenium in inflammation and immunity: From Molecular mechanisms to therapeutic opportunities</article-title><source>Antioxid. Redox Signal.</source><year>2012</year><volume>16</volume><fpage>705</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1089/ars.2011.4145</pub-id><?supplied-pmid 21955027?><pub-id pub-id-type="pmid">21955027</pub-id></element-citation></ref><ref id="B87-nutrients-13-00462"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Nan</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>L.Y.</given-names></name></person-group><article-title>Protection from H1N1 Influenza virus infections in mice by supplementation with selenium: A Comparison with selenium-deficient mice</article-title><source>Biol. Trace Elem. Res.</source><year>2010</year><volume>141</volume><fpage>254</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1007/s12011-010-8726-x</pub-id><?supplied-pmid 20490710?><pub-id pub-id-type="pmid">20490710</pub-id></element-citation></ref><ref id="B88-nutrients-13-00462"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>R.L.</given-names></name><name><surname>Hoffmann</surname><given-names>P.R.</given-names></name></person-group><article-title>Selenium and asthma</article-title><source>Mol. Asp. Med.</source><year>2012</year><volume>33</volume><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2011.10.003</pub-id></element-citation></ref><ref id="B89-nutrients-13-00462"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Taylor</surname><given-names>E.W.</given-names></name><name><surname>Bennett</surname><given-names>K.</given-names></name><name><surname>Saad</surname><given-names>R.</given-names></name><name><surname>Rayman</surname><given-names>M.P.</given-names></name></person-group><article-title>Association between regional selenium status and reported outcome of COVID-19 cases in China</article-title><source>Am. J. Clin. Nutr.</source><year>2020</year><volume>111</volume><fpage>1297</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1093/ajcn/nqaa095</pub-id><pub-id pub-id-type="pmid">32342979</pub-id></element-citation></ref><ref id="B90-nutrients-13-00462"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y.-Z.</given-names></name><name><surname>Cohen</surname><given-names>Z.S.</given-names></name><name><surname>Weaver</surname><given-names>J.A.</given-names></name><name><surname>Sordillo</surname><given-names>L.M.</given-names></name></person-group><article-title>Selenium modulates 1-O-Alkyl-2-Acetyl-sn-Glycero-3-Phosphocholine (PAF) Biosynthesis in bovine aortic endothelial cells</article-title><source>Antioxid. Redox Signal.</source><year>2001</year><volume>3</volume><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1089/152308601317203657</pub-id><pub-id pub-id-type="pmid">11813988</pub-id></element-citation></ref><ref id="B91-nutrients-13-00462"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hampel</surname><given-names>G.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Weksler</surname><given-names>B.B.</given-names></name><name><surname>Jaffe</surname><given-names>E.A.</given-names></name></person-group><article-title>Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells</article-title><source>Biochim. Biophys. Acta Lipids Lipid Metab.</source><year>1989</year><volume>1006</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(89)90189-6</pub-id></element-citation></ref><ref id="B92-nutrients-13-00462"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>H.D.</given-names></name><name><surname>Bansal</surname><given-names>M.P.</given-names></name></person-group><article-title>Studies on HDL associated enzymes under experimental hypercholesterolemia: Possible modulation on selenium supplementation</article-title><source>Lipids Health Dis.</source><year>2009</year><volume>8</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/1476-511X-8-55</pub-id><pub-id pub-id-type="pmid">19128464</pub-id></element-citation></ref><ref id="B93-nutrients-13-00462"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricetti</surname><given-names>M.M.</given-names></name><name><surname>Guidi</surname><given-names>G.C.</given-names></name><name><surname>Tecchio</surname><given-names>C.</given-names></name><name><surname>Bellisola</surname><given-names>G.</given-names></name><name><surname>Rigo</surname><given-names>A.</given-names></name><name><surname>Perona</surname><given-names>G.</given-names></name></person-group><article-title>Effects of sodium selenite on in vitro interactions between platelets and endothelial cells</article-title><source>Int. J. Clin. Lab. Res.</source><year>1999</year><volume>29</volume><fpage>80</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1007/s005990050068</pub-id><pub-id pub-id-type="pmid">10436266</pub-id></element-citation></ref><ref id="B94-nutrients-13-00462"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weill</surname><given-names>P.</given-names></name><name><surname>Plissonneau</surname><given-names>C.</given-names></name><name><surname>Legrand</surname><given-names>P.</given-names></name><name><surname>Rioux</surname><given-names>V.</given-names></name><name><surname>Thibault</surname><given-names>R.</given-names></name></person-group><article-title>May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?</article-title><source>Biochimie</source><year>2020</year><volume>179</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2020.09.003</pub-id><pub-id pub-id-type="pmid">32920170</pub-id></element-citation></ref><ref id="B95-nutrients-13-00462"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Chhibber</surname><given-names>S.</given-names></name><name><surname>Mohan</surname><given-names>H.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group><article-title>Dietary supplementation with omega-3 polyunsaturated fatty acids ameliorates acute pneumonia induced by <italic>Klebsiella pneumoniaein</italic> BALB/c mice</article-title><source>Can. J. Microbiol.</source><year>2013</year><volume>59</volume><fpage>503</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1139/cjm-2012-0521</pub-id><?supplied-pmid 23826960?><pub-id pub-id-type="pmid">23826960</pub-id></element-citation></ref><ref id="B96-nutrients-13-00462"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinojosa</surname><given-names>C.A.</given-names></name><name><surname>Gonzalez-Juarbe</surname><given-names>N.</given-names></name><name><surname>Rahman</surname><given-names>M.</given-names></name><name><surname>Fernandes</surname><given-names>G.</given-names></name><name><surname>Orihuela</surname><given-names>C.J.</given-names></name><name><surname>I Restrepo</surname><given-names>M.I.</given-names></name></person-group><article-title>Omega-3 fatty acids in contrast to omega-6 protect against pneumococcal pneumonia</article-title><source>Microb. Pathog.</source><year>2020</year><volume>141</volume><fpage>103979</fpage><pub-id pub-id-type="doi">10.1016/j.micpath.2020.103979</pub-id><?supplied-pmid 31954822?><pub-id pub-id-type="pmid">31954822</pub-id></element-citation></ref><ref id="B97-nutrients-13-00462"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwerbrock</surname><given-names>N.M.J.</given-names></name><name><surname>Karlsson</surname><given-names>E.A.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Sheridan</surname><given-names>P.A.</given-names></name><name><surname>Beck</surname><given-names>M.A.</given-names></name></person-group><article-title>Fish oil-fed mice have impaired resistance to influenza infection</article-title><source>J. Nutr.</source><year>2009</year><volume>139</volume><fpage>1588</fpage><lpage>1594</lpage><pub-id pub-id-type="doi">10.3945/jn.109.108027</pub-id><?supplied-pmid 19549756?><pub-id pub-id-type="pmid">19549756</pub-id></element-citation></ref><ref id="B98-nutrients-13-00462"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byleveld</surname><given-names>P.M.</given-names></name><name><surname>Pang</surname><given-names>G.T.</given-names></name><name><surname>Clancy</surname><given-names>R.L.</given-names></name><name><surname>Roberts</surname><given-names>D.C.K.</given-names></name></person-group><article-title>Fish Oil feeding delays influenza virus clearance and impairs production of interferon-&#x003b3; and virus-specific Immunoglobulin A in the Lungs of mice</article-title><source>J. Nutr.</source><year>1999</year><volume>129</volume><fpage>328</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1093/jn/129.2.328</pub-id><pub-id pub-id-type="pmid">10024609</pub-id></element-citation></ref><ref id="B99-nutrients-13-00462"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFilippis</surname><given-names>A.P.</given-names></name><name><surname>Rai</surname><given-names>S.N.</given-names></name><name><surname>Cambon</surname><given-names>A.</given-names></name><name><surname>Miles</surname><given-names>R.</given-names></name><name><surname>Jaffe</surname><given-names>A.S.</given-names></name><name><surname>Moser</surname><given-names>A.B.</given-names></name><name><surname>Jones</surname><given-names>R.O.</given-names></name><name><surname>Bolli</surname><given-names>R.</given-names></name><name><surname>Schulman</surname><given-names>S.P.</given-names></name></person-group><article-title>Fatty acids and TxA2 generation, in the absence of platelet-COX-1 activity</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2014</year><volume>24</volume><fpage>428</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2013.08.012</pub-id><pub-id pub-id-type="pmid">24370448</pub-id></element-citation></ref><ref id="B100-nutrients-13-00462"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh-Hashi</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Okuyama</surname><given-names>H.</given-names></name></person-group><article-title>Possible mechanisms for the differential effects of high linoleate safflower oil and high &#x003b1;-linolenate perilla oil diets on platelet-activating factor production by rat polymorphonuclear leukocytes</article-title><source>J. Lipid Mediat. Cell Signal.</source><year>1997</year><volume>17</volume><fpage>207</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/S0929-7855(97)00031-X</pub-id><pub-id pub-id-type="pmid">9524928</pub-id></element-citation></ref><ref id="B101-nutrients-13-00462"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>K.</given-names></name><name><surname>Merfels</surname><given-names>M.</given-names></name><name><surname>Muhly-Reinholz</surname><given-names>M.</given-names></name><name><surname>Gokorsch</surname><given-names>S.</given-names></name><name><surname>Rosseau</surname><given-names>S.</given-names></name><name><surname>Lohmeyer</surname><given-names>J.</given-names></name><name><surname>Schwarzer</surname><given-names>N.</given-names></name><name><surname>Kr&#x000fc;ll</surname><given-names>M.</given-names></name><name><surname>Suttorp</surname><given-names>N.</given-names></name><name><surname>Grimminger</surname><given-names>F.</given-names></name><etal/></person-group><article-title>&#x003c9;-3 Fatty acids suppress monocyte adhesion to human endothelial cells: Role of endothelial PAF generation</article-title><source>Am. J. Physiol. Circ. Physiol.</source><year>2002</year><volume>283</volume><fpage>H811</fpage><lpage>H818</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00235.2002</pub-id></element-citation></ref><ref id="B102-nutrients-13-00462"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shikano</surname><given-names>M.</given-names></name><name><surname>Masuzawa</surname><given-names>Y.</given-names></name><name><surname>Yazawa</surname><given-names>K.</given-names></name></person-group><article-title>Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1</article-title><source>J. Immunol.</source><year>1993</year><volume>150</volume><fpage>3525</fpage><lpage>3533</lpage><pub-id pub-id-type="pmid">8468486</pub-id></element-citation></ref><ref id="B103-nutrients-13-00462"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>C.</given-names></name><name><surname>Aepfelbacher</surname><given-names>M.</given-names></name><name><surname>Lux</surname><given-names>I.</given-names></name><name><surname>Zimmer</surname><given-names>B.</given-names></name><name><surname>Weber</surname><given-names>P.C.</given-names></name></person-group><article-title>Docosahexaenoic acid inhibits PAF and LTD4 stimulated [Ca2+]i-increase in differentiated monocytic U937 cells</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><year>1991</year><volume>1133</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/0167-4889(91)90239-T</pub-id></element-citation></ref><ref id="B104-nutrients-13-00462"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirivongrangson</surname><given-names>P.</given-names></name><name><surname>Kulvichit</surname><given-names>W.</given-names></name><name><surname>Payungporn</surname><given-names>S.</given-names></name><name><surname>Pisitkun</surname><given-names>T.</given-names></name><name><surname>Chindamporn</surname><given-names>A.</given-names></name><name><surname>Peerapornratana</surname><given-names>S.</given-names></name><name><surname>Pisitkun</surname><given-names>P.</given-names></name><name><surname>Chitcharoen</surname><given-names>S.</given-names></name><name><surname>Sawaswong</surname><given-names>V.</given-names></name><name><surname>Worasilchai</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Endotoxemia and circulating bacteriome in severe COVID-19 patients</article-title><source>Intensive Care Med. Exp.</source><year>2020</year><volume>8</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s40635-020-00362-8</pub-id><pub-id pub-id-type="pmid">31897796</pub-id></element-citation></ref><ref id="B105-nutrients-13-00462"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh-Hashi</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Tanabe</surname><given-names>A.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Okuyama</surname><given-names>H.</given-names></name></person-group><article-title>Dietary &#x003b1;-linolenate suppresses endotoxin-induced platelet-activating factor production in rat kidney</article-title><source>Lipids</source><year>1999</year><volume>34</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s11745-999-334-3</pub-id><?supplied-pmid 10188594?><pub-id pub-id-type="pmid">10188594</pub-id></element-citation></ref><ref id="B106-nutrients-13-00462"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akisu</surname><given-names>M.</given-names></name><name><surname>Huseyinov</surname><given-names>A.</given-names></name><name><surname>Baka</surname><given-names>M.</given-names></name><name><surname>Yalaz</surname><given-names>M.</given-names></name><name><surname>Kultursay</surname><given-names>N.</given-names></name></person-group><article-title>The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet-activating factor and leukotriene B4 in hypoxic&#x02013;ischemic brain in young mice</article-title><source>Prostaglandins Leukot. Essent. Fat. Acids</source><year>2002</year><volume>67</volume><fpage>429</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1054/plef.2002.0453</pub-id><?supplied-pmid 12468264?><pub-id pub-id-type="pmid">12468264</pub-id></element-citation></ref><ref id="B107-nutrients-13-00462"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>E.B.</given-names></name><name><surname>Koenig</surname><given-names>W.</given-names></name><name><surname>Khuseyinova</surname><given-names>N.</given-names></name><name><surname>Christensen</surname><given-names>J.H.</given-names></name></person-group><article-title>Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids</article-title><source>Atherosclerosis</source><year>2008</year><volume>196</volume><fpage>420</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2006.11.027</pub-id><?supplied-pmid 17157859?><pub-id pub-id-type="pmid">17157859</pub-id></element-citation></ref><ref id="B108-nutrients-13-00462"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>M.W.</given-names></name><name><surname>Koenig</surname><given-names>W.</given-names></name><name><surname>Christensen</surname><given-names>J.H.</given-names></name><name><surname>Schmidt</surname><given-names>E.B.</given-names></name></person-group><article-title>The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults</article-title><source>Eur. J. Nutr.</source><year>2009</year><volume>48</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1007/s00394-008-0758-z</pub-id><pub-id pub-id-type="pmid">19030909</pub-id></element-citation></ref><ref id="B109-nutrients-13-00462"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajos</surname><given-names>G.</given-names></name><name><surname>Zalewski</surname><given-names>J.</given-names></name><name><surname>Mostowik</surname><given-names>M.</given-names></name><name><surname>Konduracka</surname><given-names>E.</given-names></name><name><surname>Nessler</surname><given-names>J.</given-names></name><name><surname>Undas</surname><given-names>A.</given-names></name></person-group><article-title>Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A2 in patients with stable angina</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2014</year><volume>24</volume><fpage>434</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2013.09.011</pub-id><pub-id pub-id-type="pmid">24555913</pub-id></element-citation></ref><ref id="B110-nutrients-13-00462"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skulas-Ray</surname><given-names>A.C.</given-names></name><name><surname>Alaupovic</surname><given-names>P.</given-names></name><name><surname>Kris-Etherton</surname><given-names>P.M.</given-names></name><name><surname>West</surname><given-names>S.G.</given-names></name></person-group><article-title>Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia</article-title><source>J. Clin. Lipidol.</source><year>2015</year><volume>9</volume><fpage>360</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.jacl.2014.12.001</pub-id><pub-id pub-id-type="pmid">26073395</pub-id></element-citation></ref><ref id="B111-nutrients-13-00462"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Detopoulou</surname><given-names>P.</given-names></name><name><surname>Alepoudea</surname><given-names>E.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Kalogeropoulos</surname><given-names>N.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>Associations between red blood cells fatty acids, desaturases and metabolism of Platelet Activating Factor in healthy volunteers</article-title><source>Prostaglandins Leukotrienes Essential Fatty Acids</source><year>2021</year><volume>164</volume><fpage>2021</fpage><pub-id pub-id-type="doi">10.1016/j.plefa.2020.102234</pub-id></element-citation></ref><ref id="B112-nutrients-13-00462"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Te Velthuis</surname><given-names>A.J.W.T.</given-names></name><name><surname>van den Worm</surname><given-names>S.H.E.</given-names></name><name><surname>Sims</surname><given-names>A.C.</given-names></name><name><surname>Baric</surname><given-names>R.S.</given-names></name><name><surname>Snijder</surname><given-names>E.J.</given-names></name><name><surname>van Hemert</surname><given-names>M.J.</given-names></name></person-group><article-title>Zn2+ Inhibits coronavirus and arterivirus RNA Polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture</article-title><source>PLoS Pathog.</source><year>2010</year><volume>6</volume><elocation-id>e1001176</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1001176</pub-id><pub-id pub-id-type="pmid">21079686</pub-id></element-citation></ref><ref id="B113-nutrients-13-00462"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gombart</surname><given-names>A.F.</given-names></name><name><surname>Pierre</surname><given-names>A.</given-names></name><name><surname>Maggini</surname><given-names>S.</given-names></name></person-group><article-title>A review of micronutrients and the immune system&#x02013;working in harmony to reduce the risk of infection</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>236</elocation-id><pub-id pub-id-type="doi">10.3390/nu12010236</pub-id></element-citation></ref><ref id="B114-nutrients-13-00462"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>C.F.</given-names></name><name><surname>Black</surname><given-names>R.E.</given-names></name></person-group><article-title>Zinc and the risk for infectious disease</article-title><source>Annu. Rev. Nutr.</source><year>2004</year><volume>24</volume><fpage>255</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1146/annurev.nutr.23.011702.073054</pub-id><pub-id pub-id-type="pmid">15189121</pub-id></element-citation></ref><ref id="B115-nutrients-13-00462"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiabi</surname><given-names>F.H.</given-names></name><name><surname>Alipour</surname><given-names>A.</given-names></name><name><surname>Darvishi-Khezri</surname><given-names>H.</given-names></name><name><surname>Aliasgharian</surname><given-names>A.</given-names></name><name><surname>Zeydi</surname><given-names>A.E.</given-names></name></person-group><article-title>Zinc supplementation in adult mechanically ventilated trauma patients is associated with decreased occurrence of ventilator-associated pneumonia: A secondary analysis of a prospective, observational study</article-title><source>Indian J. Crit. Care Med.</source><year>2017</year><volume>21</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.4103/0972-5229.198324</pub-id><?supplied-pmid 28197049?><pub-id pub-id-type="pmid">28197049</pub-id></element-citation></ref><ref id="B116-nutrients-13-00462"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>J.</given-names></name><name><surname>Moyer</surname><given-names>A.</given-names></name><name><surname>Peng</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Hannafon</surname><given-names>B.N.</given-names></name><name><surname>Ding</surname><given-names>W.-Q.</given-names></name></person-group><article-title>Chloroquine is a zinc ionophore</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e109180</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0109180</pub-id><?supplied-pmid 25271834?><pub-id pub-id-type="pmid">25271834</pub-id></element-citation></ref><ref id="B117-nutrients-13-00462"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>M.A.</given-names></name><name><surname>Fischer</surname><given-names>J.G.</given-names></name><name><surname>Kays</surname><given-names>S.E.</given-names></name></person-group><article-title>Is copper an antioxidant nutrient?</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>1992</year><volume>32</volume><fpage>1</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1080/10408399209527578</pub-id><?supplied-pmid 1290583?><pub-id pub-id-type="pmid">1290583</pub-id></element-citation></ref><ref id="B118-nutrients-13-00462"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonham</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>J.M.</given-names></name><name><surname>Hannigan</surname><given-names>B.M.</given-names></name><name><surname>Strain</surname><given-names>J.J.</given-names></name></person-group><article-title>The immune system as a physiological indicator of marginal copper status?</article-title><source>Br. J. Nutr.</source><year>2002</year><volume>87</volume><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1079/BJN2002558</pub-id><pub-id pub-id-type="pmid">12010579</pub-id></element-citation></ref><ref id="B119-nutrients-13-00462"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besold</surname><given-names>A.N.</given-names></name><name><surname>Culbertson</surname><given-names>E.M.</given-names></name><name><surname>Culotta</surname><given-names>V.C.</given-names></name></person-group><article-title>The Yin and Yang of copper during infection</article-title><source>JBIC J. Biol. Inorg. Chem.</source><year>2016</year><volume>21</volume><fpage>137</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1007/s00775-016-1335-1</pub-id><pub-id pub-id-type="pmid">26790881</pub-id></element-citation></ref><ref id="B120-nutrients-13-00462"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Silva</surname><given-names>A.</given-names></name><name><surname>Atukorala</surname><given-names>S.</given-names></name><name><surname>Weerasinghe</surname><given-names>I.</given-names></name><name><surname>Ahluwalia</surname><given-names>N.</given-names></name></person-group><article-title>Iron supplementation improves iron status and reduces morbidity in children with or without upper respiratory tract infections: A randomized controlled study in Colombo, Sri Lanka</article-title><source>Am. J. Clin. Nutr.</source><year>2003</year><volume>77</volume><fpage>234</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1093/ajcn/77.1.234</pub-id><pub-id pub-id-type="pmid">12499347</pub-id></element-citation></ref><ref id="B121-nutrients-13-00462"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>J.</given-names></name><name><surname>Haider</surname><given-names>T.</given-names></name><name><surname>Gassmann</surname><given-names>M.</given-names></name><name><surname>Muckenthaler</surname><given-names>M.U.</given-names></name></person-group><article-title>Iron homeostasis in the lungs&#x02014;a balance between health and disease</article-title><source>Pharmaceuticals</source><year>2019</year><volume>12</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.3390/ph12010005</pub-id></element-citation></ref><ref id="B122-nutrients-13-00462"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Nekhai</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name></person-group><article-title>Depriving Iron supply to the virus represents a promising adjuvant therapeutic against viral survival</article-title><source>Curr. Clin. Microbiol. Rep.</source><year>2020</year><volume>7</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1007/s40588-020-00140-w</pub-id></element-citation></ref><ref id="B123-nutrients-13-00462"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mammadova-Bach</surname><given-names>E.</given-names></name><name><surname>Braun</surname><given-names>A.</given-names></name></person-group><article-title>Zinc homeostasis in platelet-related diseases</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>5258</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20215258</pub-id></element-citation></ref><ref id="B124-nutrients-13-00462"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoupras</surname><given-names>A.B.</given-names></name><name><surname>Roulia</surname><given-names>M.</given-names></name><name><surname>Ferentinos</surname><given-names>E.</given-names></name><name><surname>Stamatopoulos</surname><given-names>I.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Kyritsis</surname><given-names>P.</given-names></name></person-group><article-title>Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor</article-title><source>Bioinorg. Chem. Appl.</source><year>2010</year><volume>2010</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2010/731202</pub-id></element-citation></ref><ref id="B125-nutrients-13-00462"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papakonstantinou</surname><given-names>V.D.</given-names></name><name><surname>Lagopati</surname><given-names>N.</given-names></name><name><surname>Tsilibary</surname><given-names>E.C.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Philippopoulos</surname><given-names>A.I.</given-names></name></person-group><article-title>A Review on platelet activating factor inhibitors: Could a new class of potent metal-based anti-inflammatory drugs induce anticancer properties?</article-title><source>Bioinorg. Chem. Appl.</source><year>2017</year><volume>2017</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1155/2017/6947034</pub-id><?supplied-pmid 28458618?><pub-id pub-id-type="pmid">28458618</pub-id></element-citation></ref><ref id="B126-nutrients-13-00462"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wykle</surname><given-names>R.L.</given-names></name><name><surname>Malone</surname><given-names>B.</given-names></name><name><surname>Snyder</surname><given-names>F.</given-names></name></person-group><article-title>Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid</article-title><source>J. Biol. Chem.</source><year>1980</year><volume>255</volume><fpage>10256</fpage><lpage>10260</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)70457-8</pub-id><pub-id pub-id-type="pmid">7430122</pub-id></element-citation></ref><ref id="B127-nutrients-13-00462"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosio</surname><given-names>G.</given-names></name><name><surname>Oriente</surname><given-names>A.</given-names></name><name><surname>Napoli</surname><given-names>C.</given-names></name><name><surname>Palumbo</surname><given-names>G.</given-names></name><name><surname>Chiariello</surname><given-names>P.</given-names></name><name><surname>Marone</surname><given-names>G.</given-names></name><name><surname>Condorelli</surname><given-names>M.</given-names></name><name><surname>Triggiani</surname><given-names>M.</given-names></name></person-group><article-title>Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor</article-title><source>J. Clin. Investig.</source><year>1994</year><volume>93</volume><fpage>2408</fpage><lpage>2416</lpage><pub-id pub-id-type="doi">10.1172/JCI117248</pub-id><?supplied-pmid 8200975?><pub-id pub-id-type="pmid">8200975</pub-id></element-citation></ref><ref id="B128-nutrients-13-00462"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>A.D.</given-names></name><name><surname>Erickson</surname><given-names>K.L.</given-names></name></person-group><article-title>Alteration of Macrophage responsiveness to platelet-activating factor by interferon-&#x003b3; and lipopolysaccharide</article-title><source>Cell. Immunol.</source><year>1996</year><volume>174</volume><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1006/cimm.1996.0305</pub-id><pub-id pub-id-type="pmid">8954615</pub-id></element-citation></ref><ref id="B129-nutrients-13-00462"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.C.</given-names></name><name><surname>Kennedy</surname><given-names>T.P.</given-names></name><name><surname>Su</surname><given-names>Y.F.</given-names></name><name><surname>Watkins</surname><given-names>W.D.</given-names></name><name><surname>Whorton</surname><given-names>A.R.</given-names></name><name><surname>Piantadosi</surname><given-names>C.A.</given-names></name></person-group><article-title>Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung</article-title><source>J. Appl. Physiol.</source><year>1993</year><volume>74</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1152/jappl.1993.74.1.251</pub-id><pub-id pub-id-type="pmid">8444700</pub-id></element-citation></ref><ref id="B130-nutrients-13-00462"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrone</surname><given-names>M.A.</given-names></name><name><surname>Gualtieri</surname><given-names>P.</given-names></name><name><surname>Gratteri</surname><given-names>S.</given-names></name><name><surname>Ali</surname><given-names>W.</given-names></name><name><surname>Sergi</surname><given-names>D.</given-names></name><name><surname>Muscoli</surname><given-names>S.</given-names></name><name><surname>Cammarano</surname><given-names>A.</given-names></name><name><surname>Bernardini</surname><given-names>S.</given-names></name><name><surname>Di Renzo</surname><given-names>L.</given-names></name><name><surname>Romeo</surname><given-names>F.</given-names></name></person-group><article-title>Effects of postprandial hydroxytyrosol and derivates on oxidation of LDL, cardiometabolic state and gene expression</article-title><source>J. Cardiovasc. Med.</source><year>2019</year><volume>20</volume><fpage>419</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.2459/JCM.0000000000000816</pub-id></element-citation></ref><ref id="B131-nutrients-13-00462"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>S.</given-names></name><name><surname>Dixit</surname><given-names>M.</given-names></name></person-group><article-title>Role of polyphenols and other phytochemicals on molecular signaling</article-title><source>Oxidative Med. Cell. Longev.</source><year>2015</year><volume>2015</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1155/2015/504253</pub-id></element-citation></ref><ref id="B132-nutrients-13-00462"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;zquez-Calvo</surname><given-names>&#x000c1;.</given-names></name><name><surname>de Oya</surname><given-names>N.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name><name><surname>Garcia-Moruno</surname><given-names>E.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name></person-group><article-title>Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses west nile virus, zika virus, and dengue virus</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1314</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01314</pub-id><pub-id pub-id-type="pmid">28744282</pub-id></element-citation></ref><ref id="B133-nutrients-13-00462"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S.-C.</given-names></name><name><surname>Ho</surname><given-names>C.-T.</given-names></name><name><surname>Chuo</surname><given-names>W.-H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>T.T.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name></person-group><article-title>Effective inhibition of MERS-CoV infection by resveratrol</article-title><source>BMC Infect. Dis.</source><year>2017</year><volume>17</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/s12879-017-2253-8</pub-id><pub-id pub-id-type="pmid">28049444</pub-id></element-citation></ref><ref id="B134-nutrients-13-00462"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utomo</surname><given-names>R.Y.</given-names></name><name><surname>Ikawati</surname><given-names>M.</given-names></name><name><surname>Meiyanto</surname><given-names>E.</given-names></name></person-group><article-title>Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection</article-title><source>Preprints</source><year>2020</year><volume>2020</volume><fpage>12</fpage></element-citation></ref><ref id="B135-nutrients-13-00462"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Hood</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Kan</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name></person-group><article-title>A Novel combination of vitamin c, curcumin and glycyrrhizic acid potentially regulates immune and inflammatory response associated with coronavirus infections: A Perspective from system biology analysis</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1193</elocation-id><pub-id pub-id-type="doi">10.3390/nu12041193</pub-id><?supplied-pmid 32344708?><pub-id pub-id-type="pmid">32344708</pub-id></element-citation></ref><ref id="B136-nutrients-13-00462"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theoharides</surname><given-names>T.C.</given-names></name></person-group><article-title>COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin</article-title><source>Biofactors</source><year>2020</year><volume>46</volume><fpage>306</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1002/biof.1633</pub-id><?supplied-pmid 32339387?><pub-id pub-id-type="pmid">32339387</pub-id></element-citation></ref><ref id="B137-nutrients-13-00462"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensel</surname><given-names>A.</given-names></name><name><surname>Bauer</surname><given-names>R.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name><name><surname>Spiegler</surname><given-names>V.</given-names></name><name><surname>Kayser</surname><given-names>O.</given-names></name><name><surname>Hempel</surname><given-names>G.</given-names></name><name><surname>Kraft</surname><given-names>K.</given-names></name></person-group><article-title>Challenges at the Time of COVID-19: Opportunities and Innovations in antivirals from nature</article-title><source>Planta Med.</source><year>2020</year><volume>86</volume><fpage>659</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1055/a-1177-4396</pub-id><?supplied-pmid 32434254?><pub-id pub-id-type="pmid">32434254</pub-id></element-citation></ref><ref id="B138-nutrients-13-00462"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Apostolakis</surname><given-names>C.</given-names></name><name><surname>Pliakis</surname><given-names>E.</given-names></name><name><surname>Samiotaki</surname><given-names>M.</given-names></name><name><surname>Panayotou</surname><given-names>G.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>Biological activity of acetylated phenolic compounds</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>80</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1021/jf0627221</pub-id><pub-id pub-id-type="pmid">17199317</pub-id></element-citation></ref><ref id="B139-nutrients-13-00462"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>B.H.</given-names></name><name><surname>Nawaz</surname><given-names>Z.</given-names></name><name><surname>Pertani</surname><given-names>S.A.</given-names></name><name><surname>Roomi</surname><given-names>A.</given-names></name><name><surname>Mahmood</surname><given-names>H.</given-names></name><name><surname>Saeed</surname><given-names>S.A.</given-names></name><name><surname>Gilani</surname><given-names>A.H.</given-names></name></person-group><article-title>Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling</article-title><source>Biochem. Pharmacol.</source><year>1999</year><volume>58</volume><fpage>1167</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(99)00206-3</pub-id><pub-id pub-id-type="pmid">10484074</pub-id></element-citation></ref><ref id="B140-nutrients-13-00462"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keihanian</surname><given-names>F.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name><name><surname>Bagheri</surname><given-names>R.K.</given-names></name><name><surname>Johnston</surname><given-names>T.P.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Curcumin, hemostasis, thrombosis, and coagulation</article-title><source>J. Cell. Physiol.</source><year>2018</year><volume>233</volume><fpage>4497</fpage><lpage>4511</lpage><pub-id pub-id-type="doi">10.1002/jcp.26249</pub-id><pub-id pub-id-type="pmid">29052850</pub-id></element-citation></ref><ref id="B141-nutrients-13-00462"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Shafi</surname><given-names>Z.</given-names></name><name><surname>Mahto</surname><given-names>S.K.</given-names></name><name><surname>Yadav</surname><given-names>S.</given-names></name><name><surname>Sankhwar</surname><given-names>R.</given-names></name></person-group><article-title>Role and application of curcumin as an alternative therapeutic agent</article-title><source>Adv. Microb. Res.</source><year>2020</year><pub-id pub-id-type="doi">10.24966/AMR-694X/100014</pub-id></element-citation></ref><ref id="B142-nutrients-13-00462"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoupras</surname><given-names>A.B.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Iatrou</surname><given-names>C.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Characterization of the de novo biosynthetic enzyme of platelet activating factor, ddt-insensitive cholinephosphotransferase, of human mesangial cells</article-title><source>Mediat. Inflamm.</source><year>2007</year><volume>2007</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2007/27683</pub-id></element-citation></ref><ref id="B143-nutrients-13-00462"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xanthopoulou</surname><given-names>M.N.</given-names></name><name><surname>Asimakopoulos</surname><given-names>D.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name></person-group><article-title>Effect of robola and cabernet sauvignon extracts on platelet activating factor enzymes activity on U937 cells</article-title><source>Food Chem.</source><year>2014</year><volume>165</volume><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2014.05.085</pub-id><pub-id pub-id-type="pmid">25038648</pub-id></element-citation></ref><ref id="B144-nutrients-13-00462"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachogianni</surname><given-names>I.C.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Stamatakis</surname><given-names>G.M.</given-names></name><name><surname>Kostakis</surname><given-names>I.K.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>Platelet activating factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions</article-title><source>Prostaglandins Other Lipid Mediat.</source><year>2015</year><volume>121</volume><fpage>176</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.prostaglandins.2015.09.001</pub-id><pub-id pub-id-type="pmid">26358846</pub-id></element-citation></ref><ref id="B145-nutrients-13-00462"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanoshita</surname><given-names>R.</given-names></name><name><surname>Chang</surname><given-names>H.W.</given-names></name><name><surname>Son</surname><given-names>K.H.</given-names></name><name><surname>Kudo</surname><given-names>I.</given-names></name><name><surname>Samejima</surname><given-names>Y.</given-names></name></person-group><article-title>Inhibition of lyso PAF acetyltransferase activity by flavonoids</article-title><source>Inflamm. Res.</source><year>1996</year><volume>45</volume><fpage>546</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1007/BF02342225</pub-id><?supplied-pmid 8951505?><pub-id pub-id-type="pmid">8951505</pub-id></element-citation></ref><ref id="B146-nutrients-13-00462"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartisch</surname><given-names>C.</given-names></name><name><surname>Kolodziej</surname><given-names>H.</given-names></name><name><surname>von Bruchhausen</surname><given-names>F.</given-names></name></person-group><article-title>Dual Inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-Lipoxygenase and Lyso-PAF: Acetyl-CoA acetyltransferase1</article-title><source>Planta Med.</source><year>1997</year><volume>63</volume><fpage>106</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1055/s-2006-957623</pub-id><?supplied-pmid 9140221?><pub-id pub-id-type="pmid">9140221</pub-id></element-citation></ref><ref id="B147-nutrients-13-00462"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balestrieri</surname><given-names>M.L.</given-names></name><name><surname>Castaldo</surname><given-names>D.</given-names></name><name><surname>Balestrieri</surname><given-names>C.</given-names></name><name><surname>Quagliuolo</surname><given-names>L.</given-names></name><name><surname>Giovane</surname><given-names>A.</given-names></name><name><surname>Servillo</surname><given-names>L.</given-names></name></person-group><article-title>Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress</article-title><source>J. Lipid Res.</source><year>2003</year><volume>44</volume><fpage>380</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1194/jlr.M200292-JLR200</pub-id><?supplied-pmid 12576520?><pub-id pub-id-type="pmid">12576520</pub-id></element-citation></ref><ref id="B148-nutrients-13-00462"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagumo</surname><given-names>S.</given-names></name><name><surname>Fukuju</surname><given-names>A.</given-names></name><name><surname>Takayama</surname><given-names>M.</given-names></name><name><surname>Nagai</surname><given-names>M.</given-names></name><name><surname>Yanoshita</surname><given-names>R.</given-names></name><name><surname>Samejima</surname><given-names>Y.</given-names></name></person-group><article-title>Inhibition of LysoPAF Acetyltransferase activity by components of licorice root</article-title><source>Biol. Pharm. Bull.</source><year>1999</year><volume>22</volume><fpage>1144</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1248/bpb.22.1144</pub-id><pub-id pub-id-type="pmid">10549875</pub-id></element-citation></ref><ref id="B149-nutrients-13-00462"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>T.Y.</given-names></name></person-group><article-title>Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists</article-title><source>Lipids</source><year>1991</year><volume>26</volume><fpage>1154</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1007/BF02536521</pub-id><pub-id pub-id-type="pmid">1668110</pub-id></element-citation></ref><ref id="B150-nutrients-13-00462"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilleminault</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>E.J.</given-names></name><name><surname>Scott</surname><given-names>H.A.</given-names></name><name><surname>Berthon</surname><given-names>B.S.</given-names></name><name><surname>Jensen</surname><given-names>M.</given-names></name><name><surname>Wood</surname><given-names>L.G.</given-names></name></person-group><article-title>Diet and asthma: Is it time to adapt our message?</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>1227</elocation-id><pub-id pub-id-type="doi">10.3390/nu9111227</pub-id></element-citation></ref><ref id="B151-nutrients-13-00462"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koloverou</surname><given-names>E.</given-names></name><name><surname>Panagiotakos</surname><given-names>D.B.</given-names></name><name><surname>Pitsavos</surname><given-names>C.</given-names></name><name><surname>Chrysohoou</surname><given-names>C.</given-names></name><name><surname>Georgousopoulou</surname><given-names>E.N.</given-names></name><name><surname>Grekas</surname><given-names>A.</given-names></name><name><surname>Christou</surname><given-names>A.</given-names></name><name><surname>Chatzigeorgiou</surname><given-names>M.</given-names></name><name><surname>Skoumas</surname><given-names>I.N.</given-names></name><name><surname>Tousoulis</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Adherence to Mediterranean diet and 10-year incidence (2002&#x02013;2012) of diabetes: Correlations with inflammatory and oxidative stress biomarkers in the ATTICA cohort study</article-title><source>Diabetes Metab. Res. Rev.</source><year>2016</year><volume>32</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1002/dmrr.2672</pub-id><pub-id pub-id-type="pmid">26104243</pub-id></element-citation></ref><ref id="B152-nutrients-13-00462"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panossian</surname><given-names>A.</given-names></name><name><surname>Brendler</surname><given-names>T.</given-names></name></person-group><article-title>The role of adaptogens in prophylaxis and treatment of viral respiratory infections</article-title><source>Pharmaceuticals</source><year>2020</year><volume>13</volume><elocation-id>236</elocation-id><pub-id pub-id-type="doi">10.3390/ph13090236</pub-id></element-citation></ref><ref id="B153-nutrients-13-00462"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Mitsou</surname><given-names>E.</given-names></name><name><surname>Sitara</surname><given-names>M.</given-names></name><name><surname>Rementzis</surname><given-names>J.</given-names></name><name><surname>Mourelatos</surname><given-names>A.</given-names></name><name><surname>Ginis</surname><given-names>A.</given-names></name><name><surname>Phenekos</surname><given-names>C.</given-names></name></person-group><article-title>Effect of Traditional greek mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus</article-title><source>J. Med. Food</source><year>2006</year><volume>9</volume><fpage>356</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1089/jmf.2006.9.356</pub-id><pub-id pub-id-type="pmid">17004898</pub-id></element-citation></ref><ref id="B154-nutrients-13-00462"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Rementzis</surname><given-names>J.</given-names></name><name><surname>Phenekos</surname><given-names>C.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects&#x02019; platelet aggregation</article-title><source>Diabetes Res. Clin. Pract.</source><year>2006</year><volume>72</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2005.09.003</pub-id><pub-id pub-id-type="pmid">16236380</pub-id></element-citation></ref><ref id="B155-nutrients-13-00462"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiorino</surname><given-names>M.I.</given-names></name><name><surname>Bellastella</surname><given-names>G.</given-names></name><name><surname>Longo</surname><given-names>M.</given-names></name><name><surname>Caruso</surname><given-names>P.</given-names></name><name><surname>Esposito</surname><given-names>K.</given-names></name></person-group><article-title>Mediterranean Diet and COVID-19: Hypothesizing Potential benefits in people with diabetes</article-title><source>Front. Endocrinol.</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.3389/fendo.2020.574315</pub-id><?supplied-pmid 33042027?><pub-id pub-id-type="pmid">33042027</pub-id></element-citation></ref><ref id="B156-nutrients-13-00462"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampropoulos</surname><given-names>C.E.</given-names></name><name><surname>Konsta</surname><given-names>M.</given-names></name><name><surname>Dradaki</surname><given-names>V.</given-names></name><name><surname>Roumpou</surname><given-names>A.</given-names></name><name><surname>Dri</surname><given-names>I.</given-names></name><name><surname>Papaioannou</surname><given-names>I.</given-names></name></person-group><article-title>Effects of Mediterranean diet on hospital length of stay, medical expenses, and mortality in elderly, hospitalized patients: A 2-year observational study</article-title><source>Nutrition</source><year>2020</year><volume>80</volume><fpage>110868</fpage><pub-id pub-id-type="doi">10.1016/j.nut.2020.110868</pub-id><?supplied-pmid 32717580?><pub-id pub-id-type="pmid">32717580</pub-id></element-citation></ref><ref id="B157-nutrients-13-00462"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Buglio</surname><given-names>A.</given-names></name><name><surname>Bellanti</surname><given-names>F.</given-names></name><name><surname>Capurso</surname><given-names>C.</given-names></name><name><surname>Paglia</surname><given-names>A.</given-names></name><name><surname>Vendemiale</surname><given-names>G.</given-names></name></person-group><article-title>Adherence to Mediterranean diet, malnutrition, length of stay and mortality in elderly patients hospitalized in internal medicine wards</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>790</elocation-id><pub-id pub-id-type="doi">10.3390/nu11040790</pub-id><?supplied-pmid 30959815?><pub-id pub-id-type="pmid">30959815</pub-id></element-citation></ref><ref id="B158-nutrients-13-00462"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>A.</given-names></name><name><surname>Sciorsci</surname><given-names>R.L.</given-names></name><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name></person-group><article-title>Exploitation of some natural products for prevention and/or nutritional treatment of SARS-CoV2 infection</article-title><source>Endocr. Metab. Immune Disord. Drug Targets</source><year>2020</year><volume>20</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.2174/1871530320999200831231029</pub-id><?supplied-pmid 32875990?><pub-id pub-id-type="pmid">31942849</pub-id></element-citation></ref><ref id="B159-nutrients-13-00462"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkhatib</surname><given-names>A.</given-names></name></person-group><article-title>Antiviral functional foods and exercise lifestyle prevention of coronavirus</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>2633</elocation-id><pub-id pub-id-type="doi">10.3390/nu12092633</pub-id></element-citation></ref><ref id="B160-nutrients-13-00462"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Antithrombotic lipid minor constituents from vegetable oils. comparison between olive oils and others</article-title><source>J. Agric. Food Chem.</source><year>2002</year><volume>50</volume><fpage>1150</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1021/jf010923t</pub-id><?supplied-pmid 11853496?><pub-id pub-id-type="pmid">11853496</pub-id></element-citation></ref><ref id="B161-nutrients-13-00462"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Tsantila</surname><given-names>N.</given-names></name><name><surname>Stamatakis</surname><given-names>G.</given-names></name><name><surname>Samiotaki</surname><given-names>M.</given-names></name><name><surname>Panayotou</surname><given-names>G.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Bioactive polar lipids in olive oil, pomace and waste byproducts</article-title><source>J. Food Biochem.</source><year>2008</year><volume>32</volume><fpage>443</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1111/j.1745-4514.2008.00160.x</pub-id></element-citation></ref><ref id="B162-nutrients-13-00462"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Detopoulou</surname><given-names>M.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Mikellidi</surname><given-names>A.</given-names></name><name><surname>Vlachogianni</surname><given-names>&#x00399;.</given-names></name><name><surname>Xanthopoulou</surname><given-names>&#x0039c;.</given-names></name><name><surname>Argyrou</surname><given-names>C.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Yannakoulia</surname><given-names>M.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>Cardioprotective properties of a novel enriched yogurt with inhibitors of Platelet activating factor (PAF)</article-title><source>Proc. Nutr. Soc.</source><year>2020</year><volume>79</volume><pub-id pub-id-type="doi">10.1017/S0029665120004371</pub-id></element-citation></ref><ref id="B163-nutrients-13-00462"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panayiotou</surname><given-names>A.</given-names></name><name><surname>Samartzis</surname><given-names>D.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Lipid fractions with aggregatory and antiaggregatory activity toward platelets in fresh and fried cod (Gadus morhua): Correlation with platelet-activating factor and atherogenesis</article-title><source>J. Agric. Food Chem.</source><year>2000</year><volume>48</volume><fpage>6372</fpage><lpage>6379</lpage><pub-id pub-id-type="doi">10.1021/jf000701f</pub-id><pub-id pub-id-type="pmid">11312810</pub-id></element-citation></ref><ref id="B164-nutrients-13-00462"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasopoulou</surname><given-names>C.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Demopoulos</surname><given-names>C.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Comparison of antiatherogenic properties of lipids obtained from wild and cultured sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata)</article-title><source>Food Chem.</source><year>2007</year><volume>100</volume><fpage>560</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2005.09.074</pub-id></element-citation></ref><ref id="B165-nutrients-13-00462"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Skarvelis</surname><given-names>C.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Antiatherogenic properties of lipid fractions of raw and fried fish</article-title><source>Food Chem.</source><year>2006</year><volume>96</volume><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2005.01.060</pub-id></element-citation></ref><ref id="B166-nutrients-13-00462"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rementzis</surname><given-names>J.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Identification and Study of gangliosides from <italic>Scomber scombrus</italic> muscle</article-title><source>J. Agric. Food Chem.</source><year>1997</year><volume>45</volume><fpage>611</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1021/jf960538h</pub-id></element-citation></ref><ref id="B167-nutrients-13-00462"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasopoulou</surname><given-names>C.</given-names></name><name><surname>Tsoupras</surname><given-names>A.B.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism</article-title><source>Lipids Health Dis.</source><year>2011</year><volume>10</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-213</pub-id><?supplied-pmid 22087726?><pub-id pub-id-type="pmid">22087726</pub-id></element-citation></ref><ref id="B168-nutrients-13-00462"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasopoulou</surname><given-names>C.</given-names></name><name><surname>Karantonis</surname><given-names>H.C.</given-names></name><name><surname>Andriotis</surname><given-names>M.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Antibacterial and anti-PAF activity of lipid extracts from sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata)</article-title><source>Food Chem.</source><year>2008</year><volume>111</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2008.04.011</pub-id><?supplied-pmid 26047447?><pub-id pub-id-type="pmid">26047447</pub-id></element-citation></ref><ref id="B169-nutrients-13-00462"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kafatos</surname><given-names>A.</given-names></name><name><surname>Verhagen</surname><given-names>H.</given-names></name><name><surname>Moschandreas</surname><given-names>J.</given-names></name><name><surname>Apostolaki</surname><given-names>I.</given-names></name><name><surname>Westerop</surname><given-names>J.J.M.V.</given-names></name></person-group><article-title>Mediterranean Diet of Crete</article-title><source>J. Am. Diet. Assoc.</source><year>2000</year><volume>100</volume><fpage>1487</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1016/S0002-8223(00)00416-8</pub-id><pub-id pub-id-type="pmid">11138441</pub-id></element-citation></ref><ref id="B170-nutrients-13-00462"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skiadas</surname><given-names>P.</given-names></name><name><surname>Lascaratos</surname><given-names>J.</given-names></name></person-group><article-title>Dietetics in ancient Greek philosophy: Plato&#x02019;s concepts of healthy diet</article-title><source>Eur. J. Clin. Nutr.</source><year>2001</year><volume>55</volume><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1601179</pub-id><pub-id pub-id-type="pmid">11464226</pub-id></element-citation></ref><ref id="B171-nutrients-13-00462"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biluca</surname><given-names>F.C.</given-names></name><name><surname>da Silva</surname><given-names>B.</given-names></name><name><surname>Caon</surname><given-names>T.</given-names></name><name><surname>Mohr</surname><given-names>E.T.B.</given-names></name><name><surname>Vieira</surname><given-names>G.N.</given-names></name><name><surname>Gonzaga</surname><given-names>L.V.</given-names></name><name><surname>Vitali</surname><given-names>L.</given-names></name><name><surname>Micke</surname><given-names>G.</given-names></name><name><surname>Fett</surname><given-names>R.</given-names></name><name><surname>Dalmarco</surname><given-names>E.M.</given-names></name><etal/></person-group><article-title>Investigation of phenolic compounds, antioxidant and anti-inflammatory activities in stingless bee honey (Meliponinae)</article-title><source>Food Res. Int.</source><year>2020</year><volume>129</volume><fpage>108756</fpage><pub-id pub-id-type="doi">10.1016/j.foodres.2019.108756</pub-id><pub-id pub-id-type="pmid">32036884</pub-id></element-citation></ref><ref id="B172-nutrients-13-00462"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranneh</surname><given-names>Y.</given-names></name><name><surname>Akim</surname><given-names>A.M.</given-names></name><name><surname>Ab Hamid</surname><given-names>H.</given-names></name><name><surname>Khaza&#x02019;Ai</surname><given-names>H.</given-names></name><name><surname>Fadel</surname><given-names>A.</given-names></name><name><surname>Mahmoud</surname><given-names>A.M.</given-names></name></person-group><article-title>Stingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-&#x003ba;B and p38 MAPK</article-title><source>Nutr. Metab.</source><year>2019</year><volume>16</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1186/s12986-019-0341-z</pub-id></element-citation></ref><ref id="B173-nutrients-13-00462"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pimentel</surname><given-names>R.B.</given-names></name><name><surname>Da Costa</surname><given-names>C.A.</given-names></name><name><surname>Albuquerque</surname><given-names>P.M.</given-names></name><name><surname>Junior</surname><given-names>S.D.</given-names></name></person-group><article-title>Antimicrobial activity and rutin identification of honey produced by the stingless bee Melipona compressipes manaosensis and commercial honey</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><fpage>1</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1186/1472-6882-13-151</pub-id><pub-id pub-id-type="pmid">23280361</pub-id></element-citation></ref><ref id="B174-nutrients-13-00462"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustafa</surname><given-names>M.Z.</given-names></name><name><surname>Shamsuddin</surname><given-names>S.H.</given-names></name><name><surname>Sulaiman</surname><given-names>S.A.</given-names></name><name><surname>Abdullah</surname><given-names>J.M.</given-names></name></person-group><article-title>Anti-inflammatory properties of stingless bee honey may reduce the severity of pulmonary manifestations in COVID-19 Infections</article-title><source>Malays. J. Med Sci.</source><year>2020</year><volume>27</volume><fpage>165</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.21315/mjms2020.27.2.17</pub-id><pub-id pub-id-type="pmid">32788852</pub-id></element-citation></ref><ref id="B175-nutrients-13-00462"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname><given-names>K.S.</given-names></name><name><surname>Hossain</surname><given-names>M.G.</given-names></name><name><surname>Moni</surname><given-names>A.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Rahman</surname><given-names>U.H.</given-names></name><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Kundu</surname><given-names>S.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Hannan</surname><given-names>M.A.</given-names></name><name><surname>Uddin</surname><given-names>M.J.</given-names></name></person-group><article-title>Prospects of honey in fighting against COVID-19: Pharmacological insights and therapeutic promises</article-title><source>Heliyon</source><year>2020</year><volume>6</volume><fpage>e05798</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e05798</pub-id><?supplied-pmid 33363261?><pub-id pub-id-type="pmid">33363261</pub-id></element-citation></ref><ref id="B176-nutrients-13-00462"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashem</surname><given-names>H.E.</given-names></name></person-group><article-title>IN Silico approach of some selected honey constituents as sars-cov-2 main protease (COVID-19) inhibitors</article-title><source>Eurasian J. Med. Oncol.</source><year>2020</year><pub-id pub-id-type="doi">10.14744/ejmo.2020.36102</pub-id></element-citation></ref><ref id="B177-nutrients-13-00462"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>R.A.</given-names></name><name><surname>Azim</surname><given-names>M.K.</given-names></name><name><surname>Saeed</surname><given-names>S.A.</given-names></name><name><surname>Mesaik</surname><given-names>M.A.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Imran</surname><given-names>I.</given-names></name></person-group><article-title>Effect of natural honey on human platelets and blood coagulation proteins</article-title><source>Pak. J. Pharm. Sci.</source><year>2011</year><volume>24</volume><fpage>389</fpage><lpage>397</lpage><?supplied-pmid 21715274?><pub-id pub-id-type="pmid">21715274</pub-id></element-citation></ref><ref id="B178-nutrients-13-00462"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koussissis</surname><given-names>G.</given-names></name><name><surname>Semidalas</surname><given-names>E.</given-names></name><name><surname>Hadjistavrou</surname><given-names>E.</given-names></name><name><surname>Kalyvas</surname><given-names>V.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>PAF antagonists in food: Isolation and identification of PAF antagonists in honey and wax</article-title><source>Rev. Fr. Corps Gras</source><year>1994</year><volume>5/6</volume><fpage>127</fpage><lpage>132</lpage></element-citation></ref><ref id="B179-nutrients-13-00462"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardani</surname><given-names>R.</given-names></name><name><surname>Alamdary</surname><given-names>A.</given-names></name><name><surname>Nasab</surname><given-names>S.M.</given-names></name><name><surname>Gholami</surname><given-names>A.</given-names></name><name><surname>Ahmadi</surname><given-names>N.</given-names></name></person-group><article-title>Association of vitamin D with the modulation of the disease severity in COVID-19</article-title><source>Virus Res.</source><year>2020</year><volume>289</volume><fpage>198148</fpage><pub-id pub-id-type="doi">10.1016/j.virusres.2020.198148</pub-id><?supplied-pmid 32866536?><pub-id pub-id-type="pmid">32866536</pub-id></element-citation></ref><ref id="B180-nutrients-13-00462"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>F.H.</given-names></name><name><surname>Majumder</surname><given-names>R.</given-names></name><name><surname>Torabi</surname><given-names>R.</given-names></name><name><surname>Saeg</surname><given-names>F.</given-names></name><name><surname>Hoffman</surname><given-names>R.</given-names></name><name><surname>Cirillo</surname><given-names>J.D.</given-names></name><name><surname>Greiffenstein</surname><given-names>P.</given-names></name></person-group><article-title>Vitamin D Insufficiency is prevalent in severe Covid-19</article-title><source>MedRxiv</source><year>2020</year></element-citation></ref><ref id="B181-nutrients-13-00462"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panagiotou</surname><given-names>G.</given-names></name><name><surname>Tee</surname><given-names>S.A.</given-names></name><name><surname>Ihsan</surname><given-names>Y.</given-names></name><name><surname>Athar</surname><given-names>W.</given-names></name><name><surname>Marchitelli</surname><given-names>G.</given-names></name><name><surname>Kelly</surname><given-names>D.</given-names></name><name><surname>Boot</surname><given-names>C.S.</given-names></name><name><surname>Stock</surname><given-names>N.</given-names></name><name><surname>Macfarlane</surname><given-names>J.</given-names></name><name><surname>Martineau</surname><given-names>A.R.</given-names></name><etal/></person-group><article-title>Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity</article-title><source>Clin. Endocrinol.</source><year>2020</year><volume>93</volume><fpage>508</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1111/cen.14276</pub-id></element-citation></ref><ref id="B182-nutrients-13-00462"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Semidalas</surname><given-names>C.E.</given-names></name><name><surname>Koussissis</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Platelet-Activating factor (PAF) Antagonists in foods: A study of lipids with paf or anti-paf-like activity in cow&#x02019;s milk and yogurt</article-title><source>J. Agric. Food Chem.</source><year>1996</year><volume>44</volume><fpage>3047</fpage><lpage>3051</lpage><pub-id pub-id-type="doi">10.1021/jf950619y</pub-id></element-citation></ref><ref id="B183-nutrients-13-00462"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lordan</surname><given-names>R.</given-names></name><name><surname>Vidal</surname><given-names>N.P.</given-names></name><name><surname>Pham</surname><given-names>T.H.</given-names></name><name><surname>Tsoupras</surname><given-names>A.</given-names></name><name><surname>Thomas</surname><given-names>R.H.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Yoghurt fermentation alters the composition and antiplatelet properties of milk polar lipids</article-title><source>Food Chem.</source><year>2020</year><volume>332</volume><fpage>127384</fpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2020.127384</pub-id><pub-id pub-id-type="pmid">32615384</pub-id></element-citation></ref><ref id="B184-nutrients-13-00462"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lordan</surname><given-names>R.</given-names></name><name><surname>Walsh</surname><given-names>A.M.</given-names></name><name><surname>Crispie</surname><given-names>F.</given-names></name><name><surname>Finnegan</surname><given-names>L.</given-names></name><name><surname>Cotter</surname><given-names>P.D.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>The effect of ovine milk fermentation on the antithrombotic properties of polar lipids</article-title><source>J. Funct. Foods</source><year>2019</year><volume>54</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2019.01.029</pub-id></element-citation></ref><ref id="B185-nutrients-13-00462"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megalemou</surname><given-names>K.</given-names></name><name><surname>Sioriki</surname><given-names>E.</given-names></name><name><surname>Lordan</surname><given-names>R.</given-names></name><name><surname>Dermiki</surname><given-names>M.</given-names></name><name><surname>Nasopoulou</surname><given-names>C.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name></person-group><article-title>Evaluation of sensory and in vitro anti-thrombotic properties of traditional Greek yogurts derived from different types of milk</article-title><source>Heliyon</source><year>2017</year><volume>3</volume><fpage>e00227</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2016.e00227</pub-id><?supplied-pmid 28119955?><pub-id pub-id-type="pmid">28119955</pub-id></element-citation></ref><ref id="B186-nutrients-13-00462"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaghaghi</surname><given-names>N.</given-names></name></person-group><article-title>Molecular Docking Study of Novel COVID-19 Protease with Low Risk Terpenoides Compounds of Plants</article-title><source>Chemrixiv</source><year>2020</year><pub-id pub-id-type="doi">10.26434/chemrxiv.11935722.v1</pub-id></element-citation></ref><ref id="B187-nutrients-13-00462"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K.-L.</given-names></name><name><surname>Li</surname><given-names>Z.-Q.</given-names></name><name><surname>Cao</surname><given-names>Z.-Y.</given-names></name><name><surname>Ke</surname><given-names>Z.-P.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Z.-Z.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name></person-group><article-title>Effects of ginkgolide A, B and K on platelet aggregation</article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2017</year><volume>42</volume><fpage>4722</fpage><lpage>4726</lpage><?supplied-pmid 29493137?><pub-id pub-id-type="pmid">29493137</pub-id></element-citation></ref><ref id="B188-nutrients-13-00462"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Detopoulou</surname><given-names>P.</given-names></name><name><surname>Aggeli</surname><given-names>M.</given-names></name><name><surname>Andrioti</surname><given-names>E.</given-names></name><name><surname>Detopoulou</surname><given-names>M.</given-names></name></person-group><article-title>Macronutrient content and food exchanges for 48 Greek Mediterranean dishes</article-title><source>Nutr. Diet.</source><year>2016</year><volume>74</volume><fpage>200</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1111/1747-0080.12329</pub-id><pub-id pub-id-type="pmid">28731641</pub-id></element-citation></ref><ref id="B189-nutrients-13-00462"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>C.</given-names></name><name><surname>Poyser Norman</surname><given-names>L.</given-names></name></person-group><article-title>Inhibition of platelet aggregation by onion extracts</article-title><source>Lancet</source><year>1978</year><volume>311</volume><fpage>1051</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(78)90785-7</pub-id></element-citation></ref><ref id="B190-nutrients-13-00462"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H.</given-names></name><name><surname>Kubota</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>A.</given-names></name><name><surname>Seki</surname><given-names>T.</given-names></name><name><surname>Ariga</surname><given-names>T.</given-names></name></person-group><article-title>Inhibitory effect of sulfur-containing compounds in <italic>Scorodocarpus borneensis</italic> Becc. on the Aggregation of rabbit platelets</article-title><source>Biosci. Biotechnol. Biochem.</source><year>1999</year><volume>63</volume><fpage>298</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1271/bbb.63.298</pub-id><pub-id pub-id-type="pmid">10192909</pub-id></element-citation></ref><ref id="B191-nutrients-13-00462"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Detopoulou</surname><given-names>P.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Pliakis</surname><given-names>E.</given-names></name><name><surname>Panagiotakos</surname><given-names>D.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>Mediterranean wild plants reduce postprandial platelet aggregation in patients with metabolic syndrome</article-title><source>Metabolism</source><year>2012</year><volume>61</volume><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2011.07.006</pub-id><pub-id pub-id-type="pmid">21944262</pub-id></element-citation></ref><ref id="B192-nutrients-13-00462"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>W.-T.</given-names></name><name><surname>Ismail</surname><given-names>M.</given-names></name><name><surname>Imam</surname><given-names>M.U.</given-names></name><name><surname>Zhang</surname><given-names>Y.-D.</given-names></name></person-group><article-title>Modulation of platelet functions by crude rice (Oryza sativa) bran policosanol extract</article-title><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/s12906-016-1223-9</pub-id><pub-id pub-id-type="pmid">26729470</pub-id></element-citation></ref><ref id="B193-nutrients-13-00462"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rungratanawanich</surname><given-names>W.</given-names></name><name><surname>Cenini</surname><given-names>G.</given-names></name><name><surname>Mastinu</surname><given-names>A.</given-names></name><name><surname>Sylvester</surname><given-names>M.</given-names></name><name><surname>Wilkening</surname><given-names>A.</given-names></name><name><surname>Abate</surname><given-names>G.</given-names></name><name><surname>Bonini</surname><given-names>S.</given-names></name><name><surname>Aria</surname><given-names>F.</given-names></name><name><surname>Marziano</surname><given-names>M.</given-names></name><name><surname>Maccarinelli</surname><given-names>G.</given-names></name><etal/></person-group><article-title>&#x003b3;-Oryzanol improves cognitive function and modulates hippocampal proteome in mice</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>753</elocation-id><pub-id pub-id-type="doi">10.3390/nu11040753</pub-id></element-citation></ref><ref id="B194-nutrients-13-00462"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousquest</surname><given-names>J.</given-names></name><name><surname>Cristol</surname><given-names>J.-P.</given-names></name><name><surname>Czarlewski</surname><given-names>W.</given-names></name><name><surname>Anto</surname><given-names>J.M.</given-names></name><name><surname>Martineau</surname><given-names>A.</given-names></name><name><surname>Haahtela</surname><given-names>T.</given-names></name><name><surname>Fonseca</surname><given-names>S.C.</given-names></name><name><surname>Iaccarino</surname><given-names>G.</given-names></name><name><surname>Blain</surname><given-names>H.</given-names></name><name><surname>Fiocchi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Nrf2-interacting nutrients and COVID-19: Time for research to develop adaptation strategies</article-title><source>Clin. Transl. Allergy</source><year>2020</year><volume>10</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s13601-020-00362-7</pub-id><pub-id pub-id-type="pmid">31908763</pub-id></element-citation></ref><ref id="B195-nutrients-13-00462"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tufekci</surname><given-names>K.U.</given-names></name><name><surname>Bayin</surname><given-names>E.C.</given-names></name><name><surname>Genc</surname><given-names>S.</given-names></name><name><surname>Genc</surname><given-names>K.</given-names></name></person-group><article-title>The Nrf2/ARE Pathway: A Promising target to counteract mitochondrial dysfunction in parkinson&#x02019;s disease</article-title><source>Park. Dis.</source><year>2011</year><volume>2011</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.4061/2011/314082</pub-id><?supplied-pmid 21403858?><pub-id pub-id-type="pmid">21403858</pub-id></element-citation></ref><ref id="B196-nutrients-13-00462"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name></person-group><article-title>The French paradox three decades later: Role of inflammation and thrombosis</article-title><source>Clin. Chim. Acta</source><year>2020</year><volume>510</volume><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2020.07.013</pub-id><?supplied-pmid 32653485?><pub-id pub-id-type="pmid">32653485</pub-id></element-citation></ref><ref id="B197-nutrients-13-00462"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xanthopoulou</surname><given-names>M.N.</given-names></name><name><surname>Kalathara</surname><given-names>K.</given-names></name><name><surname>Melachroinou</surname><given-names>S.</given-names></name><name><surname>Arampatzi-Menenakou</surname><given-names>K.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Yannakoulia</surname><given-names>M.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name></person-group><article-title>Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men</article-title><source>Eur. J. Nutr.</source><year>2016</year><volume>56</volume><fpage>1485</fpage><lpage>1492</lpage><pub-id pub-id-type="doi">10.1007/s00394-016-1194-0</pub-id><?supplied-pmid 26936842?><pub-id pub-id-type="pmid">26936842</pub-id></element-citation></ref><ref id="B198-nutrients-13-00462"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argyrou</surname><given-names>C.</given-names></name><name><surname>Vlachogianni</surname><given-names>I.</given-names></name><name><surname>Stamatakis</surname><given-names>G.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name></person-group><article-title>Postprandial effects of wine consumption on platelet activating factor metabolic enzymes</article-title><source>Prostaglandins Other Lipid Mediat.</source><year>2017</year><volume>130</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.prostaglandins.2017.03.002</pub-id><?supplied-pmid 28323197?><pub-id pub-id-type="pmid">28323197</pub-id></element-citation></ref><ref id="B199-nutrients-13-00462"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Biologically active lipids with antiatherogenic properties from white wine and must</article-title><source>J. Agric. Food Chem.</source><year>2002</year><volume>50</volume><fpage>2684</fpage><lpage>2694</lpage><pub-id pub-id-type="doi">10.1021/jf011288u</pub-id><?supplied-pmid 11958642?><pub-id pub-id-type="pmid">11958642</pub-id></element-citation></ref><ref id="B200-nutrients-13-00462"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Mitsopoulou</surname><given-names>C.A.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Separation of biologically active lipids from red wine</article-title><source>J. Agric. Food Chem.</source><year>2000</year><volume>48</volume><fpage>1234</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1021/jf990554p</pub-id><pub-id pub-id-type="pmid">10775377</pub-id></element-citation></ref><ref id="B201-nutrients-13-00462"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Tsantila</surname><given-names>N.</given-names></name><name><surname>Mitropoulou</surname><given-names>A.</given-names></name><name><surname>Zabetakis</surname><given-names>I.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Biological activity of total lipids from red and white wine/must</article-title><source>J. Agric. Food Chem.</source><year>2001</year><volume>49</volume><fpage>5186</fpage><lpage>5193</lpage><pub-id pub-id-type="doi">10.1021/jf0106392</pub-id><?supplied-pmid 11714301?><pub-id pub-id-type="pmid">11714301</pub-id></element-citation></ref><ref id="B202-nutrients-13-00462"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragopoulou</surname><given-names>E.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Nomikos</surname><given-names>T.</given-names></name><name><surname>Demopoulos</surname><given-names>C.A.</given-names></name></person-group><article-title>Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties</article-title><source>Biochim. Biophys. Acta Mol. Cell Biol. Lipids</source><year>2003</year><volume>1632</volume><fpage>90</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/S1388-1981(03)00066-0</pub-id></element-citation></ref><ref id="B203-nutrients-13-00462"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choleva</surname><given-names>M.</given-names></name><name><surname>Boulougouri</surname><given-names>V.</given-names></name><name><surname>Panara</surname><given-names>A.</given-names></name><name><surname>Panagopoulou</surname><given-names>E.</given-names></name><name><surname>Chiou</surname><given-names>A.</given-names></name><name><surname>&#x003a4;homaidis</surname><given-names>&#x0039d;.S.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name></person-group><article-title>Evaluation of anti-platelet activity of grape pomace extracts</article-title><source>Food Funct.</source><year>2019</year><volume>10</volume><fpage>8069</fpage><lpage>8080</lpage><pub-id pub-id-type="doi">10.1039/C9FO02138H</pub-id><pub-id pub-id-type="pmid">31761914</pub-id></element-citation></ref><ref id="B204-nutrients-13-00462"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T.A.</given-names></name><name><surname>Beilin</surname><given-names>L.J.</given-names></name><name><surname>Burke</surname><given-names>V.</given-names></name><name><surname>Morris</surname><given-names>J.</given-names></name><name><surname>Ritchie</surname><given-names>J.</given-names></name></person-group><article-title>Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease</article-title><source>Arter. Thromb. Vasc. Biol.</source><year>1997</year><volume>17</volume><fpage>279</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.17.2.279</pub-id></element-citation></ref><ref id="B205-nutrients-13-00462"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimminger</surname><given-names>F.</given-names></name><name><surname>Mayser</surname><given-names>P.</given-names></name><name><surname>Papavassilis</surname><given-names>C.</given-names></name><name><surname>Thomas</surname><given-names>M.</given-names></name><name><surname>Schlotzer</surname><given-names>E.</given-names></name><name><surname>Heuer</surname><given-names>K.-U.</given-names></name><name><surname>F&#x000fc;hrer</surname><given-names>D.</given-names></name><name><surname>Hinsch</surname><given-names>K.-D.</given-names></name><name><surname>Walmrath</surname><given-names>D.</given-names></name><name><surname>Schill</surname><given-names>W.-B.</given-names></name><etal/></person-group><article-title>A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis</article-title><source>J. Mol. Med.</source><year>1993</year><volume>71</volume><fpage>634</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1007/BF00184491</pub-id><?supplied-pmid 8219661?><pub-id pub-id-type="pmid">8219661</pub-id></element-citation></ref><ref id="B206-nutrients-13-00462"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavriil</surname><given-names>L.</given-names></name><name><surname>Detopoulou</surname><given-names>M.</given-names></name><name><surname>Petsini</surname><given-names>F.</given-names></name><name><surname>Antonopoulou</surname><given-names>S.</given-names></name><name><surname>Fragopoulou</surname><given-names>E.</given-names></name></person-group><article-title>Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: A randomised, double-blind and placebo-controlled trial</article-title><source>Br. J. Nutr.</source><year>2019</year><volume>121</volume><fpage>982</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1017/S0007114519000308</pub-id><?supplied-pmid 30940217?><pub-id pub-id-type="pmid">30940217</pub-id></element-citation></ref><ref id="B207-nutrients-13-00462"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>K.F.</given-names></name><name><surname>Dent</surname><given-names>G.</given-names></name><name><surname>McCusker</surname><given-names>M.</given-names></name><name><surname>Guinot</surname><given-names>P.</given-names></name><name><surname>Page</surname><given-names>C.</given-names></name><name><surname>Barnes</surname><given-names>P.J.</given-names></name></person-group><article-title>Effect of a ginkgolide mixture (bn 52063) in antagonising skin and platelet responses to platelet activating factor in man</article-title><source>Lancet</source><year>1987</year><volume>329</volume><fpage>248</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(87)90066-3</pub-id></element-citation></ref><ref id="B208-nutrients-13-00462"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayaraghavan</surname><given-names>K.</given-names></name><name><surname>Szerlip</surname><given-names>H.M.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Philip</surname><given-names>S.</given-names></name><name><surname>Doyle</surname><given-names>R.T.</given-names></name><name><surname>Juliano</surname><given-names>R.A.</given-names></name><name><surname>Granowitz</surname><given-names>C.</given-names></name></person-group><article-title>Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides</article-title><source>Postgrad. Med.</source><year>2019</year><volume>131</volume><fpage>390</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1080/00325481.2019.1643633</pub-id><pub-id pub-id-type="pmid">31306043</pub-id></element-citation></ref><ref id="B209-nutrients-13-00462"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinton</surname><given-names>E.A.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Kastelein</surname><given-names>J.J.P.</given-names></name><name><surname>Braeckman</surname><given-names>R.A.</given-names></name><name><surname>Soni</surname><given-names>P.N.</given-names></name></person-group><article-title>Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200&#x02013;500 mg/dL), and on statin therapy at LDL-C goal: The ANCHOR study</article-title><source>Cardiovasc. Diabetol.</source><year>2013</year><volume>12</volume><fpage>1</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1186/1475-2840-12-100</pub-id><pub-id pub-id-type="pmid">23280391</pub-id></element-citation></ref><ref id="B210-nutrients-13-00462"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodman</surname><given-names>R.J.</given-names></name><name><surname>Mori</surname><given-names>T.A.</given-names></name><name><surname>Burke</surname><given-names>V.</given-names></name><name><surname>Puddey</surname><given-names>I.B.</given-names></name><name><surname>Barden</surname><given-names>A.</given-names></name><name><surname>Watts</surname><given-names>G.F.</given-names></name><name><surname>Beilin</surname><given-names>L.J.</given-names></name></person-group><article-title>Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients</article-title><source>Atheroscler.</source><year>2003</year><volume>166</volume><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(02)00307-6</pub-id></element-citation></ref><ref id="B211-nutrients-13-00462"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastelein</surname><given-names>J.J.P.</given-names></name><name><surname>Maki</surname><given-names>K.C.</given-names></name><name><surname>Susekov</surname><given-names>A.</given-names></name><name><surname>Ezhov</surname><given-names>M.</given-names></name><name><surname>Nordestgaard</surname><given-names>B.G.</given-names></name><name><surname>Machielse</surname><given-names>B.N.</given-names></name><name><surname>Kling</surname><given-names>D.</given-names></name><name><surname>Davidson</surname><given-names>M.H.</given-names></name></person-group><article-title>Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The Epanova for lowering very high triglycerides (EVOLVE) trial</article-title><source>J. Clin. Lipidol.</source><year>2014</year><volume>8</volume><fpage>94</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.jacl.2013.10.003</pub-id><pub-id pub-id-type="pmid">24528690</pub-id></element-citation></ref><ref id="B212-nutrients-13-00462"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosca</surname><given-names>L.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Guyton</surname><given-names>J.R.</given-names></name><name><surname>Philip</surname><given-names>S.</given-names></name><name><surname>Doyle</surname><given-names>R.T.</given-names></name><name><surname>Juliano</surname><given-names>R.A.</given-names></name></person-group><article-title>Usefulness of icosapent ethyl (eicosapentaenoic acid ethyl ester) in women to lower triglyceride levels (results from the marine and anchor trials)</article-title><source>Am. J. Cardiol.</source><year>2017</year><volume>119</volume><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2016.10.027</pub-id><pub-id pub-id-type="pmid">27939227</pub-id></element-citation></ref><ref id="B213-nutrients-13-00462"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krantz</surname><given-names>M.J.</given-names></name><name><surname>Havranek</surname><given-names>E.P.</given-names></name><name><surname>Pereira</surname><given-names>R.I.</given-names></name><name><surname>Beaty</surname><given-names>B.</given-names></name><name><surname>Mehler</surname><given-names>P.S.</given-names></name><name><surname>Long</surname><given-names>C.S.</given-names></name></person-group><article-title>Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: A randomized pilot study</article-title><source>J. Negat. Results Biomed.</source><year>2015</year><volume>14</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1186/s12952-015-0040-x</pub-id><pub-id pub-id-type="pmid">25566870</pub-id></element-citation></ref><ref id="B214-nutrients-13-00462"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>J.S.</given-names></name><name><surname>Nambi</surname><given-names>P.</given-names></name><name><surname>Gillard</surname><given-names>B.K.</given-names></name><name><surname>Pownall</surname><given-names>H.J.</given-names></name><name><surname>Coraza</surname><given-names>I.</given-names></name><name><surname>Scott</surname><given-names>L.W.</given-names></name><name><surname>Nambi</surname><given-names>V.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Balasubramanyam</surname><given-names>A.</given-names></name></person-group><article-title>intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients</article-title><source>Med. Sci. Sports Exerc.</source><year>2013</year><volume>45</volume><fpage>1043</fpage><lpage>1050</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3182843961</pub-id><pub-id pub-id-type="pmid">23299761</pub-id></element-citation></ref><ref id="B215-nutrients-13-00462"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Jeung</surname><given-names>S.R.</given-names></name><name><surname>Jeong</surname><given-names>T.-S.</given-names></name><name><surname>Lee</surname><given-names>S.-H.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name></person-group><article-title>Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D</article-title><source>J. Lipid Res.</source><year>2014</year><volume>55</volume><fpage>1762</fpage><lpage>1771</lpage><pub-id pub-id-type="doi">10.1194/jlr.M044834</pub-id><?supplied-pmid 24904022?><pub-id pub-id-type="pmid">24904022</pub-id></element-citation></ref><ref id="B216-nutrients-13-00462"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>J.</given-names></name><name><surname>Burke</surname><given-names>V.</given-names></name><name><surname>Mori</surname><given-names>T.A.</given-names></name><name><surname>Vandongen</surname><given-names>R.</given-names></name><name><surname>Beilin</surname><given-names>L.J.</given-names></name></person-group><article-title>Effects of garlic extract on platelet aggregation: A randomized placebo-controlled double-blind study</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><year>1995</year><volume>22</volume><fpage>414</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.1995.tb02032.x</pub-id><?supplied-pmid 8582091?><pub-id pub-id-type="pmid">8582091</pub-id></element-citation></ref><ref id="B217-nutrients-13-00462"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asztalos</surname><given-names>I.B.</given-names></name><name><surname>Gleason</surname><given-names>J.A.</given-names></name><name><surname>Sever</surname><given-names>S.</given-names></name><name><surname>Gedik</surname><given-names>R.</given-names></name><name><surname>Asztalos</surname><given-names>B.F.</given-names></name><name><surname>Horvath</surname><given-names>K.V.</given-names></name><name><surname>Dansinger</surname><given-names>M.L.</given-names></name><name><surname>Lamon-Fava</surname><given-names>S.</given-names></name><name><surname>Schaefer</surname><given-names>E.J.</given-names></name></person-group><article-title>Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: A randomized clinical trial</article-title><source>Metabolism</source><year>2016</year><volume>65</volume><fpage>1636</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2016.07.010</pub-id><?supplied-pmid 27733252?><pub-id pub-id-type="pmid">27733252</pub-id></element-citation></ref><ref id="B218-nutrients-13-00462"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maki</surname><given-names>K.C.</given-names></name><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Dicklin</surname><given-names>M.R.</given-names></name><name><surname>Johnson</surname><given-names>S.L.</given-names></name><name><surname>Shabbout</surname><given-names>M.</given-names></name></person-group><article-title>Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia</article-title><source>J. Clin. Lipidol.</source><year>2011</year><volume>5</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/j.jacl.2011.09.001</pub-id><pub-id pub-id-type="pmid">22108152</pub-id></element-citation></ref><ref id="B219-nutrients-13-00462"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Kastelein</surname><given-names>J.J.</given-names></name><name><surname>Isaacsohn</surname><given-names>J.L.</given-names></name><name><surname>Braeckman</surname><given-names>R.A.</given-names></name><name><surname>Soni</surname><given-names>P.N.</given-names></name></person-group><article-title>Eicosapentaenoic acid ethyl ester (amr101) therapy in patients with very high triglyceride levels (from the multi-center, placebo-controlled, randomized, double-blind, 12-week study with an open-label extension [marine] trial)</article-title><source>Am. J. Cardiol.</source><year>2011</year><volume>108</volume><fpage>682</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2011.04.015</pub-id><pub-id pub-id-type="pmid">21683321</pub-id></element-citation></ref><ref id="B220-nutrients-13-00462"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>R.L.</given-names></name><name><surname>Nicholls</surname><given-names>S.J.</given-names></name><name><surname>Maki</surname><given-names>K.C.</given-names></name><name><surname>Roth</surname><given-names>E.M.</given-names></name><name><surname>Orloff</surname><given-names>D.G.</given-names></name><name><surname>Curcio</surname><given-names>D.</given-names></name><name><surname>Johnson</surname><given-names>J.</given-names></name><name><surname>Kling</surname><given-names>D.</given-names></name><name><surname>Davidson</surname><given-names>M.H.</given-names></name></person-group><article-title>Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: A randomized, controlled, double-blind trial</article-title><source>Lipids Health Dis.</source><year>2015</year><volume>14</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/s12944-015-0100-8</pub-id><pub-id pub-id-type="pmid">25575766</pub-id></element-citation></ref><ref id="B221-nutrients-13-00462"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedengran</surname><given-names>A.</given-names></name><name><surname>Szecsi</surname><given-names>P.B.</given-names></name><name><surname>Dyerberg</surname><given-names>J.</given-names></name><name><surname>Harris</surname><given-names>W.S.</given-names></name><name><surname>Stender</surname><given-names>S.</given-names></name></person-group><article-title>N-3 PUFA Esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: A randomized trial</article-title><source>Lipids</source><year>2014</year><volume>50</volume><fpage>165</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1007/s11745-014-3968-6</pub-id><pub-id pub-id-type="pmid">25403919</pub-id></element-citation></ref><ref id="B222-nutrients-13-00462"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>K.</given-names></name><name><surname>Fegbeutel</surname><given-names>C.</given-names></name><name><surname>Hattar</surname><given-names>K.</given-names></name><name><surname>Sibelius</surname><given-names>U.</given-names></name><name><surname>Kr&#x000e4;mer</surname><given-names>H.-J.</given-names></name><name><surname>Heuer</surname><given-names>K.-U.</given-names></name><name><surname>Temmesfeld-Wollbr&#x000fc;ck</surname><given-names>B.</given-names></name><name><surname>Gokorsch</surname><given-names>S.</given-names></name><name><surname>Grimminger</surname><given-names>F.</given-names></name><name><surname>Seeger</surname><given-names>W.</given-names></name></person-group><article-title>&#x003c9;-3 vs. &#x003c9;-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: Impact on plasma fatty acids and lipid mediator generation</article-title><source>Intensive Care Med.</source><year>2003</year><volume>29</volume><fpage>1472</fpage><lpage>1481</lpage><pub-id pub-id-type="doi">10.1007/s00134-003-1900-2</pub-id><pub-id pub-id-type="pmid">12897994</pub-id></element-citation></ref><ref id="B223-nutrients-13-00462"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerely</surname><given-names>C.P.</given-names></name><name><surname>Hutchinson</surname><given-names>K.</given-names></name><name><surname>Bramham</surname><given-names>J.</given-names></name><name><surname>McGowan</surname><given-names>A.</given-names></name><name><surname>Faul</surname><given-names>J.</given-names></name><name><surname>Cormican</surname><given-names>L.</given-names></name></person-group><article-title>Vitamin D Improves selected metabolic parameters but not neuropsychological or quality of life indices in osa: A Pilot Study</article-title><source>J. Clin. Sleep Med.</source><year>2017</year><volume>13</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.5664/jcsm.6378</pub-id><pub-id pub-id-type="pmid">27707440</pub-id></element-citation></ref><ref id="B224-nutrients-13-00462"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T.A.</given-names></name><name><surname>Vandongen</surname><given-names>R.</given-names></name><name><surname>Mahanian</surname><given-names>F.</given-names></name><name><surname>Douglas</surname><given-names>A.</given-names></name></person-group><article-title>Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation</article-title><source>Metabolism</source><year>1992</year><volume>41</volume><fpage>1059</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/0026-0495(92)90286-J</pub-id><pub-id pub-id-type="pmid">1328817</pub-id></element-citation></ref><ref id="B225-nutrients-13-00462"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Kastelein</surname><given-names>J.J.</given-names></name><name><surname>Stein</surname><given-names>E.</given-names></name><name><surname>Isaacsohn</surname><given-names>J.L.</given-names></name><name><surname>Braeckman</surname><given-names>R.A.</given-names></name><name><surname>Soni</surname><given-names>P.N.</given-names></name></person-group><article-title>Efficacy and safety of eicosapentaenoic acid ethyl ester (amr101) therapy in statin-treated patients with persistent high triglycerides (from the anchor study)</article-title><source>Am. J. Cardiol.</source><year>2012</year><volume>110</volume><fpage>984</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2012.05.031</pub-id><?supplied-pmid 22819432?><pub-id pub-id-type="pmid">22819432</pub-id></element-citation></ref><ref id="B226-nutrients-13-00462"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Granowitz</surname><given-names>C.</given-names></name><name><surname>Doyle</surname><given-names>R.T.</given-names></name><name><surname>Juliano</surname><given-names>R.A.</given-names></name><name><surname>Philip</surname><given-names>S.</given-names></name></person-group><article-title>Effects of icosapent ethyl (eicosapentaenoic acid ethyl ester) on atherogenic lipid/lipoprotein, apolipoprotein, and inflammatory parameters in patients with elevated high-sensitivity c-reactive protein (from the anchor study)</article-title><source>Am. J. Cardiol.</source><year>2019</year><volume>124</volume><fpage>696</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2019.05.057</pub-id><?supplied-pmid 31277790?><pub-id pub-id-type="pmid">31277790</pub-id></element-citation></ref><ref id="B227-nutrients-13-00462"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beulens</surname><given-names>J.W.J.</given-names></name><name><surname>van den Berg</surname><given-names>R.</given-names></name><name><surname>Kok</surname><given-names>F.J.</given-names></name><name><surname>Helander</surname><given-names>A.</given-names></name><name><surname>Vermunt</surname><given-names>S.H.F.</given-names></name><name><surname>Hendriks</surname><given-names>H.F.</given-names></name></person-group><article-title>Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2008</year><volume>18</volume><fpage>539</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2007.07.002</pub-id><?supplied-pmid 18061416?><pub-id pub-id-type="pmid">18061416</pub-id></element-citation></ref><ref id="B228-nutrients-13-00462"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Conesa</surname><given-names>M.-T.</given-names></name><name><surname>Philippou</surname><given-names>E.</given-names></name><name><surname>Pafilas</surname><given-names>C.</given-names></name><name><surname>Massaro</surname><given-names>M.</given-names></name><name><surname>Quarta</surname><given-names>S.</given-names></name><name><surname>Andrade</surname><given-names>V.</given-names></name><name><surname>Jorge</surname><given-names>R.</given-names></name><name><surname>Chervenkov</surname><given-names>M.</given-names></name><name><surname>Ivanova</surname><given-names>T.</given-names></name><name><surname>Dimitrova</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Exploring the Validity of the 14-Item Mediterranean Diet Adherence Screener (MEDAS): A Cross-National Study in Seven European Countries around the Mediterranean Region</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>2960</elocation-id><pub-id pub-id-type="doi">10.3390/nu12102960</pub-id><?supplied-pmid 32992649?><pub-id pub-id-type="pmid">32992649</pub-id></element-citation></ref><ref id="B229-nutrients-13-00462"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelucchi</surname><given-names>C.</given-names></name><name><surname>Galeone</surname><given-names>C.</given-names></name><name><surname>Negri</surname><given-names>E.</given-names></name><name><surname>La Vecchia</surname><given-names>C.</given-names></name></person-group><article-title>Trends in adherence to the Mediterranean diet in an Italian population between 1991 and 2006</article-title><source>Eur. J. Clin. Nutr.</source><year>2010</year><volume>64</volume><fpage>1052</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1038/ejcn.2010.158</pub-id><pub-id pub-id-type="pmid">20717133</pub-id></element-citation></ref><ref id="B230-nutrients-13-00462"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Renzo</surname><given-names>L.</given-names></name><name><surname>Gualtieri</surname><given-names>P.</given-names></name><name><surname>Pivari</surname><given-names>F.</given-names></name><name><surname>Soldati</surname><given-names>L.</given-names></name><name><surname>Attin&#x000e0;</surname><given-names>A.</given-names></name><name><surname>Cinelli</surname><given-names>G.</given-names></name><name><surname>Leggeri</surname><given-names>C.</given-names></name><name><surname>Caparello</surname><given-names>G.</given-names></name><name><surname>Barrea</surname><given-names>L.</given-names></name><name><surname>Scerbo</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Eating habits and lifestyle changes during COVID-19 lockdown: An Italian survey</article-title><source>J. Transl. Med.</source><year>2020</year><volume>18</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s12967-020-02399-5</pub-id><pub-id pub-id-type="pmid">31900168</pub-id></element-citation></ref><ref id="B231-nutrients-13-00462"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Roso</surname><given-names>M.B.</given-names></name><name><surname>de Carvalho Padilha</surname><given-names>P.</given-names></name><name><surname>Mantilla-Escalante</surname><given-names>D.C.</given-names></name><name><surname>Ulloa</surname><given-names>N.</given-names></name><name><surname>Brun</surname><given-names>P.</given-names></name><name><surname>Acevedo-Correa</surname><given-names>D.</given-names></name><name><surname>Arrantes Ferreira Peres</surname><given-names>W.</given-names></name><name><surname>Martorell</surname><given-names>M.</given-names></name><name><surname>Aires</surname><given-names>M.T.</given-names></name><name><surname>de Oliveira Cardoso</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Covid-19 Confinement and Changes of Adolescent&#x02019;s Dietary Trends in Italy, Spain, Chile, Colombia and Brazil</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1807</elocation-id><pub-id pub-id-type="doi">10.3390/nu12061807</pub-id></element-citation></ref><ref id="B232-nutrients-13-00462"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname><given-names>C.</given-names></name><name><surname>Molina-Montes</surname><given-names>E.</given-names></name><name><surname>Verardo</surname><given-names>V.</given-names></name><name><surname>Artacho</surname><given-names>R.</given-names></name><name><surname>Garc&#x000ed;a-Villanova</surname><given-names>B.</given-names></name><name><surname>Guerra-Hern&#x000e1;ndez</surname><given-names>E.J.</given-names></name><name><surname>Ruiz-L&#x000f3;pez</surname><given-names>M.-D.</given-names></name></person-group><article-title>Changes in dietary behaviours during the COVID-19 Outbreak Confinement in the Spanish COVIDiet Study</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1730</elocation-id><pub-id pub-id-type="doi">10.3390/nu12061730</pub-id></element-citation></ref><ref id="B233-nutrients-13-00462"><label>233.</label><element-citation publication-type="web"><article-title>PRESS RELEASE&#x02014;The Role of Nutrition in the COVID-19 Era</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.hda.gr/deltio-typoy-o-rolos-tis-diatrofis-stin-epochi-tis-covid-19-prolipsi-antimetopisi-kai-o-paragontas-tis-pachusarkias/">https://www.hda.gr/deltio-typoy-o-rolos-tis-diatrofis-stin-epochi-tis-covid-19-prolipsi-antimetopisi-kai-o-paragontas-tis-pachusarkias/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-01-27">(accessed on 27 January 2021)</date-in-citation></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-13-00462-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Protective role of nutrition against COVID-19 through modulation of PAF actions and metabolism. Figure legend: Various agents activate cells (usually mast cells) and secrete platelet activating factor (PAF). The produced PAF then affects various target cells (tissue-organs). In activated target cells, coronavirus 19 binds to PAF receptors (PAFRs) exposed to their pericellular membrane, enters these cells more easily and further induces PAF production. The action of PAF through inflammasomes, which is not mediated through PAFRs should not be ignored. Of course, the virus can also enter and act on the initially activated cells (usually mast cells) causing its known actions. Prolonged and replenished PAF production (feedback control) goes hand in hand with a prolonged inflammatory and prothrombotic response and the characteristic phenotypic manifestations of COVID-19. PAF inhibitors can act (i) by inactivating PAFRs and (ii) by affecting PAF metabolism. PAF inhibitors have been found to typically reduce the activity of one or both PAF key biosynthetic enzymes (regulatory enzymes) and/or increase the activity of the PAF key degrading enzyme. The role of antioxidants, micronutrients and phytochemicals that limits the initial activation by reducing oxidative stress and/or the production of PAF-like activity compounds in a non-enzymatic way is also pointed out.</p></caption><graphic xlink:href="nutrients-13-00462-g001"/></fig><table-wrap id="nutrients-13-00462-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00462-t001_Table 1</object-id><label>Table 1</label><caption><p>Human clinical trials regarding the effects of foods/nutrients on PAF and its metabolism.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nutrient/Food</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Volunteers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Health Status</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PAF Induced Platelet Aggregation </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PAF Levels</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PAF Biosynthetic Enzymes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PAF Catabolic Enzymes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">15 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 10<break/><italic>n</italic> = 9 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">56 &#x000b1; 10 <break/>52 &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B223-nutrients-13-00462" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Fish oils, omega-3</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fish oil<break/>Olive oil</td><td align="center" valign="middle" rowspan="1" colspan="1">10 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 15 (fish oil) <break/><italic>n</italic> = 15 (olive oil)</td><td align="center" valign="middle" rowspan="1" colspan="1">61.9 &#x000b1; 1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">Peripheral vascular disease</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;<break/>In the fish oil group<break/>&#x02191; in the olive oil group</td><td align="center" valign="middle" rowspan="1" colspan="1">no changes (measured in neutrophils)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B224-nutrients-13-00462" ref-type="bibr">224</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fish<break/>Fish oil (2 doses)<break/>Fish + fish oil<break/>placebo</td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 120 (for all groups)</td><td align="center" valign="middle" rowspan="1" colspan="1">30&#x02013;60</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;<break/>(not in the control group)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B204-nutrients-13-00462" ref-type="bibr">204</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA + DHA<break/>omega-6</td><td align="center" valign="middle" rowspan="1" colspan="1">acute</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 20</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Psoriasis</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193; in n-3<break/>Group<break/>&#x02191; in the n-6 group</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B205-nutrients-13-00462" ref-type="bibr">205</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-3 +atorvastatin <break/>placebo + atorvastatin</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> =123<break/><italic>n</italic> = 122</td><td align="center" valign="middle" rowspan="1" colspan="1">56.1 &#x000b1; 10.2</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193; (n-3 + atorvastatin vs. placebo + atorvastatin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B218-nutrients-13-00462" ref-type="bibr">218</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA (2 doses) *</td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 702 (for all groups)</td><td align="center" valign="middle" rowspan="1" colspan="1">61 &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B225-nutrients-13-00462" ref-type="bibr">225</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA *</td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 126<break/><italic>n</italic> = 120 </td><td align="center" valign="middle" rowspan="1" colspan="1">60.2 &#x000b1; 9.7<break/>61.0 &#x000b1; 9.9</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia, high CRP</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B226-nutrients-13-00462" ref-type="bibr">226</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA *</td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 19 (4 g)<break/><italic>n</italic> = 30 (2 g)<break/>n = 36 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">68.2 &#x000b1; 7.2<break/>67.9 &#x000b1; 8.3<break/>68.0 &#x000b1; 8.4</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia, and chronic kidney disease </td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B208-nutrients-13-00462" ref-type="bibr">208</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA * (2 doses)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">171 (2 g)_<break/>165 (4 g)<break/>165(control)</td><td align="center" valign="middle" rowspan="1" colspan="1">Not reported</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia, diabetes mellitus-2 and statin therapy</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;<break/>(high dose)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B209-nutrients-13-00462" ref-type="bibr">209</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA or<break/>DHA</td><td align="center" valign="middle" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 59 (for all groups, men)</td><td align="center" valign="middle" rowspan="1" colspan="1">61.2&#x02009; &#x000b1; &#x02009;51.2</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertention and type 2 diabetes</td><td align="center" valign="middle" rowspan="1" colspan="1">no changes</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B210-nutrients-13-00462" ref-type="bibr">210</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-3</td><td align="center" valign="middle" rowspan="1" colspan="1">30 days</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 54</td><td align="center" valign="middle" rowspan="1" colspan="1">30&#x02013;80</td><td align="center" valign="middle" rowspan="1" colspan="1">angina</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B109-nutrients-13-00462" ref-type="bibr">109</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA+ DHA<break/>0/0.85/ 3.4 g/day</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 25 (crossover)</td><td align="center" valign="middle" rowspan="1" colspan="1">44.3 &#x000b1; 9.8</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B110-nutrients-13-00462" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA (2 g, 4 g)<break/>(control)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 77 (4 g)<break/><italic>n</italic> = 76 (2 g)<break/>n = 76 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">52.9 &#x000b1;&#x02009;9.34</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B219-nutrients-13-00462" ref-type="bibr">219</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-3 (2 g, 4 g)<break/>control</td><td align="center" valign="middle" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 209 (2 g)<break/>n= 207 (4 g)<break/><italic>n</italic> = 211 (control</td><td align="center" valign="middle" rowspan="1" colspan="1">60.8 &#x000b1; &#x02009;9.6 </td><td align="center" valign="middle" rowspan="1" colspan="1">Statin-treated patients<break/>with residual hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B220-nutrients-13-00462" ref-type="bibr">220</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-3 esterified to glycerol or as ethyl esters</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 120</td><td align="center" valign="middle" rowspan="1" colspan="1">62.4 &#x000b1; 10.0</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;<break/>With ethyl esters of n-3</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B221-nutrients-13-00462" ref-type="bibr">221</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-6 or omega -3 (parenteral nutrition)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 days</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 10 patients<break/><italic>n</italic> = 8 healthy control</td><td align="center" valign="middle" rowspan="1" colspan="1">53.7 &#x000b1;&#x02009;13.8</td><td align="center" valign="middle" rowspan="1" colspan="1">Sepsis</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02191;in the n-3 group (baseline levels were suppressed)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B222-nutrients-13-00462" ref-type="bibr">222</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-3 2 g, 3, 4 g </td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 100 (2 g)<break/><italic>n</italic> = 101 (3 g)<break/><italic>n</italic> - = 99 (4 g)<break/>n = 99 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">51.1 &#x000b1; 9.8<break/>51.2 &#x000b1; 8.8<break/>52.9 &#x000b1; 10.9<break/>50.8 &#x000b1; 10.6</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B211-nutrients-13-00462" ref-type="bibr">211</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA (2 g, 4 g)<break/>control</td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 215 (women)</td><td align="center" valign="middle" rowspan="1" colspan="1">~60 &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertriglyceridemia</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B212-nutrients-13-00462" ref-type="bibr">212</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-3</td><td align="center" valign="middle" rowspan="1" colspan="1">3 months</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 27<break/><italic>n</italic> = 35 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">62.3 &#x000b1; 9.7<break/>60.2 &#x000b1; 10.8</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">no change</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B213-nutrients-13-00462" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">a-linolenic acid<break/>EPA+DHA</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 20 ALA<break/><italic>n</italic> = 20 EPA + DHA<break/><italic>n</italic> - = 19 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">63.4 &#x000b1; 8.2<break/>62.1 &#x000b1; 7.7<break/>58.6 &#x000b1; 6.3</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">no change</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">omega-3 (2 g, 6.6 g) <break/>control (olive oil) </td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 20 (2 g)<break/><italic>n</italic> = 20 (6.6 g)<break/><italic>n</italic> = 20 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.5 &#x000b1; 11<break/>37.0 &#x000b1; 10<break/>37.9 &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">no change</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B108-nutrients-13-00462" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">olive oil (control) <break/>EPA 600 mg/day<break/>EPA 1800 mg/day, DHA 600 mg/day</td><td align="center" valign="middle" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 26 (control)<break/><italic>n</italic> = 27 (600 mg EPA)<break/><italic>n</italic> = 26 (1800 mg EPA)<break/><italic>n</italic> = 28 (600 mg DHA)</td><td align="center" valign="middle" rowspan="1" colspan="1">52.2 &#x000b1; 10.4 52.8 &#x000b1; 11.6<break/>52.2 &#x000b1; 11.6<break/>52.3 &#x000b1; 12.6 </td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;<break/>high dose EPA</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B217-nutrients-13-00462" ref-type="bibr">217</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mediterranean diet</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fast-food Mediterranean-type diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic> = 22 healthy<break/><italic>n</italic> = 22 type 2 diabetes<break/><italic>n</italic> = 22 control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56 &#x000b1; 15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy and with type 2 diabetes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;<break/>(not in the control group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B154-nutrients-13-00462" ref-type="bibr">154</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">traditional Greek Mediterranean-type meals</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic> = 22 healthy<break/><italic>n</italic> = 24 type 2 diabetes<break/><italic>n</italic> = 22 type 2 diabetes -control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53 &#x000b1; 12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy and with type 2 diabetes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;<break/>(not in the control group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-nutrients-13-00462" ref-type="bibr">153</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet and exercise</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet and exercise</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic> = 22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.0 &#x000b1; 1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B214-nutrients-13-00462" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">substitution of whole grains and legumes for refined rice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic> = 50 (whole grain) <break/><italic>n</italic> = 49 (control)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.3 &#x000b1; 1.2<break/>55.4 &#x000b1; 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Impaired fasting glucose, impaired glucose tolerance or newly diagnosed T2D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B215-nutrients-13-00462" ref-type="bibr">215</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plants and plant extracts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">wild plant meals, namely, Reichardia picroides, Cynara cardunculus, Urospermum picroides and Chrysanthemum coronarium, and a control meal, which contained no wild plant</td><td align="center" valign="middle" rowspan="1" colspan="1">acute</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 24</td><td align="center" valign="middle" rowspan="1" colspan="1">58.6 &#x000b1; 11.3</td><td align="center" valign="middle" rowspan="1" colspan="1">Metabolic syndrome</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193; with the Urospermum picroides meal</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B191-nutrients-13-00462" ref-type="bibr">191</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">plant extract supplement</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 30 (supplement)<break/><italic>n</italic> = 28 (control)</td><td align="center" valign="middle" rowspan="1" colspan="1">34.9&#x02009; &#x000b1; &#x02009;5.8 (supplement)<break/>32.9&#x02009; &#x000b1; &#x02009;5.6 (control group)</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">no change</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02191;</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B206-nutrients-13-00462" ref-type="bibr">206</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">ginkgolide mixture</td><td align="center" valign="middle" rowspan="1" colspan="1">acute</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 6</td><td align="center" valign="middle" rowspan="1" colspan="1">25&#x02013;35</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B207-nutrients-13-00462" ref-type="bibr">207</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Garlic extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic> = 14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20&#x02013;55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no change</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B216-nutrients-13-00462" ref-type="bibr">216</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol and wine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Wine (Robola, Cabernet Sauvignon)</td><td align="center" valign="middle" rowspan="1" colspan="1">acute</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 12</td><td align="center" valign="middle" rowspan="1" colspan="1">31.3 &#x000b1; 4.3y</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;lyso-PAf-AT<break/>&#x02193; PAF-CPT</td><td align="center" valign="middle" rowspan="1" colspan="1">no changes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B198-nutrients-13-00462" ref-type="bibr">198</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Wine (Robola, Cabernet Sauvignon)</td><td align="center" valign="middle" rowspan="1" colspan="1">acute</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 10</td><td align="center" valign="middle" rowspan="1" colspan="1">31.3 &#x000b1; 4.3</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy </td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B197-nutrients-13-00462" ref-type="bibr">197</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Beer or alcohol-free</td><td align="center" valign="middle" rowspan="1" colspan="1">3 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>n</italic> = 11 lean<break/><italic>n</italic> = 9 overweight</td><td align="center" valign="middle" rowspan="1" colspan="1">19 &#x000b1; 2<break/>21 &#x000b1; 2</td><td align="center" valign="middle" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">no changes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B227-nutrients-13-00462" ref-type="bibr">227</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Others</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yogurt with bioactive<break/>ingredients from olive-oil by-products</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic> = 92</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35&#x02013;65</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B162-nutrients-13-00462" ref-type="bibr">162</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>* Results from the same study (ANCHOR study). &#x02193;: reduction; &#x02191;: increase; EPA: Eicosapentaenoic acid; DHA: Docosahexaenoic acid; CRP: C-reactive protein; ALA: alpha-linolenic acid; AT:acetyltransferase, CPT: cholinephosphotransferase.</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-13-00462-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00462-t002_Table 2</object-id><label>Table 2</label><caption><p>Clinical trials regarding COVID-19 and foods or nutrients with anti-PAF actions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nutrient-Food</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Quantity </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Volunteers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Outcomes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Registration at <uri xlink:href="www.clinicaltrials.gov">www.clinicaltrials.gov</uri></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C</td><td align="center" valign="middle" rowspan="1" colspan="1">10 g</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">400 </td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04584437</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C</td><td align="center" valign="middle" rowspan="1" colspan="1">10 g intravenously</td><td align="center" valign="middle" rowspan="1" colspan="1">72 hours</td><td align="center" valign="middle" rowspan="1" colspan="1">500</td><td align="center" valign="middle" rowspan="1" colspan="1">In-hospital mortality, length of stay, virus load</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04323514</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C and melatonin</td><td align="center" valign="middle" rowspan="1" colspan="1">1 g vitamin C<break/>10 mg melatonin</td><td align="center" valign="middle" rowspan="1" colspan="1">14 days</td><td align="center" valign="middle" rowspan="1" colspan="1">150</td><td align="center" valign="middle" rowspan="1" colspan="1">Symptom severity</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04530539</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C and zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">8 g vitamin C or<break/>50 mg zinc or<break/>8 g vitamin C + 50 mg zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">28 days</td><td align="center" valign="middle" rowspan="1" colspan="1">520</td><td align="center" valign="middle" rowspan="1" colspan="1">Symptom duration</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04342728</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C, vitamin D, zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">Not reported</td><td align="center" valign="middle" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">600</td><td align="center" valign="middle" rowspan="1" colspan="1">Rate of recover, symptoms,</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04334512</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C, vitamin D, zinc, B12</td><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C 28 g intravenously<break/>zinc Citrate 30 mg <break/>Vitamin D3 5000 IU daily <break/>Vitamin B12 500 ug </td><td align="center" valign="middle" rowspan="1" colspan="1">7&#x02013;14 days</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">Symptoms, length of stay</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04395768</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C, vitamin D, zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">Not reported</td><td align="center" valign="middle" rowspan="1" colspan="1">14 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">600 medical workers</td><td align="center" valign="middle" rowspan="1" colspan="1">Prevention of COVID-19 symptoms </td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04335084</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">9600 IU/day on days 1 and 2, and 3200 IU/day on days 3 through 28</td><td align="center" valign="middle" rowspan="1" colspan="1">28 days</td><td align="center" valign="middle" rowspan="1" colspan="1">2700 participants with newly diagnosed COVID-19</td><td align="center" valign="middle" rowspan="1" colspan="1">Hospitalization or death in index cases,<break/>self-reported disease severity in index cases <break/>time to hospitalization or death in index cases, ICU admission/ventilation support in index cases, <break/>SARS-CoV-2 infection in close household contacts, <break/>self-reported disease severity in close household contacts</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04536298</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">50,000 IU/week</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytokine levels </td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04476745</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">200,000 IU on admission</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">240</td><td align="center" valign="middle" rowspan="1" colspan="1">Length of hospitalization, Number of cases admitted to Intensive Care Unit, Length of use of mechanic ventilator<break/>inflammatory markers, vitamin D, </td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04449718</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">10,000 IU bolus dose followed by 10,000 IU once a week </td><td align="center" valign="middle" rowspan="1" colspan="1">16 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">2414 health care workers</td><td align="center" valign="middle" rowspan="1" colspan="1">Distribution of disease severity, disease severity</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04483635</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">800 IU<break/>3200 IU</td><td align="center" valign="middle" rowspan="1" colspan="1">6 m</td><td align="center" valign="middle" rowspan="1" colspan="1">6200 individuals with 25-hydroxyvitamin D level &#x0003c;75 nmol/L</td><td align="center" valign="middle" rowspan="1" colspan="1">Acute respiratory infection, COVID-19 diagnosis</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04579640</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">10,000 IU/day (age 18&#x02013;69 years) or 15,000 IU/day (age 70+)<break/><break/>2 w: if vitamin D &#x0003c;30 ng/mL, continue the dosage for 3 more weeks. If vitamin D: 30&#x02013;49 ng/mL, continue at a dosage of 5000 IU/day. <break/>If vitamin D &#x0003e;50 ng/mL, stop supplementation.</td><td align="center" valign="middle" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">41</td><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D, severity of COVID-19 symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04407286</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">6000 IU<break/>6000 IU + 20,000 IU vitamin D3 daily for 3 days</td><td align="center" valign="middle" rowspan="1" colspan="1">12 m</td><td align="center" valign="middle" rowspan="1" colspan="1">140</td><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D, Change in SARS-CoV-2 antibody titers, inflammatory markers</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04482673</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" rowspan="1" colspan="1">5000 IU)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 m</td><td align="center" valign="middle" rowspan="1" colspan="1">2099 hospital workers</td><td align="center" valign="middle" rowspan="1" colspan="1">Respiratory tract infections</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04596657</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">vitamin D<break/>and zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">2000 IU<break/>30 mg</td><td align="center" valign="middle" rowspan="1" colspan="1">2 m</td><td align="center" valign="middle" rowspan="1" colspan="1">3140</td><td align="center" valign="middle" rowspan="1" colspan="1">Survival rate </td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04351490</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">vitamin D<break/>and zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">180,000 international units (IU)<break/>40 mg of zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">700</td><td align="center" valign="middle" rowspan="1" colspan="1">Time to recover, all-cause mortality, symptoms, levels of vitamins</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04641195</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Omega-3</td><td align="center" valign="middle" rowspan="1" colspan="1">300 mg of omega3-FA</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">100 </td><td align="center" valign="middle" rowspan="1" colspan="1">Serum ACE levels, serum ACE2 levels, lipid profile</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04658433</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fish oil</td><td align="center" valign="middle" rowspan="1" colspan="1">wild salmon and fish oil complex 1 g, 300 mg omega-3</td><td align="center" valign="middle" rowspan="1" colspan="1">8 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytokine levels, lipid profile, glucose levels</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04483271</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fish oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Cod liver oil: 5 mL<break/>(Contains: 10 ug of vitamin D, 1.2 g of long-chained n-3 polyunsaturated fatty acids (DHA 0.6 g and EPA 0.4 g), 250 ug vitamin A and 10 mg vitamin E).</td><td align="center" valign="middle" rowspan="1" colspan="1">6 m</td><td align="center" valign="middle" rowspan="1" colspan="1">80,000</td><td align="center" valign="middle" rowspan="1" colspan="1">Number of participants diagnosed with serious Covid-19, self-reported airway infection, hospitalization, infections</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04609423</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Zinc, Quercetin, Bromelain and Vitamin C</td><td align="center" valign="middle" rowspan="1" colspan="1">zinc 50 mg<break/>vitamin C 1000 mg</td><td align="center" valign="middle" rowspan="1" colspan="1">5&#x02013;10 days</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">Time to hospital discharge<break/>serum zinc <break/>Time of negativization of COVID-PCR </td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04468139</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Zinc, vitamin C</td><td align="center" valign="middle" rowspan="1" colspan="1">Zinc 220 mg<break/>vitamin C 1 g</td><td align="center" valign="middle" rowspan="1" colspan="1">10 days</td><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">Symptoms reduction time frame, severity of symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04558424</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">high dose Zinc supplementation in combination with copper, vitamin C/E and beta-carotene vs. low dose zinc and multivitamin supplement</td><td align="center" valign="middle" rowspan="1" colspan="1">3 m</td><td align="center" valign="middle" rowspan="1" colspan="1">4500</td><td align="center" valign="middle" rowspan="1" colspan="1">Hospitalization, Illness without hospitalization, mortality</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04551339</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory/antioxidant supplement</td><td align="center" valign="middle" rowspan="1" colspan="1">vitamin A (as &#x003b2;-carotene) 500 ug, Vitamin C 250 mg, vitamin E 90 mg, Selenium 15 ug,<break/>Zinc 7.5 mg.</td><td align="center" valign="middle" rowspan="1" colspan="1">14 days</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">Nutritional risk, inflammatory indices, ferritin, anthropometry etc.</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04323228</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td><td align="center" valign="middle" rowspan="1" colspan="1">500 mg </td><td align="center" valign="middle" rowspan="1" colspan="1">30 days</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">Survival time, Length of stay in hospital, days of mechanical ventilation, blood exams etc.</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04578158</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Licorice</td><td align="center" valign="middle" rowspan="1" colspan="1">250 mg standardized extract (25% Glycyrrhizin - 62.5 mg) </td><td align="center" valign="middle" rowspan="1" colspan="1">10 days</td><td align="center" valign="middle" rowspan="1" colspan="1">70</td><td align="center" valign="middle" rowspan="1" colspan="1">Number of people recovering from COVID-19, mechanical support, hospital stay</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04487964</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Plant polyphenol</td><td align="center" valign="middle" rowspan="1" colspan="1">Plant polyphenol<break/>+Vitamin D3 100,000 IU on day 1</td><td align="center" valign="middle" rowspan="1" colspan="1">15 days</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">Hospitalization rates for COVID-19</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04400890</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Herbal extract (Cretan IAMA)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mL/day<break/>Thymbra 59 capitata (L.) Cav., Origanum dictamnus L., Salvia fruticosa Mill. in extra virgin olive oil</td><td align="center" valign="middle" rowspan="1" colspan="1">2 weeks</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">Symptom resolution</td><td align="center" valign="middle" rowspan="1" colspan="1">NCT04705753</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Honey</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 gm/kg/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rate of recovery, resolution of lung inflammation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04323345</td></tr></tbody></table><table-wrap-foot><fn><p>ACE: Angiotensin converting enzyme.</p></fn></table-wrap-foot></table-wrap></floats-group></article>